# num of genes	num of total genes	Log of odds ratio	P-value	Adjusted p-value	GO term ID	GO term name	GO type
5	5	4.78335187967	-	6.19e-08	GO:0055012	ventricular cardiac muscle cell differentiation	BP
5	5	4.78335187967	-	6.19e-08	GO:0010606	positive regulation of cytoplasmic mRNA processing body assembly	BP
4	4	4.78335187967	-	1.72e-06	GO:0060534	trachea cartilage development	BP
3	3	4.78335187967	-	4.76e-05	GO:0060745	mammary gland branching involved in pregnancy	BP
3	3	4.78335187967	-	4.76e-05	GO:0072539	T-helper 17 cell differentiation	BP
3	3	4.78335187967	-	4.76e-05	GO:0010871	negative regulation of receptor biosynthetic process	BP
3	3	4.78335187967	-	4.76e-05	GO:0018076	N-terminal peptidyl-lysine acetylation	BP
3	3	4.78335187967	-	4.76e-05	GO:0002068	glandular epithelial cell development	BP
2	2	4.78335187967	-	1.32e-03	GO:2001055	positive regulation of mesenchymal cell apoptotic process	BP
2	2	4.78335187967	-	1.32e-03	GO:0008050	female courtship behavior	BP
2	2	4.78335187967	-	1.32e-03	GO:0072182	regulation of nephron tubule epithelial cell differentiation	BP
2	2	4.78335187967	-	1.32e-03	GO:0055092	sterol homeostasis	BP
2	2	4.78335187967	-	1.32e-03	GO:0036315	cellular response to sterol	BP
2	2	4.78335187967	-	1.32e-03	GO:2000327	positive regulation of ligand-dependent nuclear receptor transcription coactivator activity	BP
2	2	4.78335187967	-	1.32e-03	GO:0061145	lung smooth muscle development	BP
2	2	4.78335187967	-	1.32e-03	GO:1901558	response to metformin	BP
2	2	4.78335187967	-	1.32e-03	GO:0061614	pri-miRNA transcription from RNA polymerase II promoter	BP
2	2	4.78335187967	-	1.32e-03	GO:0090427	activation of meiosis	BP
2	2	4.78335187967	-	1.32e-03	GO:0035947	regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter	BP
2	2	4.78335187967	-	1.32e-03	GO:1904017	cellular response to Thyroglobulin triiodothyronine	BP
2	2	4.78335187967	-	1.32e-03	GO:2000017	positive regulation of determination of dorsal identity	BP
2	2	4.78335187967	-	1.32e-03	GO:0060577	pulmonary vein morphogenesis	BP
2	2	4.78335187967	-	1.32e-03	GO:0002268	follicular dendritic cell differentiation	BP
2	2	4.78335187967	-	1.32e-03	GO:0038183	bile acid signaling pathway	BP
2	2	4.78335187967	-	1.32e-03	GO:0060532	bronchus cartilage development	BP
2	2	4.78335187967	-	1.32e-03	GO:1990791	dorsal root ganglion development	BP
2	2	4.78335187967	-	1.32e-03	GO:0060849	regulation of transcription involved in lymphatic endothelial cell fate commitment	BP
2	2	4.78335187967	-	1.32e-03	GO:0086098	angiotensin-activated signaling pathway involved in heart process	BP
1	1	4.78335187967	-	3.63e-02	GO:0090340	positive regulation of secretion of lysosomal enzymes	BP
1	1	4.78335187967	-	3.63e-02	GO:0006591	ornithine metabolic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0090341	negative regulation of secretion of lysosomal enzymes	BP
1	1	4.78335187967	-	3.63e-02	GO:2000108	positive regulation of leukocyte apoptotic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0061085	regulation of histone H3-K27 methylation	BP
1	1	4.78335187967	-	3.63e-02	GO:1903988	ferrous iron export across plasma membrane	BP
1	1	4.78335187967	-	3.63e-02	GO:0071351	cellular response to interleukin-18	BP
1	1	4.78335187967	-	3.63e-02	GO:1904899	positive regulation of hepatic stellate cell proliferation	BP
1	1	4.78335187967	-	3.63e-02	GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	1	4.78335187967	-	3.63e-02	GO:0051238	sequestering of metal ion	BP
1	1	4.78335187967	-	3.63e-02	GO:0046824	positive regulation of nucleocytoplasmic transport	BP
1	1	4.78335187967	-	3.63e-02	GO:0019676	ammonia assimilation cycle	BP
1	1	4.78335187967	-	3.63e-02	GO:0061326	renal tubule development	BP
1	1	4.78335187967	-	3.63e-02	GO:0061324	canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation	BP
1	1	4.78335187967	-	3.63e-02	GO:0072615	interleukin-17 secretion	BP
1	1	4.78335187967	-	3.63e-02	GO:0051729	germline cell cycle switching, mitotic to meiotic cell cycle	BP
1	1	4.78335187967	-	3.63e-02	GO:0010522	regulation of calcium ion transport into cytosol	BP
1	1	4.78335187967	-	3.63e-02	GO:0003171	atrioventricular valve development	BP
1	1	4.78335187967	-	3.63e-02	GO:0003175	tricuspid valve development	BP
1	1	4.78335187967	-	3.63e-02	GO:0038097	positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway	BP
1	1	4.78335187967	-	3.63e-02	GO:1901994	negative regulation of meiotic cell cycle phase transition	BP
1	1	4.78335187967	-	3.63e-02	GO:0060345	spleen trabecula formation	BP
1	1	4.78335187967	-	3.63e-02	GO:1903788	positive regulation of glutathione biosynthetic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0032776	DNA methylation on cytosine	BP
1	1	4.78335187967	-	3.63e-02	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	1	4.78335187967	-	3.63e-02	GO:0003138	primary heart field specification	BP
1	1	4.78335187967	-	3.63e-02	GO:1904998	negative regulation of leukocyte adhesion to arterial endothelial cell	BP
1	1	4.78335187967	-	3.63e-02	GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process	BP
1	1	4.78335187967	-	3.63e-02	GO:1900239	regulation of phenotypic switching	BP
1	1	4.78335187967	-	3.63e-02	GO:1902396	protein localization to bicellular tight junction	BP
1	1	4.78335187967	-	3.63e-02	GO:0071387	cellular response to cortisol stimulus	BP
1	1	4.78335187967	-	3.63e-02	GO:0060552	positive regulation of fructose 1,6-bisphosphate metabolic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0060550	positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity	BP
1	1	4.78335187967	-	3.63e-02	GO:0060558	regulation of calcidiol 1-monooxygenase activity	BP
1	1	4.78335187967	-	3.63e-02	GO:1904828	positive regulation of hydrogen sulfide biosynthetic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0000117	regulation of transcription involved in G2/M transition of mitotic cell cycle	BP
1	1	4.78335187967	-	3.63e-02	GO:1904793	regulation of euchromatin binding	BP
1	1	4.78335187967	-	3.63e-02	GO:0060517	epithelial cell proliferation involved in prostatic bud elongation	BP
1	1	4.78335187967	-	3.63e-02	GO:0010768	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	1	4.78335187967	-	3.63e-02	GO:2000173	negative regulation of branching morphogenesis of a nerve	BP
1	1	4.78335187967	-	3.63e-02	GO:0051866	general adaptation syndrome	BP
1	1	4.78335187967	-	3.63e-02	GO:2000612	regulation of thyroid-stimulating hormone secretion	BP
1	1	4.78335187967	-	3.63e-02	GO:0021572	rhombomere 6 development	BP
1	1	4.78335187967	-	3.63e-02	GO:0033233	regulation of protein sumoylation	BP
1	1	4.78335187967	-	3.63e-02	GO:0048561	establishment of animal organ orientation	BP
1	1	4.78335187967	-	3.63e-02	GO:0006117	acetaldehyde metabolic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0035622	intrahepatic bile duct development	BP
1	1	4.78335187967	-	3.63e-02	GO:1990442	intrinsic apoptotic signaling pathway in response to nitrosative stress	BP
1	1	4.78335187967	-	3.63e-02	GO:0035624	receptor transactivation	BP
1	1	4.78335187967	-	3.63e-02	GO:1900085	negative regulation of peptidyl-tyrosine autophosphorylation	BP
1	1	4.78335187967	-	3.63e-02	GO:2000794	regulation of epithelial cell proliferation involved in lung morphogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:0043954	cellular component maintenance	BP
1	1	4.78335187967	-	3.63e-02	GO:0019089	transmission of virus	BP
1	1	4.78335187967	-	3.63e-02	GO:0043402	glucocorticoid mediated signaling pathway	BP
1	1	4.78335187967	-	3.63e-02	GO:0061144	alveolar secondary septum development	BP
1	1	4.78335187967	-	3.63e-02	GO:0000433	negative regulation of transcription from RNA polymerase II promoter by glucose	BP
1	1	4.78335187967	-	3.63e-02	GO:0000435	positive regulation of transcription from RNA polymerase II promoter by galactose	BP
1	1	4.78335187967	-	3.63e-02	GO:0060784	regulation of cell proliferation involved in tissue homeostasis	BP
1	1	4.78335187967	-	3.63e-02	GO:2001250	positive regulation of ammonia assimilation cycle	BP
1	1	4.78335187967	-	3.63e-02	GO:0072308	negative regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0090049	regulation of cell migration involved in sprouting angiogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:0001080	nitrogen catabolite activation of transcription from RNA polymerase II promoter	BP
1	1	4.78335187967	-	3.63e-02	GO:1903755	positive regulation of SUMO transferase activity	BP
1	1	4.78335187967	-	3.63e-02	GO:0046725	negative regulation by virus of viral protein levels in host cell	BP
1	1	4.78335187967	-	3.63e-02	GO:0072303	positive regulation of glomerular metanephric mesangial cell proliferation	BP
1	1	4.78335187967	-	3.63e-02	GO:0035042	fertilization, exchange of chromosomal proteins	BP
1	1	4.78335187967	-	3.63e-02	GO:0072110	glomerular mesangial cell proliferation	BP
1	1	4.78335187967	-	3.63e-02	GO:2000213	positive regulation of glutamate metabolic process	BP
1	1	4.78335187967	-	3.63e-02	GO:1904353	regulation of telomere capping	BP
1	1	4.78335187967	-	3.63e-02	GO:0001543	ovarian follicle rupture	BP
1	1	4.78335187967	-	3.63e-02	GO:1903815	negative regulation of collecting lymphatic vessel constriction	BP
1	1	4.78335187967	-	3.63e-02	GO:0061550	cranial ganglion development	BP
1	1	4.78335187967	-	3.63e-02	GO:0009956	radial pattern formation	BP
1	1	4.78335187967	-	3.63e-02	GO:0060980	cell migration involved in coronary vasculogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:2001286	regulation of caveolin-mediated endocytosis	BP
1	1	4.78335187967	-	3.63e-02	GO:1905695	positive regulation of phosphatidic acid biosynthetic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0034255	regulation of urea metabolic process	BP
1	1	4.78335187967	-	3.63e-02	GO:1905208	negative regulation of cardiocyte differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0098749	cerebellar neuron development	BP
1	1	4.78335187967	-	3.63e-02	GO:0098746	fast, calcium ion-dependent exocytosis of neurotransmitter	BP
1	1	4.78335187967	-	3.63e-02	GO:1904501	positive regulation of chromatin-mediated maintenance of transcription	BP
1	1	4.78335187967	-	3.63e-02	GO:0030421	defecation	BP
1	1	4.78335187967	-	3.63e-02	GO:1903305	regulation of regulated secretory pathway	BP
1	1	4.78335187967	-	3.63e-02	GO:2001178	positive regulation of mediator complex assembly	BP
1	1	4.78335187967	-	3.63e-02	GO:0043380	regulation of memory T cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0090425	acinar cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0060123	regulation of growth hormone secretion	BP
1	1	4.78335187967	-	3.63e-02	GO:0060127	prolactin secreting cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0043969	histone H2B acetylation	BP
1	1	4.78335187967	-	3.63e-02	GO:0003226	right ventricular compact myocardium morphogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:0002572	pro-T cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0021877	forebrain neuron fate commitment	BP
1	1	4.78335187967	-	3.63e-02	GO:0021872	forebrain generation of neurons	BP
1	1	4.78335187967	-	3.63e-02	GO:0002683	negative regulation of immune system process	BP
1	1	4.78335187967	-	3.63e-02	GO:0100057	regulation of phenotypic switching by transcription from RNA polymerase II promoter	BP
1	1	4.78335187967	-	3.63e-02	GO:1902038	positive regulation of hematopoietic stem cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0042659	regulation of cell fate specification	BP
1	1	4.78335187967	-	3.63e-02	GO:0001840	neural plate development	BP
1	1	4.78335187967	-	3.63e-02	GO:0046016	positive regulation of transcription by glucose	BP
1	1	4.78335187967	-	3.63e-02	GO:0061114	branching involved in pancreas morphogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:1903766	positive regulation of potassium ion export across plasma membrane	BP
1	1	4.78335187967	-	3.63e-02	GO:2000979	positive regulation of forebrain neuron differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:2000971	negative regulation of detection of glucose	BP
1	1	4.78335187967	-	3.63e-02	GO:1905337	positive regulation of aggrephagy	BP
1	1	4.78335187967	-	3.63e-02	GO:0001544	initiation of primordial ovarian follicle growth	BP
1	1	4.78335187967	-	3.63e-02	GO:2000703	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation	BP
1	1	4.78335187967	-	3.63e-02	GO:0031279	regulation of cyclase activity	BP
1	1	4.78335187967	-	3.63e-02	GO:0003185	sinoatrial valve morphogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:0048621	post-embryonic digestive tract morphogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:1905643	positive regulation of DNA methylation	BP
1	1	4.78335187967	-	3.63e-02	GO:1905642	negative regulation of DNA methylation	BP
1	1	4.78335187967	-	3.63e-02	GO:0001806	type IV hypersensitivity	BP
1	1	4.78335187967	-	3.63e-02	GO:0060479	lung cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0040034	regulation of development, heterochronic	BP
1	1	4.78335187967	-	3.63e-02	GO:1901978	positive regulation of cell cycle checkpoint	BP
1	1	4.78335187967	-	3.63e-02	GO:2000016	negative regulation of determination of dorsal identity	BP
1	1	4.78335187967	-	3.63e-02	GO:0051541	elastin metabolic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0019102	male somatic sex determination	BP
1	1	4.78335187967	-	3.63e-02	GO:1900117	regulation of execution phase of apoptosis	BP
1	1	4.78335187967	-	3.63e-02	GO:0002194	hepatocyte cell migration	BP
1	1	4.78335187967	-	3.63e-02	GO:0060578	superior vena cava morphogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:1904800	negative regulation of neuron remodeling	BP
1	1	4.78335187967	-	3.63e-02	GO:1904639	cellular response to resveratrol	BP
1	1	4.78335187967	-	3.63e-02	GO:1904635	positive regulation of glomerular visceral epithelial cell apoptotic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0036306	embryonic heart tube elongation	BP
1	1	4.78335187967	-	3.63e-02	GO:0003433	chondrocyte development involved in endochondral bone morphogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:0045624	positive regulation of T-helper cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0038185	intracellular bile acid receptor signaling pathway	BP
1	1	4.78335187967	-	3.63e-02	GO:0035112	genitalia morphogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:0098759	cellular response to interleukin-8	BP
1	1	4.78335187967	-	3.63e-02	GO:0090108	positive regulation of high-density lipoprotein particle assembly	BP
1	1	4.78335187967	-	3.63e-02	GO:0044111	development involved in symbiotic interaction	BP
1	1	4.78335187967	-	3.63e-02	GO:0061395	positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	4.78335187967	-	3.63e-02	GO:0061394	regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	4.78335187967	-	3.63e-02	GO:0007403	glial cell fate determination	BP
1	1	4.78335187967	-	3.63e-02	GO:0030844	positive regulation of intermediate filament depolymerization	BP
1	1	4.78335187967	-	3.63e-02	GO:0000414	regulation of histone H3-K36 methylation	BP
1	1	4.78335187967	-	3.63e-02	GO:0072599	establishment of protein localization to endoplasmic reticulum	BP
1	1	4.78335187967	-	3.63e-02	GO:0050865	regulation of cell activation	BP
1	1	4.78335187967	-	3.63e-02	GO:0002154	thyroid hormone mediated signaling pathway	BP
1	1	4.78335187967	-	3.63e-02	GO:0061445	endocardial cushion cell fate commitment	BP
1	1	4.78335187967	-	3.63e-02	GO:1903489	positive regulation of lactation	BP
1	1	4.78335187967	-	3.63e-02	GO:0052547	regulation of peptidase activity	BP
1	1	4.78335187967	-	3.63e-02	GO:2000734	negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation	BP
1	1	4.78335187967	-	3.63e-02	GO:1901863	positive regulation of muscle tissue development	BP
1	1	4.78335187967	-	3.63e-02	GO:0072362	regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	4.78335187967	-	3.63e-02	GO:0072363	regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	4.78335187967	-	3.63e-02	GO:0072366	regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	4.78335187967	-	3.63e-02	GO:0072365	regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	4.78335187967	-	3.63e-02	GO:0071873	response to norepinephrine	BP
1	1	4.78335187967	-	3.63e-02	GO:0071250	cellular response to nitrite	BP
1	1	4.78335187967	-	3.63e-02	GO:0046521	sphingoid catabolic process	BP
1	1	4.78335187967	-	3.63e-02	GO:1901534	positive regulation of hematopoietic progenitor cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0043049	otic placode formation	BP
1	1	4.78335187967	-	3.63e-02	GO:0048370	lateral mesoderm formation	BP
1	1	4.78335187967	-	3.63e-02	GO:0045713	low-density lipoprotein particle receptor biosynthetic process	BP
1	1	4.78335187967	-	3.63e-02	GO:1902870	negative regulation of amacrine cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:1902691	respiratory basal cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0061046	regulation of branching involved in lung morphogenesis	BP
1	1	4.78335187967	-	3.63e-02	GO:0007538	primary sex determination	BP
1	1	4.78335187967	-	3.63e-02	GO:2000683	regulation of cellular response to X-ray	BP
1	1	4.78335187967	-	3.63e-02	GO:0070377	negative regulation of ERK5 cascade	BP
1	1	4.78335187967	-	3.63e-02	GO:0035898	parathyroid hormone secretion	BP
1	1	4.78335187967	-	3.63e-02	GO:0060010	Sertoli cell fate commitment	BP
1	1	4.78335187967	-	3.63e-02	GO:2000184	positive regulation of progesterone biosynthetic process	BP
1	1	4.78335187967	-	3.63e-02	GO:2000230	negative regulation of pancreatic stellate cell proliferation	BP
1	1	4.78335187967	-	3.63e-02	GO:1900100	positive regulation of plasma cell differentiation	BP
1	1	4.78335187967	-	3.63e-02	GO:0060694	regulation of cholesterol transporter activity	BP
1	1	4.78335187967	-	3.63e-02	GO:0060691	epithelial cell maturation involved in salivary gland development	BP
1	1	4.78335187967	-	3.63e-02	GO:1901860	positive regulation of mitochondrial DNA metabolic process	BP
1	1	4.78335187967	-	3.63e-02	GO:0021763	subthalamic nucleus development	BP
1	1	4.78335187967	-	3.63e-02	GO:0042501	serine phosphorylation of STAT protein	BP
1	1	4.78335187967	-	3.63e-02	GO:0033567	DNA replication, Okazaki fragment processing	BP
1	1	4.78335187967	-	3.63e-02	GO:0031128	developmental induction	BP
1	1	4.78335187967	-	3.63e-02	GO:0009444	pyruvate oxidation	BP
1	1	4.78335187967	-	3.63e-02	GO:2000607	negative regulation of cell proliferation involved in mesonephros development	BP
1	1	4.78335187967	-	3.63e-02	GO:0060520	activation of prostate induction by androgen receptor signaling pathway	BP
7	7	4.78335187967	-	7.99e-11	GO:0004887	thyroid hormone receptor activity	MF
5	5	4.78335187967	-	6.19e-08	GO:0003708	retinoic acid receptor activity	MF
3	3	4.78335187967	-	4.76e-05	GO:0004886	9-cis retinoic acid receptor activity	MF
2	2	4.78335187967	-	1.32e-03	GO:0098531	transcription factor activity, direct ligand regulated sequence-specific DNA binding	MF
2	2	4.78335187967	-	1.32e-03	GO:0050682	AF-2 domain binding	MF
2	2	4.78335187967	-	1.32e-03	GO:0038052	RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding	MF
2	2	4.78335187967	-	1.32e-03	GO:0032810	sterol response element binding	MF
2	2	4.78335187967	-	1.32e-03	GO:0034212	peptide N-acetyltransferase activity	MF
2	2	4.78335187967	-	1.32e-03	GO:0004874	aryl hydrocarbon receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0043924	suramin binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0004955	prostaglandin receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0038051	glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0061733	peptide-lysine-N-acetyltransferase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0001010	transcription factor activity, sequence-specific DNA binding transcription factor recruiting	MF
1	1	4.78335187967	-	3.63e-02	GO:0043997	histone acetyltransferase activity (H4-K12 specific)	MF
1	1	4.78335187967	-	3.63e-02	GO:0008434	calcitriol receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0008116	prostaglandin-I synthase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0061629	RNA polymerase II sequence-specific DNA binding transcription factor binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0036468	L-dopa decarboxylase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0070539	linoleic acid binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0001128	RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly	MF
1	1	4.78335187967	-	3.63e-02	GO:0031531	thyrotropin-releasing hormone receptor binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0044377	RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending	MF
1	1	4.78335187967	-	3.63e-02	GO:0030549	acetylcholine receptor activator activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0097655	serpin family protein binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0071855	neuropeptide receptor binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0000250	lanosterol synthase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0004058	aromatic-L-amino-acid decarboxylase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:1902122	chenodeoxycholic acid binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0030273	melanin-concentrating hormone receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:1990188	euchromatin binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0061656	SUMO conjugating enzyme activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0001133	RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0004876	complement component C3a receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0004728	signal transducer, downstream of receptor, with protein tyrosine phosphatase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0070320	inward rectifier potassium channel inhibitor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0001226	RNA polymerase II transcription corepressor binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0004883	glucocorticoid receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0001034	RNA polymerase III transcription factor activity, sequence-specific DNA binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0001595	angiotensin receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0051427	hormone receptor binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0034593	phosphatidylinositol bisphosphate phosphatase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0070974	POU domain binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0015126	canalicular bile acid transmembrane transporter activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0044213	intronic transcription regulatory region DNA binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0038186	lithocholic acid receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0008829	dCTP deaminase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0005133	interferon-gamma receptor binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0008554	sodium-exporting ATPase activity, phosphorylative mechanism	MF
1	1	4.78335187967	-	3.63e-02	GO:0002153	steroid receptor RNA activator RNA binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0036403	arachidonate 8(S)-lipoxygenase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0004925	prolactin receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0010855	adenylate cyclase inhibitor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0003908	methylated-DNA-[protein]-cysteine S-methyltransferase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0032448	DNA hairpin binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0035258	steroid hormone receptor binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0050692	DBD domain binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0017168	5-oxoprolinase (ATP-hydrolyzing) activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0001642	group III metabotropic glutamate receptor activity	MF
1	1	4.78335187967	-	3.63e-02	GO:0050104	L-gulonate 3-dehydrogenase activity	MF
1	1	4.78335187967	-	3.63e-02	GO:1902121	lithocholic acid binding	MF
1	1	4.78335187967	-	3.63e-02	GO:0097689	iron channel activity	MF
1	1	4.78335187967	-	3.63e-02	GO:1902098	calcitriol binding	MF
14	15	4.68381620612	-	9.31e-12	GO:0046965	retinoid X receptor binding	MF
31	35	4.60826517312	-	6.67e-12	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	MF
5	6	4.52031747384	-	3.60e-07	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	BP
32	39	4.49794966081	-	3.79e-11	GO:0030522	intracellular receptor signaling pathway	BP
43	53	4.48169617981	-	1.03e-10	GO:0003707	steroid hormone receptor activity	MF
4	5	4.46142378479	-	8.35e-06	GO:0060850	regulation of transcription involved in cell fate commitment	BP
3	4	4.3683143804	-	4.76e-05	GO:0048550	negative regulation of pinocytosis	BP
3	4	4.3683143804	-	1.85e-04	GO:0035948	positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter	BP
3	4	4.3683143804	-	1.85e-04	GO:0045064	T-helper 2 cell differentiation	BP
3	4	4.3683143804	-	1.85e-04	GO:0060336	negative regulation of interferon-gamma-mediated signaling pathway	BP
3	4	4.3683143804	-	1.85e-04	GO:0046886	positive regulation of hormone biosynthetic process	BP
3	4	4.3683143804	-	4.76e-05	GO:0044323	retinoic acid-responsive element binding	MF
3	4	4.3683143804	-	1.85e-04	GO:0030375	thyroid hormone receptor coactivator activity	MF
3	4	4.3683143804	-	1.85e-04	GO:0034056	estrogen response element binding	MF
3	4	4.3683143804	-	1.85e-04	GO:0050693	LBD domain binding	MF
40	54	4.3503924724	-	1.13e-11	GO:0043401	steroid hormone mediated signaling pathway	BP
4	6	4.19838937895	-	8.35e-06	GO:0010887	negative regulation of cholesterol storage	BP
4	6	4.19838937895	-	2.43e-05	GO:0046321	positive regulation of fatty acid oxidation	BP
2	3	4.19838937895	-	1.32e-03	GO:0001547	antral ovarian follicle growth	BP
2	3	4.19838937895	-	1.32e-03	GO:0060769	positive regulation of epithelial cell proliferation involved in prostate gland development	BP
2	3	4.19838937895	-	3.85e-03	GO:0055005	ventricular cardiac myofibril assembly	BP
2	3	4.19838937895	-	3.85e-03	GO:0070562	regulation of vitamin D receptor signaling pathway	BP
2	3	4.19838937895	-	3.85e-03	GO:2001016	positive regulation of skeletal muscle cell differentiation	BP
2	3	4.19838937895	-	3.85e-03	GO:0098903	regulation of membrane repolarization during action potential	BP
2	3	4.19838937895	-	3.85e-03	GO:0033590	response to cobalamin	BP
2	3	4.19838937895	-	3.85e-03	GO:2000074	regulation of type B pancreatic cell development	BP
2	3	4.19838937895	-	3.85e-03	GO:0072574	hepatocyte proliferation	BP
2	3	4.19838937895	-	3.85e-03	GO:1904798	positive regulation of core promoter binding	BP
2	3	4.19838937895	-	3.85e-03	GO:0045604	regulation of epidermal cell differentiation	BP
2	3	4.19838937895	-	3.85e-03	GO:2000611	positive regulation of thyroid hormone generation	BP
2	3	4.19838937895	-	3.85e-03	GO:0045925	positive regulation of female receptivity	BP
2	3	4.19838937895	-	3.85e-03	GO:0000432	positive regulation of transcription from RNA polymerase II promoter by glucose	BP
2	3	4.19838937895	-	3.85e-03	GO:1904753	negative regulation of vascular associated smooth muscle cell migration	BP
2	3	4.19838937895	-	3.85e-03	GO:0019218	regulation of steroid metabolic process	BP
2	3	4.19838937895	-	3.85e-03	GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
2	3	4.19838937895	-	3.85e-03	GO:1903025	regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
2	3	4.19838937895	-	3.85e-03	GO:0061198	fungiform papilla formation	BP
2	3	4.19838937895	-	3.85e-03	GO:0035880	embryonic nail plate morphogenesis	BP
2	3	4.19838937895	-	3.85e-03	GO:0035886	vascular smooth muscle cell differentiation	BP
2	3	4.19838937895	-	3.85e-03	GO:2001141	regulation of RNA biosynthetic process	BP
2	3	4.19838937895	-	3.85e-03	GO:0071409	cellular response to cycloheximide	BP
2	3	4.19838937895	-	3.85e-03	GO:0021697	cerebellar cortex formation	BP
2	3	4.19838937895	-	3.85e-03	GO:1900222	negative regulation of beta-amyloid clearance	BP
2	3	4.19838937895	-	3.85e-03	GO:0061577	calcium ion transmembrane transport via high voltage-gated calcium channel	BP
8	12	4.19838937895	-	1.25e-09	GO:0042974	retinoic acid receptor binding	MF
4	6	4.19838937895	-	2.43e-05	GO:0001221	transcription cofactor binding	MF
2	3	4.19838937895	-	3.85e-03	GO:0001012	RNA polymerase II regulatory region DNA binding	MF
2	3	4.19838937895	-	3.85e-03	GO:0070644	vitamin D response element binding	MF
2	3	4.19838937895	-	3.85e-03	GO:0001161	intronic transcription regulatory region sequence-specific DNA binding	MF
2	3	4.19838937895	-	3.85e-03	GO:0004882	androgen receptor activity	MF
10	16	4.10527997456	-	3.21e-12	GO:0048384	retinoic acid receptor signaling pathway	BP
8	13	4.08291216153	-	1.25e-09	GO:0004535	poly(A)-specific ribonuclease activity	MF
3	5	4.04638628551	-	1.85e-04	GO:0071557	histone H3-K27 demethylation	BP
3	5	4.04638628551	-	1.85e-04	GO:0060509	Type I pneumocyte differentiation	BP
3	5	4.04638628551	-	1.85e-04	GO:0003406	retinal pigment epithelium development	BP
3	5	4.04638628551	-	4.51e-04	GO:0071599	otic vesicle development	BP
3	5	4.04638628551	-	4.51e-04	GO:0071376	cellular response to corticotropin-releasing hormone stimulus	BP
12	20	4.04638628551	-	1.62e-11	GO:0016922	ligand-dependent nuclear receptor binding	MF
3	5	4.04638628551	-	1.85e-04	GO:0071558	histone demethylase activity (H3-K27 specific)	MF
3	5	4.04638628551	-	4.51e-04	GO:0051525	NFAT protein binding	MF
4	7	3.97599695762	-	5.51e-05	GO:0071499	cellular response to laminar fluid shear stress	BP
5	9	3.93535497312	-	6.91e-06	GO:2000188	regulation of cholesterol homeostasis	BP
12	22	3.90888276176	-	6.38e-11	GO:0035257	nuclear hormone receptor binding	MF
6	11	3.90888276176	-	8.80e-07	GO:0035259	glucocorticoid receptor binding	MF
6	12	3.78335187967	-	1.71e-06	GO:2000273	positive regulation of receptor activity	BP
5	10	3.78335187967	-	1.34e-05	GO:0033148	positive regulation of intracellular estrogen receptor signaling pathway	BP
4	8	3.78335187967	-	5.51e-05	GO:0030850	prostate gland development	BP
4	8	3.78335187967	-	5.51e-05	GO:0035357	peroxisome proliferator activated receptor signaling pathway	BP
4	8	3.78335187967	-	1.07e-04	GO:0002467	germinal center formation	BP
4	8	3.78335187967	-	1.07e-04	GO:0042753	positive regulation of circadian rhythm	BP
4	8	3.78335187967	-	1.07e-04	GO:2000020	positive regulation of male gonad development	BP
3	6	3.78335187967	-	4.51e-04	GO:0061469	regulation of type B pancreatic cell proliferation	BP
3	6	3.78335187967	-	8.77e-04	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
3	6	3.78335187967	-	8.77e-04	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	BP
3	6	3.78335187967	-	8.77e-04	GO:0010742	macrophage derived foam cell differentiation	BP
3	6	3.78335187967	-	8.77e-04	GO:0051152	positive regulation of smooth muscle cell differentiation	BP
3	6	3.78335187967	-	8.77e-04	GO:0061312	BMP signaling pathway involved in heart development	BP
2	4	3.78335187967	-	1.32e-03	GO:0042481	regulation of odontogenesis	BP
2	4	3.78335187967	-	3.85e-03	GO:0070384	Harderian gland development	BP
2	4	3.78335187967	-	3.85e-03	GO:0060742	epithelial cell differentiation involved in prostate gland development	BP
2	4	3.78335187967	-	3.85e-03	GO:0070858	negative regulation of bile acid biosynthetic process	BP
2	4	3.78335187967	-	3.85e-03	GO:0007290	spermatid nucleus elongation	BP
2	4	3.78335187967	-	3.85e-03	GO:0060571	morphogenesis of an epithelial fold	BP
2	4	3.78335187967	-	3.85e-03	GO:0003257	positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	BP
2	4	3.78335187967	-	7.52e-03	GO:0030578	PML body organization	BP
2	4	3.78335187967	-	7.52e-03	GO:0046545	development of primary female sexual characteristics	BP
2	4	3.78335187967	-	7.52e-03	GO:0032369	negative regulation of lipid transport	BP
2	4	3.78335187967	-	7.52e-03	GO:0014044	Schwann cell development	BP
2	4	3.78335187967	-	7.52e-03	GO:0045415	negative regulation of interleukin-8 biosynthetic process	BP
2	4	3.78335187967	-	7.52e-03	GO:0033136	serine phosphorylation of STAT3 protein	BP
2	4	3.78335187967	-	7.52e-03	GO:0050847	progesterone receptor signaling pathway	BP
2	4	3.78335187967	-	7.52e-03	GO:0032376	positive regulation of cholesterol transport	BP
2	4	3.78335187967	-	7.52e-03	GO:0018393	internal peptidyl-lysine acetylation	BP
2	4	3.78335187967	-	7.52e-03	GO:0048679	regulation of axon regeneration	BP
2	4	3.78335187967	-	7.52e-03	GO:0048386	positive regulation of retinoic acid receptor signaling pathway	BP
2	4	3.78335187967	-	7.52e-03	GO:0002155	regulation of thyroid hormone mediated signaling pathway	BP
2	4	3.78335187967	-	7.52e-03	GO:0072289	metanephric nephron tubule formation	BP
2	4	3.78335187967	-	7.52e-03	GO:0060018	astrocyte fate commitment	BP
2	4	3.78335187967	-	7.52e-03	GO:2000189	positive regulation of cholesterol homeostasis	BP
2	4	3.78335187967	-	7.52e-03	GO:0060750	epithelial cell proliferation involved in mammary gland duct elongation	BP
2	4	3.78335187967	-	7.52e-03	GO:0006990	positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response	BP
2	4	3.78335187967	-	7.52e-03	GO:0060528	secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development	BP
1	2	3.78335187967	-	3.63e-02	GO:0072079	nephron tubule formation	BP
1	2	3.78335187967	-	3.63e-02	GO:0045720	negative regulation of integrin biosynthetic process	BP
1	2	3.78335187967	-	3.63e-02	GO:0033594	response to hydroxyisoflavone	BP
1	2	3.78335187967	-	3.63e-02	GO:1903860	negative regulation of dendrite extension	BP
1	2	3.78335187967	-	3.63e-02	GO:1901857	positive regulation of cellular respiration	BP
1	2	3.78335187967	-	3.63e-02	GO:0003415	chondrocyte hypertrophy	BP
1	2	3.78335187967	-	3.63e-02	GO:0007423	sensory organ development	BP
1	2	3.78335187967	-	3.63e-02	GO:0086029	Purkinje myocyte to ventricular cardiac muscle cell signaling	BP
1	2	3.78335187967	-	3.63e-02	GO:0048520	positive regulation of behavior	BP
1	2	3.78335187967	-	3.63e-02	GO:0072190	ureter urothelium development	BP
1	2	3.78335187967	-	3.63e-02	GO:0035574	histone H4-K20 demethylation	BP
1	2	3.78335187967	-	3.63e-02	GO:0060460	left lung morphogenesis	BP
1	2	3.78335187967	-	3.63e-02	GO:0045976	negative regulation of mitotic cell cycle, embryonic	BP
1	2	3.78335187967	-	3.63e-02	GO:1901979	regulation of inward rectifier potassium channel activity	BP
1	2	3.78335187967	-	3.63e-02	GO:0030641	regulation of cellular pH	BP
1	2	3.78335187967	-	3.63e-02	GO:1900111	positive regulation of histone H3-K9 dimethylation	BP
1	2	3.78335187967	-	3.63e-02	GO:0060738	epithelial-mesenchymal signaling involved in prostate gland development	BP
1	2	3.78335187967	-	3.63e-02	GO:0090187	positive regulation of pancreatic juice secretion	BP
1	2	3.78335187967	-	3.63e-02	GO:0071393	cellular response to progesterone stimulus	BP
1	2	3.78335187967	-	3.63e-02	GO:0072560	type B pancreatic cell maturation	BP
1	2	3.78335187967	-	3.63e-02	GO:2000143	negative regulation of DNA-templated transcription, initiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0045659	negative regulation of neutrophil differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0003207	cardiac chamber formation	BP
1	2	3.78335187967	-	7.13e-02	GO:1902257	negative regulation of apoptotic process involved in outflow tract morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:1902255	positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	2	3.78335187967	-	7.13e-02	GO:0090402	oncogene-induced cell senescence	BP
1	2	3.78335187967	-	7.13e-02	GO:0061325	cell proliferation involved in outflow tract morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0017055	negative regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
1	2	3.78335187967	-	7.13e-02	GO:0001776	leukocyte homeostasis	BP
1	2	3.78335187967	-	7.13e-02	GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	BP
1	2	3.78335187967	-	7.13e-02	GO:0021855	hypothalamus cell migration	BP
1	2	3.78335187967	-	7.13e-02	GO:0014740	negative regulation of muscle hyperplasia	BP
1	2	3.78335187967	-	7.13e-02	GO:2000724	positive regulation of cardiac vascular smooth muscle cell differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0098907	regulation of SA node cell action potential	BP
1	2	3.78335187967	-	7.13e-02	GO:0071417	cellular response to organonitrogen compound	BP
1	2	3.78335187967	-	7.13e-02	GO:0071929	alpha-tubulin acetylation	BP
1	2	3.78335187967	-	7.13e-02	GO:0021681	cerebellar granular layer development	BP
1	2	3.78335187967	-	7.13e-02	GO:0060599	lateral sprouting involved in mammary gland duct morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0043370	regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0014040	positive regulation of Schwann cell differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0060025	regulation of synaptic activity	BP
1	2	3.78335187967	-	7.13e-02	GO:0060557	positive regulation of vitamin D biosynthetic process	BP
1	2	3.78335187967	-	7.13e-02	GO:1901666	positive regulation of NAD+ ADP-ribosyltransferase activity	BP
1	2	3.78335187967	-	7.13e-02	GO:0060748	tertiary branching involved in mammary gland duct morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0035585	calcium-mediated signaling using extracellular calcium source	BP
1	2	3.78335187967	-	7.13e-02	GO:0034971	histone H3-R17 methylation	BP
1	2	3.78335187967	-	7.13e-02	GO:0021571	rhombomere 5 development	BP
1	2	3.78335187967	-	7.13e-02	GO:0071306	cellular response to vitamin E	BP
1	2	3.78335187967	-	7.13e-02	GO:0032915	positive regulation of transforming growth factor beta2 production	BP
1	2	3.78335187967	-	7.13e-02	GO:0003188	heart valve formation	BP
1	2	3.78335187967	-	7.13e-02	GO:0034395	regulation of transcription from RNA polymerase II promoter in response to iron	BP
1	2	3.78335187967	-	7.13e-02	GO:0045645	positive regulation of eosinophil differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0072054	renal outer medulla development	BP
1	2	3.78335187967	-	7.13e-02	GO:0071624	positive regulation of granulocyte chemotaxis	BP
1	2	3.78335187967	-	7.13e-02	GO:0035470	positive regulation of vascular wound healing	BP
1	2	3.78335187967	-	7.13e-02	GO:0045023	G0 to G1 transition	BP
1	2	3.78335187967	-	7.13e-02	GO:0010874	regulation of cholesterol efflux	BP
1	2	3.78335187967	-	7.13e-02	GO:0003220	left ventricular cardiac muscle tissue morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0000430	regulation of transcription from RNA polymerase II promoter by glucose	BP
1	2	3.78335187967	-	7.13e-02	GO:0045684	positive regulation of epidermis development	BP
1	2	3.78335187967	-	7.13e-02	GO:0030821	negative regulation of cAMP catabolic process	BP
1	2	3.78335187967	-	7.13e-02	GO:1900078	positive regulation of cellular response to insulin stimulus	BP
1	2	3.78335187967	-	7.13e-02	GO:1903038	negative regulation of leukocyte cell-cell adhesion	BP
1	2	3.78335187967	-	7.13e-02	GO:0044334	canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition	BP
1	2	3.78335187967	-	7.13e-02	GO:0051284	positive regulation of sequestering of calcium ion	BP
1	2	3.78335187967	-	7.13e-02	GO:0035408	histone H3-T6 phosphorylation	BP
1	2	3.78335187967	-	7.13e-02	GO:0070101	positive regulation of chemokine-mediated signaling pathway	BP
1	2	3.78335187967	-	7.13e-02	GO:0072197	ureter morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0044860	protein localization to plasma membrane raft	BP
1	2	3.78335187967	-	7.13e-02	GO:2000594	positive regulation of metanephric DCT cell differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0030997	regulation of centriole-centriole cohesion	BP
1	2	3.78335187967	-	7.13e-02	GO:0006542	glutamine biosynthetic process	BP
1	2	3.78335187967	-	7.13e-02	GO:0035026	leading edge cell differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:1903894	regulation of IRE1-mediated unfolded protein response	BP
1	2	3.78335187967	-	7.13e-02	GO:0048145	regulation of fibroblast proliferation	BP
1	2	3.78335187967	-	7.13e-02	GO:0072305	negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0003062	regulation of heart rate by chemical signal	BP
1	2	3.78335187967	-	7.13e-02	GO:0061188	negative regulation of chromatin silencing at rDNA	BP
1	2	3.78335187967	-	7.13e-02	GO:0033032	regulation of myeloid cell apoptotic process	BP
1	2	3.78335187967	-	7.13e-02	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0022037	metencephalon development	BP
1	2	3.78335187967	-	7.13e-02	GO:0071506	cellular response to mycophenolic acid	BP
1	2	3.78335187967	-	7.13e-02	GO:0001712	ectodermal cell fate commitment	BP
1	2	3.78335187967	-	7.13e-02	GO:2000291	regulation of myoblast proliferation	BP
1	2	3.78335187967	-	7.13e-02	GO:0052314	phytoalexin metabolic process	BP
1	2	3.78335187967	-	7.13e-02	GO:0003193	pulmonary valve formation	BP
1	2	3.78335187967	-	7.13e-02	GO:2001038	regulation of cellular response to drug	BP
1	2	3.78335187967	-	7.13e-02	GO:0046619	optic placode formation involved in camera-type eye formation	BP
1	2	3.78335187967	-	7.13e-02	GO:0090241	negative regulation of histone H4 acetylation	BP
1	2	3.78335187967	-	7.13e-02	GO:0072053	renal inner medulla development	BP
1	2	3.78335187967	-	7.13e-02	GO:0048513	animal organ development	BP
1	2	3.78335187967	-	7.13e-02	GO:0003156	regulation of animal organ formation	BP
1	2	3.78335187967	-	7.13e-02	GO:0044324	regulation of transcription involved in anterior/posterior axis specification	BP
1	2	3.78335187967	-	7.13e-02	GO:2000707	positive regulation of dense core granule biogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0035802	adrenal cortex formation	BP
1	2	3.78335187967	-	7.13e-02	GO:0060086	circadian temperature homeostasis	BP
1	2	3.78335187967	-	7.13e-02	GO:0021986	habenula development	BP
1	2	3.78335187967	-	7.13e-02	GO:0060297	regulation of sarcomere organization	BP
1	2	3.78335187967	-	7.13e-02	GO:0045872	positive regulation of rhodopsin gene expression	BP
1	2	3.78335187967	-	7.13e-02	GO:1900215	negative regulation of apoptotic process involved in metanephric collecting duct development	BP
1	2	3.78335187967	-	7.13e-02	GO:1900218	negative regulation of apoptotic process involved in metanephric nephron tubule development	BP
1	2	3.78335187967	-	7.13e-02	GO:0007521	muscle cell fate determination	BP
1	2	3.78335187967	-	7.13e-02	GO:0003057	regulation of the force of heart contraction by chemical signal	BP
1	2	3.78335187967	-	7.13e-02	GO:0035051	cardiocyte differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:2000191	regulation of fatty acid transport	BP
1	2	3.78335187967	-	7.13e-02	GO:0019100	male germ-line sex determination	BP
1	2	3.78335187967	-	7.13e-02	GO:0021599	abducens nerve formation	BP
1	2	3.78335187967	-	7.13e-02	GO:1902722	positive regulation of prolactin secretion	BP
1	2	3.78335187967	-	7.13e-02	GO:0090149	mitochondrial membrane fission	BP
1	2	3.78335187967	-	7.13e-02	GO:0044154	histone H3-K14 acetylation	BP
1	2	3.78335187967	-	7.13e-02	GO:0007070	negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle	BP
1	2	3.78335187967	-	7.13e-02	GO:0035922	foramen ovale closure	BP
1	2	3.78335187967	-	7.13e-02	GO:0072160	nephron tubule epithelial cell differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0003430	growth plate cartilage chondrocyte growth	BP
1	2	3.78335187967	-	7.13e-02	GO:0060251	regulation of glial cell proliferation	BP
1	2	3.78335187967	-	7.13e-02	GO:2000342	negative regulation of chemokine (C-X-C motif) ligand 2 production	BP
1	2	3.78335187967	-	7.13e-02	GO:0035397	helper T cell enhancement of adaptive immune response	BP
1	2	3.78335187967	-	7.13e-02	GO:0021514	ventral spinal cord interneuron differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0003218	cardiac left ventricle formation	BP
1	2	3.78335187967	-	7.13e-02	GO:2000309	positive regulation of tumor necrosis factor (ligand) superfamily member 11 production	BP
1	2	3.78335187967	-	7.13e-02	GO:0002302	CD8-positive, alpha-beta T cell differentiation involved in immune response	BP
1	2	3.78335187967	-	7.13e-02	GO:2000845	positive regulation of testosterone secretion	BP
1	2	3.78335187967	-	7.13e-02	GO:0043970	histone H3-K9 acetylation	BP
1	2	3.78335187967	-	7.13e-02	GO:0033484	nitric oxide homeostasis	BP
1	2	3.78335187967	-	7.13e-02	GO:0035411	catenin import into nucleus	BP
1	2	3.78335187967	-	7.13e-02	GO:0043006	activation of phospholipase A2 activity by calcium-mediated signaling	BP
1	2	3.78335187967	-	7.13e-02	GO:0072368	regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter	BP
1	2	3.78335187967	-	7.13e-02	GO:0072369	regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter	BP
1	2	3.78335187967	-	7.13e-02	GO:0032834	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response	BP
1	2	3.78335187967	-	7.13e-02	GO:0003290	atrial septum secundum morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0061290	canonical Wnt signaling pathway involved in metanephric kidney development	BP
1	2	3.78335187967	-	7.13e-02	GO:0045082	positive regulation of interleukin-10 biosynthetic process	BP
1	2	3.78335187967	-	7.13e-02	GO:0032764	negative regulation of mast cell cytokine production	BP
1	2	3.78335187967	-	7.13e-02	GO:2000779	regulation of double-strand break repair	BP
1	2	3.78335187967	-	7.13e-02	GO:0039003	pronephric field specification	BP
1	2	3.78335187967	-	7.13e-02	GO:0048638	regulation of developmental growth	BP
1	2	3.78335187967	-	7.13e-02	GO:0048822	enucleate erythrocyte development	BP
1	2	3.78335187967	-	7.13e-02	GO:0044027	hypermethylation of CpG island	BP
1	2	3.78335187967	-	7.13e-02	GO:0050725	positive regulation of interleukin-1 beta biosynthetic process	BP
1	2	3.78335187967	-	7.13e-02	GO:0070375	ERK5 cascade	BP
1	2	3.78335187967	-	7.13e-02	GO:0097050	type B pancreatic cell apoptotic process	BP
1	2	3.78335187967	-	7.13e-02	GO:2000182	regulation of progesterone biosynthetic process	BP
1	2	3.78335187967	-	7.13e-02	GO:0072179	nephric duct formation	BP
1	2	3.78335187967	-	7.13e-02	GO:0021894	cerebral cortex GABAergic interneuron development	BP
1	2	3.78335187967	-	7.13e-02	GO:0021892	cerebral cortex GABAergic interneuron differentiation	BP
1	2	3.78335187967	-	7.13e-02	GO:0071888	macrophage apoptotic process	BP
1	2	3.78335187967	-	7.13e-02	GO:0033561	regulation of water loss via skin	BP
1	2	3.78335187967	-	7.13e-02	GO:0060713	labyrinthine layer morphogenesis	BP
1	2	3.78335187967	-	7.13e-02	GO:0038194	thyroid-stimulating hormone signaling pathway	BP
1	2	3.78335187967	-	7.13e-02	GO:0045994	positive regulation of translational initiation by iron	BP
1	2	3.78335187967	-	7.13e-02	GO:0072033	renal vesicle formation	BP
5	10	3.78335187967	-	1.34e-05	GO:0042975	peroxisome proliferator activated receptor binding	MF
2	4	3.78335187967	-	7.52e-03	GO:0016361	activin receptor activity, type I	MF
2	4	3.78335187967	-	7.52e-03	GO:0071535	RING-like zinc finger domain binding	MF
2	4	3.78335187967	-	7.52e-03	GO:0017162	aryl hydrocarbon receptor binding	MF
1	2	3.78335187967	-	3.63e-02	GO:0017050	D-erythro-sphingosine kinase activity	MF
1	2	3.78335187967	-	3.63e-02	GO:0035575	histone demethylase activity (H4-K20 specific)	MF
1	2	3.78335187967	-	3.63e-02	GO:0008481	sphinganine kinase activity	MF
1	2	3.78335187967	-	3.63e-02	GO:0038181	bile acid receptor activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0004996	thyroid-stimulating hormone receptor activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0033142	progesterone receptor binding	MF
1	2	3.78335187967	-	7.13e-02	GO:0001632	leukotriene B4 receptor activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0015432	bile acid-exporting ATPase activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0016165	linoleate 13S-lipoxygenase activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0010736	serum response element binding	MF
1	2	3.78335187967	-	7.13e-02	GO:0035403	histone kinase activity (H3-T6 specific)	MF
1	2	3.78335187967	-	7.13e-02	GO:0016890	site-specific endodeoxyribonuclease activity, specific for altered base	MF
1	2	3.78335187967	-	7.13e-02	GO:0034988	Fc-gamma receptor I complex binding	MF
1	2	3.78335187967	-	7.13e-02	GO:0001071	nucleic acid binding transcription factor activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0045322	unmethylated CpG binding	MF
1	2	3.78335187967	-	7.13e-02	GO:0005006	epidermal growth factor-activated receptor activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0035014	phosphatidylinositol 3-kinase regulator activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0004105	choline-phosphate cytidylyltransferase activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0004356	glutamate-ammonia ligase activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0017002	activin-activated receptor activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0017129	triglyceride binding	MF
1	2	3.78335187967	-	7.13e-02	GO:0001640	adenylate cyclase inhibiting G-protein coupled glutamate receptor activity	MF
1	2	3.78335187967	-	7.13e-02	GO:0001025	RNA polymerase III transcription factor binding	MF
1	2	3.78335187967	-	7.13e-02	GO:0008124	4-alpha-hydroxytetrahydrobiopterin dehydratase activity	MF
13	27	3.72890409565	-	4.88e-11	GO:0046966	thyroid hormone receptor binding	MF
7	15	3.68381620612	-	2.20e-07	GO:0001076	transcription factor activity, RNA polymerase II transcription factor binding	MF
6	13	3.66787466225	-	1.71e-06	GO:0010745	negative regulation of macrophage derived foam cell differentiation	BP
5	11	3.64584835592	-	1.34e-05	GO:0006473	protein acetylation	BP
5	11	3.64584835592	-	2.38e-05	GO:0035195	gene silencing by miRNA	BP
4	9	3.61342687823	-	5.51e-05	GO:0003143	embryonic heart tube morphogenesis	BP
4	9	3.61342687823	-	1.07e-04	GO:0003197	endocardial cushion development	BP
7	16	3.59070680173	-	6.87e-07	GO:0030518	intracellular steroid hormone receptor signaling pathway	BP
65	150	3.57690100221	-	1.18e-10	GO:0006367	transcription initiation from RNA polymerase II promoter	BP
3	7	3.56095945834	-	4.51e-04	GO:0060740	prostate gland epithelium morphogenesis	BP
3	7	3.56095945834	-	8.77e-04	GO:0071455	cellular response to hyperoxia	BP
3	7	3.56095945834	-	8.77e-04	GO:0045722	positive regulation of gluconeogenesis	BP
3	7	3.56095945834	-	1.49e-03	GO:0042921	glucocorticoid receptor signaling pathway	BP
3	7	3.56095945834	-	1.49e-03	GO:0010870	positive regulation of receptor biosynthetic process	BP
3	7	3.56095945834	-	1.49e-03	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	BP
3	7	3.56095945834	-	1.49e-03	GO:0021795	cerebral cortex cell migration	BP
3	7	3.56095945834	-	1.49e-03	GO:0043983	histone H4-K12 acetylation	BP
3	7	3.56095945834	-	1.49e-03	GO:2000144	positive regulation of DNA-templated transcription, initiation	BP
6	14	3.56095945834	-	1.71e-06	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
11	26	3.54234378017	-	6.12e-10	GO:0035035	histone acetyltransferase binding	MF
7	17	3.50324396048	-	6.87e-07	GO:0042789	mRNA transcription from RNA polymerase II promoter	BP
7	17	3.50324396048	-	3.99e-07	GO:0001190	transcriptional activator activity, RNA polymerase II transcription factor binding	MF
4	10	3.46142378479	-	1.87e-04	GO:1902894	negative regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
4	10	3.46142378479	-	3.03e-04	GO:0051775	response to redox state	BP
2	5	3.46142378479	-	7.52e-03	GO:0003417	growth plate cartilage development	BP
2	5	3.46142378479	-	7.52e-03	GO:0048311	mitochondrion distribution	BP
2	5	3.46142378479	-	7.52e-03	GO:0019217	regulation of fatty acid metabolic process	BP
2	5	3.46142378479	-	7.52e-03	GO:0048752	semicircular canal morphogenesis	BP
2	5	3.46142378479	-	1.22e-02	GO:0051891	positive regulation of cardioblast differentiation	BP
2	5	3.46142378479	-	1.22e-02	GO:0042634	regulation of hair cycle	BP
2	5	3.46142378479	-	1.22e-02	GO:0003289	atrial septum primum morphogenesis	BP
2	5	3.46142378479	-	1.22e-02	GO:0036091	positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
2	5	3.46142378479	-	1.22e-02	GO:1902808	positive regulation of cell cycle G1/S phase transition	BP
2	5	3.46142378479	-	1.22e-02	GO:0060744	mammary gland branching involved in thelarche	BP
2	5	3.46142378479	-	1.22e-02	GO:0002634	regulation of germinal center formation	BP
2	5	3.46142378479	-	1.22e-02	GO:0071504	cellular response to heparin	BP
2	5	3.46142378479	-	1.22e-02	GO:0071332	cellular response to fructose stimulus	BP
2	5	3.46142378479	-	1.22e-02	GO:0060430	lung saccule development	BP
2	5	3.46142378479	-	1.22e-02	GO:0010828	positive regulation of glucose transport	BP
2	5	3.46142378479	-	1.22e-02	GO:0033600	negative regulation of mammary gland epithelial cell proliferation	BP
2	5	3.46142378479	-	1.22e-02	GO:0051546	keratinocyte migration	BP
2	5	3.46142378479	-	1.22e-02	GO:0060761	negative regulation of response to cytokine stimulus	BP
2	5	3.46142378479	-	1.22e-02	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	BP
2	5	3.46142378479	-	1.22e-02	GO:0010891	negative regulation of sequestering of triglyceride	BP
8	20	3.46142378479	-	1.52e-07	GO:0033613	activating transcription factor binding	MF
6	15	3.46142378479	-	8.42e-06	GO:0042809	vitamin D receptor binding	MF
2	5	3.46142378479	-	1.22e-02	GO:0004532	exoribonuclease activity	MF
2	5	3.46142378479	-	1.22e-02	GO:0008142	oxysterol binding	MF
2	5	3.46142378479	-	1.22e-02	GO:0030284	estrogen receptor activity	MF
17	43	3.44454996622	-	8.29e-11	GO:0001046	core promoter sequence-specific DNA binding	MF
16	41	3.42579987506	-	5.64e-11	GO:0030521	androgen receptor signaling pathway	BP
7	18	3.42078180029	-	1.13e-06	GO:0001892	embryonic placenta development	BP
5	13	3.40484025642	-	2.38e-05	GO:0061029	eyelid development in camera-type eye	BP
15	39	3.40484025642	-	1.64e-11	GO:0030331	estrogen receptor binding	MF
11	29	3.38480250318	-	1.59e-09	GO:0000289	nuclear-transcribed mRNA poly(A) tail shortening	BP
3	8	3.3683143804	-	8.77e-04	GO:0048646	anatomical structure formation involved in morphogenesis	BP
3	8	3.3683143804	-	1.49e-03	GO:0032330	regulation of chondrocyte differentiation	BP
3	8	3.3683143804	-	2.33e-03	GO:0010941	regulation of cell death	BP
4	11	3.32392026104	-	3.03e-04	GO:0071498	cellular response to fluid shear stress	BP
4	11	3.32392026104	-	3.03e-04	GO:0060213	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	BP
4	11	3.32392026104	-	3.03e-04	GO:1990440	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
12	33	3.32392026104	-	5.37e-10	GO:0001104	RNA polymerase II transcription cofactor activity	MF
4	11	3.32392026104	-	3.03e-04	GO:0016407	acetyltransferase activity	MF
4	11	3.32392026104	-	3.03e-04	GO:0001223	transcription coactivator binding	MF
17	47	3.31622586925	-	8.18e-12	GO:0000976	transcription regulatory region sequence-specific DNA binding	MF
5	14	3.2979250525	-	3.97e-05	GO:0060065	uterus development	BP
23	65	3.2845460227	-	2.32e-11	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
6	17	3.28085153914	-	8.42e-06	GO:0021542	dentate gyrus development	BP
14	40	3.26877870684	-	7.55e-11	GO:0044255	cellular lipid metabolic process	BP
7	20	3.26877870684	-	1.79e-06	GO:0030520	intracellular estrogen receptor signaling pathway	BP
7	20	3.26877870684	-	4.10e-06	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
17	49	3.25610487681	-	3.71e-11	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	MF
5	15	3.19838937895	-	6.25e-05	GO:0007548	sex differentiation	BP
4	12	3.19838937895	-	4.63e-04	GO:0033147	negative regulation of intracellular estrogen receptor signaling pathway	BP
4	12	3.19838937895	-	6.74e-04	GO:0001829	trophectodermal cell differentiation	BP
4	12	3.19838937895	-	6.74e-04	GO:0043149	stress fiber assembly	BP
4	12	3.19838937895	-	6.74e-04	GO:0036499	PERK-mediated unfolded protein response	BP
3	9	3.19838937895	-	1.49e-03	GO:0030903	notochord development	BP
3	9	3.19838937895	-	2.33e-03	GO:1990403	embryonic brain development	BP
3	9	3.19838937895	-	2.33e-03	GO:0060674	placenta blood vessel development	BP
3	9	3.19838937895	-	2.33e-03	GO:0030857	negative regulation of epithelial cell differentiation	BP
3	9	3.19838937895	-	3.39e-03	GO:0007196	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway	BP
2	6	3.19838937895	-	7.52e-03	GO:0010694	positive regulation of alkaline phosphatase activity	BP
2	6	3.19838937895	-	7.52e-03	GO:2001054	negative regulation of mesenchymal cell apoptotic process	BP
2	6	3.19838937895	-	7.52e-03	GO:0009913	epidermal cell differentiation	BP
2	6	3.19838937895	-	7.52e-03	GO:0045743	positive regulation of fibroblast growth factor receptor signaling pathway	BP
2	6	3.19838937895	-	1.22e-02	GO:0002320	lymphoid progenitor cell differentiation	BP
2	6	3.19838937895	-	1.22e-02	GO:0032792	negative regulation of CREB transcription factor activity	BP
2	6	3.19838937895	-	1.22e-02	GO:0032808	lacrimal gland development	BP
2	6	3.19838937895	-	1.22e-02	GO:0035315	hair cell differentiation	BP
2	6	3.19838937895	-	1.22e-02	GO:0051150	regulation of smooth muscle cell differentiation	BP
2	6	3.19838937895	-	1.79e-02	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	BP
2	6	3.19838937895	-	1.79e-02	GO:2000288	positive regulation of myoblast proliferation	BP
2	6	3.19838937895	-	1.79e-02	GO:2000323	negative regulation of glucocorticoid receptor signaling pathway	BP
2	6	3.19838937895	-	1.79e-02	GO:0060789	hair follicle placode formation	BP
2	6	3.19838937895	-	1.79e-02	GO:0001661	conditioned taste aversion	BP
2	6	3.19838937895	-	1.79e-02	GO:0061154	endothelial tube morphogenesis	BP
2	6	3.19838937895	-	1.79e-02	GO:0003180	aortic valve morphogenesis	BP
2	6	3.19838937895	-	1.79e-02	GO:0060536	cartilage morphogenesis	BP
2	6	3.19838937895	-	1.79e-02	GO:0045661	regulation of myoblast differentiation	BP
2	6	3.19838937895	-	1.79e-02	GO:0031087	deadenylation-independent decapping of nuclear-transcribed mRNA	BP
2	6	3.19838937895	-	1.79e-02	GO:0045084	positive regulation of interleukin-12 biosynthetic process	BP
2	6	3.19838937895	-	1.79e-02	GO:0060440	trachea formation	BP
1	3	3.19838937895	-	3.63e-02	GO:2000721	positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	BP
1	3	3.19838937895	-	3.63e-02	GO:0006670	sphingosine metabolic process	BP
1	3	3.19838937895	-	3.63e-02	GO:0030858	positive regulation of epithelial cell differentiation	BP
1	3	3.19838937895	-	3.63e-02	GO:0060005	vestibular reflex	BP
1	3	3.19838937895	-	7.13e-02	GO:0021524	visceral motor neuron differentiation	BP
1	3	3.19838937895	-	7.13e-02	GO:0070561	vitamin D receptor signaling pathway	BP
1	3	3.19838937895	-	7.13e-02	GO:1990418	response to insulin-like growth factor stimulus	BP
1	3	3.19838937895	-	7.13e-02	GO:1900625	positive regulation of monocyte aggregation	BP
1	3	3.19838937895	-	7.13e-02	GO:0060066	oviduct development	BP
1	3	3.19838937895	-	7.13e-02	GO:0045726	positive regulation of integrin biosynthetic process	BP
1	3	3.19838937895	-	7.13e-02	GO:0072278	metanephric comma-shaped body morphogenesis	BP
1	3	3.19838937895	-	7.13e-02	GO:0072102	glomerulus morphogenesis	BP
1	3	3.19838937895	-	7.13e-02	GO:0001781	neutrophil apoptotic process	BP
1	3	3.19838937895	-	7.13e-02	GO:0061031	endodermal digestive tract morphogenesis	BP
1	3	3.19838937895	-	7.13e-02	GO:2000078	positive regulation of type B pancreatic cell development	BP
1	3	3.19838937895	-	7.13e-02	GO:0046167	glycerol-3-phosphate biosynthetic process	BP
1	3	3.19838937895	-	7.13e-02	GO:0070859	positive regulation of bile acid biosynthetic process	BP
1	3	3.19838937895	-	7.13e-02	GO:0060916	mesenchymal cell proliferation involved in lung development	BP
1	3	3.19838937895	-	7.13e-02	GO:0044336	canonical Wnt signaling pathway involved in negative regulation of apoptotic process	BP
1	3	3.19838937895	-	7.13e-02	GO:0010573	vascular endothelial growth factor production	BP
1	3	3.19838937895	-	7.13e-02	GO:0033076	isoquinoline alkaloid metabolic process	BP
1	3	3.19838937895	-	7.13e-02	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
1	3	3.19838937895	-	7.13e-02	GO:0010909	positive regulation of heparan sulfate proteoglycan biosynthetic process	BP
1	3	3.19838937895	-	7.13e-02	GO:0021502	neural fold elevation formation	BP
1	3	3.19838937895	-	7.13e-02	GO:0060947	cardiac vascular smooth muscle cell differentiation	BP
1	3	3.19838937895	-	7.13e-02	GO:0060164	regulation of timing of neuron differentiation	BP
1	3	3.19838937895	-	7.13e-02	GO:0010980	positive regulation of vitamin D 24-hydroxylase activity	BP
1	3	3.19838937895	-	7.13e-02	GO:1902990	mitotic telomere maintenance via semi-conservative replication	BP
1	3	3.19838937895	-	7.13e-02	GO:0061113	pancreas morphogenesis	BP
1	3	3.19838937895	-	7.13e-02	GO:0046885	regulation of hormone biosynthetic process	BP
1	3	3.19838937895	-	7.13e-02	GO:0000305	response to oxygen radical	BP
1	3	3.19838937895	-	7.13e-02	GO:1900114	positive regulation of histone H3-K9 trimethylation	BP
1	3	3.19838937895	-	7.13e-02	GO:0003350	pulmonary myocardium development	BP
1	3	3.19838937895	-	7.13e-02	GO:0036023	embryonic skeletal limb joint morphogenesis	BP
1	3	3.19838937895	-	7.13e-02	GO:1902617	response to fluoride	BP
1	3	3.19838937895	-	7.13e-02	GO:1901536	negative regulation of DNA demethylation	BP
1	3	3.19838937895	-	7.13e-02	GO:0072136	metanephric mesenchymal cell proliferation involved in metanephros development	BP
1	3	3.19838937895	-	7.13e-02	GO:0050954	sensory perception of mechanical stimulus	BP
1	3	3.19838937895	-	7.13e-02	GO:0042461	photoreceptor cell development	BP
1	3	3.19838937895	-	7.13e-02	GO:0060523	prostate epithelial cord elongation	BP
1	3	3.19838937895	-	7.13e-02	GO:0042427	serotonin biosynthetic process	BP
1	3	3.19838937895	-	1.05e-01	GO:0034770	histone H4-K20 methylation	BP
1	3	3.19838937895	-	1.05e-01	GO:1902661	positive regulation of glucose mediated signaling pathway	BP
1	3	3.19838937895	-	1.05e-01	GO:0045652	regulation of megakaryocyte differentiation	BP
1	3	3.19838937895	-	1.05e-01	GO:1903984	positive regulation of TRAIL-activated apoptotic signaling pathway	BP
1	3	3.19838937895	-	1.05e-01	GO:0035993	deltoid tuberosity development	BP
1	3	3.19838937895	-	1.05e-01	GO:0043415	positive regulation of skeletal muscle tissue regeneration	BP
1	3	3.19838937895	-	1.05e-01	GO:0060923	cardiac muscle cell fate commitment	BP
1	3	3.19838937895	-	1.05e-01	GO:0006499	N-terminal protein myristoylation	BP
1	3	3.19838937895	-	1.05e-01	GO:0060492	lung induction	BP
1	3	3.19838937895	-	1.05e-01	GO:0060491	regulation of cell projection assembly	BP
1	3	3.19838937895	-	1.05e-01	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	BP
1	3	3.19838937895	-	1.05e-01	GO:2001015	negative regulation of skeletal muscle cell differentiation	BP
1	3	3.19838937895	-	1.05e-01	GO:0090261	positive regulation of inclusion body assembly	BP
1	3	3.19838937895	-	1.05e-01	GO:0098904	regulation of AV node cell action potential	BP
1	3	3.19838937895	-	1.05e-01	GO:0098908	regulation of neuronal action potential	BP
1	3	3.19838937895	-	1.05e-01	GO:0046985	positive regulation of hemoglobin biosynthetic process	BP
1	3	3.19838937895	-	1.05e-01	GO:0061138	morphogenesis of a branching epithelium	BP
1	3	3.19838937895	-	1.05e-01	GO:0031587	positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	BP
1	3	3.19838937895	-	1.05e-01	GO:1903208	negative regulation of hydrogen peroxide-induced neuron death	BP
1	3	3.19838937895	-	1.05e-01	GO:0060414	aorta smooth muscle tissue morphogenesis	BP
1	3	3.19838937895	-	1.05e-01	GO:1904996	positive regulation of leukocyte adhesion to vascular endothelial cell	BP
1	3	3.19838937895	-	1.05e-01	GO:0007500	mesodermal cell fate determination	BP
1	3	3.19838937895	-	1.05e-01	GO:0014041	regulation of neuron maturation	BP
1	3	3.19838937895	-	1.05e-01	GO:0016553	base conversion or substitution editing	BP
1	3	3.19838937895	-	1.05e-01	GO:0071386	cellular response to corticosterone stimulus	BP
1	3	3.19838937895	-	1.05e-01	GO:0060559	positive regulation of calcidiol 1-monooxygenase activity	BP
1	3	3.19838937895	-	1.05e-01	GO:0070602	regulation of centromeric sister chromatid cohesion	BP
1	3	3.19838937895	-	1.05e-01	GO:0055098	response to low-density lipoprotein particle	BP
1	3	3.19838937895	-	1.05e-01	GO:1901896	positive regulation of calcium-transporting ATPase activity	BP
1	3	3.19838937895	-	1.05e-01	GO:0089700	protein kinase D signaling	BP
1	3	3.19838937895	-	1.05e-01	GO:0060743	epithelial cell maturation involved in prostate gland development	BP
1	3	3.19838937895	-	1.05e-01	GO:0060741	prostate gland stromal morphogenesis	BP
1	3	3.19838937895	-	1.05e-01	GO:0022028	tangential migration from the subventricular zone to the olfactory bulb	BP
1	3	3.19838937895	-	1.05e-01	GO:0035284	brain segmentation	BP
1	3	3.19838937895	-	1.05e-01	GO:0021885	forebrain cell migration	BP
1	3	3.19838937895	-	1.05e-01	GO:0010766	negative regulation of sodium ion transport	BP
1	3	3.19838937895	-	1.05e-01	GO:1990737	response to manganese-induced endoplasmic reticulum stress	BP
1	3	3.19838937895	-	1.05e-01	GO:0003413	chondrocyte differentiation involved in endochondral bone morphogenesis	BP
1	3	3.19838937895	-	1.05e-01	GO:0051795	positive regulation of timing of catagen	BP
1	3	3.19838937895	-	1.05e-01	GO:0003274	endocardial cushion fusion	BP
1	3	3.19838937895	-	1.05e-01	GO:0015722	canalicular bile acid transport	BP
1	3	3.19838937895	-	1.05e-01	GO:0045061	thymic T cell selection	BP
1	3	3.19838937895	-	1.05e-01	GO:2000138	positive regulation of cell proliferation involved in heart morphogenesis	BP
1	3	3.19838937895	-	1.05e-01	GO:0090259	regulation of retinal ganglion cell axon guidance	BP
1	3	3.19838937895	-	1.05e-01	GO:0048294	negative regulation of isotype switching to IgE isotypes	BP
1	3	3.19838937895	-	1.05e-01	GO:0035986	senescence-associated heterochromatin focus assembly	BP
1	3	3.19838937895	-	1.05e-01	GO:0035984	cellular response to trichostatin A	BP
1	3	3.19838937895	-	1.05e-01	GO:0070141	response to UV-A	BP
1	3	3.19838937895	-	1.05e-01	GO:0051712	positive regulation of killing of cells of other organism	BP
1	3	3.19838937895	-	1.05e-01	GO:0090043	regulation of tubulin deacetylation	BP
1	3	3.19838937895	-	1.05e-01	GO:0038163	thrombopoietin-mediated signaling pathway	BP
1	3	3.19838937895	-	1.05e-01	GO:0038161	prolactin signaling pathway	BP
1	3	3.19838937895	-	1.05e-01	GO:0032692	negative regulation of interleukin-1 production	BP
1	3	3.19838937895	-	1.05e-01	GO:0060374	mast cell differentiation	BP
1	3	3.19838937895	-	1.05e-01	GO:0051365	cellular response to potassium ion starvation	BP
1	3	3.19838937895	-	1.05e-01	GO:0072193	ureter smooth muscle cell differentiation	BP
1	3	3.19838937895	-	1.05e-01	GO:0090003	regulation of establishment of protein localization to plasma membrane	BP
1	3	3.19838937895	-	1.05e-01	GO:0098910	regulation of atrial cardiac muscle cell action potential	BP
1	3	3.19838937895	-	1.05e-01	GO:0098912	membrane depolarization during atrial cardiac muscle cell action potential	BP
1	3	3.19838937895	-	1.05e-01	GO:1901491	negative regulation of lymphangiogenesis	BP
1	3	3.19838937895	-	1.05e-01	GO:1903421	regulation of synaptic vesicle recycling	BP
1	3	3.19838937895	-	1.05e-01	GO:0018394	peptidyl-lysine acetylation	BP
1	3	3.19838937895	-	1.05e-01	GO:0070966	nuclear-transcribed mRNA catabolic process, no-go decay	BP
1	3	3.19838937895	-	1.05e-01	GO:0090245	axis elongation involved in somitogenesis	BP
1	3	3.19838937895	-	1.05e-01	GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway	BP
1	3	3.19838937895	-	1.05e-01	GO:0030917	midbrain-hindbrain boundary development	BP
1	3	3.19838937895	-	1.05e-01	GO:2000286	receptor internalization involved in canonical Wnt signaling pathway	BP
1	3	3.19838937895	-	1.05e-01	GO:0045408	regulation of interleukin-6 biosynthetic process	BP
1	3	3.19838937895	-	1.05e-01	GO:0021545	cranial nerve development	BP
1	3	3.19838937895	-	1.05e-01	GO:0048597	post-embryonic camera-type eye morphogenesis	BP
1	3	3.19838937895	-	1.05e-01	GO:0001922	B-1 B cell homeostasis	BP
1	3	3.19838937895	-	1.05e-01	GO:0042524	negative regulation of tyrosine phosphorylation of Stat5 protein	BP
1	3	3.19838937895	-	1.05e-01	GO:0035166	post-embryonic hemopoiesis	BP
1	3	3.19838937895	-	1.05e-01	GO:0032651	regulation of interleukin-1 beta production	BP
1	3	3.19838937895	-	1.05e-01	GO:0003199	endocardial cushion to mesenchymal transition involved in heart valve formation	BP
1	3	3.19838937895	-	1.05e-01	GO:1990785	response to water-immersion restraint stress	BP
1	3	3.19838937895	-	1.05e-01	GO:0060126	somatotropin secreting cell differentiation	BP
1	3	3.19838937895	-	1.05e-01	GO:0002317	plasma cell differentiation	BP
1	3	3.19838937895	-	1.05e-01	GO:2000504	positive regulation of blood vessel remodeling	BP
1	3	3.19838937895	-	1.05e-01	GO:1902037	negative regulation of hematopoietic stem cell differentiation	BP
1	3	3.19838937895	-	1.05e-01	GO:1903598	positive regulation of gap junction assembly	BP
1	3	3.19838937895	-	1.05e-01	GO:1904468	negative regulation of tumor necrosis factor secretion	BP
1	3	3.19838937895	-	1.05e-01	GO:1900212	negative regulation of mesenchymal cell apoptotic process involved in metanephros development	BP
1	3	3.19838937895	-	1.05e-01	GO:0048858	cell projection morphogenesis	BP
1	3	3.19838937895	-	1.05e-01	GO:0035054	embryonic heart tube anterior/posterior pattern specification	BP
1	3	3.19838937895	-	1.05e-01	GO:0072125	negative regulation of glomerular mesangial cell proliferation	BP
1	3	3.19838937895	-	1.05e-01	GO:0043504	mitochondrial DNA repair	BP
1	3	3.19838937895	-	1.05e-01	GO:2000195	negative regulation of female gonad development	BP
1	3	3.19838937895	-	1.05e-01	GO:0001555	oocyte growth	BP
1	3	3.19838937895	-	1.05e-01	GO:0034201	response to oleic acid	BP
1	3	3.19838937895	-	1.05e-01	GO:0070168	negative regulation of biomineral tissue development	BP
1	3	3.19838937895	-	1.05e-01	GO:0035359	negative regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	3	3.19838937895	-	1.05e-01	GO:0030888	regulation of B cell proliferation	BP
1	3	3.19838937895	-	1.05e-01	GO:0033687	osteoblast proliferation	BP
1	3	3.19838937895	-	1.05e-01	GO:0060729	intestinal epithelial structure maintenance	BP
1	3	3.19838937895	-	1.05e-01	GO:0021553	olfactory nerve development	BP
1	3	3.19838937895	-	1.05e-01	GO:0090258	negative regulation of mitochondrial fission	BP
1	3	3.19838937895	-	1.05e-01	GO:1905232	cellular response to L-glutamate	BP
1	3	3.19838937895	-	1.05e-01	GO:0000720	pyrimidine dimer repair by nucleotide-excision repair	BP
1	3	3.19838937895	-	1.05e-01	GO:2000345	regulation of hepatocyte proliferation	BP
1	3	3.19838937895	-	1.05e-01	GO:1901165	positive regulation of trophoblast cell migration	BP
1	3	3.19838937895	-	1.05e-01	GO:0009648	photoperiodism	BP
1	3	3.19838937895	-	1.05e-01	GO:2000111	positive regulation of macrophage apoptotic process	BP
1	3	3.19838937895	-	1.05e-01	GO:0002118	aggressive behavior	BP
1	3	3.19838937895	-	1.05e-01	GO:1902593	single-organism nuclear import	BP
1	3	3.19838937895	-	1.05e-01	GO:2000630	positive regulation of miRNA metabolic process	BP
1	3	3.19838937895	-	1.05e-01	GO:0046068	cGMP metabolic process	BP
1	3	3.19838937895	-	1.05e-01	GO:0019065	receptor-mediated endocytosis of virus by host cell	BP
1	3	3.19838937895	-	1.05e-01	GO:0051154	negative regulation of striated muscle cell differentiation	BP
1	3	3.19838937895	-	1.05e-01	GO:0003166	bundle of His development	BP
1	3	3.19838937895	-	1.05e-01	GO:0010992	ubiquitin homeostasis	BP
1	3	3.19838937895	-	1.05e-01	GO:0002520	immune system development	BP
1	3	3.19838937895	-	1.05e-01	GO:0032765	positive regulation of mast cell cytokine production	BP
1	3	3.19838937895	-	1.05e-01	GO:0071871	response to epinephrine	BP
1	3	3.19838937895	-	1.05e-01	GO:0045682	regulation of epidermis development	BP
1	3	3.19838937895	-	1.05e-01	GO:0042977	activation of JAK2 kinase activity	BP
1	3	3.19838937895	-	1.05e-01	GO:0060058	positive regulation of apoptotic process involved in mammary gland involution	BP
1	3	3.19838937895	-	1.05e-01	GO:0001560	regulation of cell growth by extracellular stimulus	BP
1	3	3.19838937895	-	1.05e-01	GO:1904646	cellular response to beta-amyloid	BP
1	3	3.19838937895	-	1.05e-01	GO:1904640	response to methionine	BP
1	3	3.19838937895	-	1.05e-01	GO:0060221	retinal rod cell differentiation	BP
1	3	3.19838937895	-	1.05e-01	GO:0043137	DNA replication, removal of RNA primer	BP
1	3	3.19838937895	-	1.05e-01	GO:0072034	renal vesicle induction	BP
9	27	3.19838937895	-	1.84e-07	GO:0001205	transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding	MF
5	15	3.19838937895	-	9.44e-05	GO:0000987	core promoter proximal region sequence-specific DNA binding	MF
4	12	3.19838937895	-	6.74e-04	GO:0000983	transcription factor activity, RNA polymerase II core promoter sequence-specific	MF
2	6	3.19838937895	-	1.22e-02	GO:0004468	lysine N-acetyltransferase activity, acting on acetyl phosphate as donor	MF
2	6	3.19838937895	-	1.22e-02	GO:0070324	thyroid hormone binding	MF
1	3	3.19838937895	-	3.63e-02	GO:0047844	deoxycytidine deaminase activity	MF
1	3	3.19838937895	-	3.63e-02	GO:0033218	amide binding	MF
1	3	3.19838937895	-	7.13e-02	GO:0050473	arachidonate 15-lipoxygenase activity	MF
1	3	3.19838937895	-	7.13e-02	GO:0102490	8-oxo-dGTP phosphohydrolase activity	MF
1	3	3.19838937895	-	7.13e-02	GO:0004370	glycerol kinase activity	MF
1	3	3.19838937895	-	7.13e-02	GO:0016149	translation release factor activity, codon specific	MF
1	3	3.19838937895	-	1.05e-01	GO:0050816	phosphothreonine binding	MF
1	3	3.19838937895	-	1.05e-01	GO:0086056	voltage-gated calcium channel activity involved in AV node cell action potential	MF
1	3	3.19838937895	-	1.05e-01	GO:0004505	phenylalanine 4-monooxygenase activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0010484	H3 histone acetyltransferase activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0019166	trans-2-enoyl-CoA reductase (NADPH) activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0044729	hemi-methylated DNA-binding	MF
1	3	3.19838937895	-	1.05e-01	GO:0055106	ubiquitin-protein transferase regulator activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0043812	phosphatidylinositol-4-phosphate phosphatase activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0050508	glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0008384	IkappaB kinase activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0030348	syntaxin-3 binding	MF
1	3	3.19838937895	-	1.05e-01	GO:0070095	fructose-6-phosphate binding	MF
1	3	3.19838937895	-	1.05e-01	GO:0004060	arylamine N-acetyltransferase activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0004351	glutamate decarboxylase activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0043398	HLH domain binding	MF
1	3	3.19838937895	-	1.05e-01	GO:0042978	ornithine decarboxylase activator activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0015093	ferrous iron transmembrane transporter activity	MF
1	3	3.19838937895	-	1.05e-01	GO:0070905	serine binding	MF
1	3	3.19838937895	-	1.05e-01	GO:0043139	5'-3' DNA helicase activity	MF
19	58	3.17329839799	-	3.09e-11	GO:0031490	chromatin DNA binding	MF
6	19	3.12038686695	-	4.03e-05	GO:0051568	histone H3-K4 methylation	BP
6	19	3.12038686695	-	8.42e-06	GO:0001158	enhancer sequence-specific DNA binding	MF
5	16	3.10527997456	-	1.94e-04	GO:0035994	response to muscle stretch	BP
4	13	3.08291216153	-	3.03e-04	GO:0031076	embryonic camera-type eye development	BP
4	13	3.08291216153	-	3.03e-04	GO:0045618	positive regulation of keratinocyte differentiation	BP
4	13	3.08291216153	-	4.63e-04	GO:0051145	smooth muscle cell differentiation	BP
4	13	3.08291216153	-	4.63e-04	GO:0031641	regulation of myelination	BP
3	10	3.04638628551	-	4.51e-04	GO:0048387	negative regulation of retinoic acid receptor signaling pathway	BP
3	10	3.04638628551	-	1.49e-03	GO:0090009	primitive streak formation	BP
3	10	3.04638628551	-	3.39e-03	GO:0006307	DNA dealkylation involved in DNA repair	BP
3	10	3.04638628551	-	4.72e-03	GO:0051272	positive regulation of cellular component movement	BP
3	10	3.04638628551	-	4.72e-03	GO:0051247	positive regulation of protein metabolic process	BP
3	10	3.04638628551	-	4.72e-03	GO:0033327	Leydig cell differentiation	BP
15	50	3.04638628551	-	3.71e-11	GO:0001085	RNA polymerase II transcription factor binding	MF
3	10	3.04638628551	-	3.39e-03	GO:0032454	histone demethylase activity (H3-K9 specific)	MF
3	10	3.04638628551	-	4.72e-03	GO:0033558	protein deacetylase activity	MF
8	27	3.02846437751	-	3.83e-07	GO:0005496	steroid binding	MF
5	17	3.01781713331	-	1.94e-04	GO:0033189	response to vitamin A	BP
5	17	3.01781713331	-	2.66e-04	GO:0042800	histone methyltransferase activity (H3-K4 specific)	MF
12	41	3.01076237578	-	1.39e-08	GO:0050681	androgen receptor binding	MF
8	28	2.97599695762	-	8.66e-07	GO:0035116	embryonic hindlimb morphogenesis	BP
4	14	2.97599695762	-	6.74e-04	GO:0010832	negative regulation of myotube differentiation	BP
4	14	2.97599695762	-	6.74e-04	GO:1900153	positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	BP
4	14	2.97599695762	-	9.46e-04	GO:0060441	epithelial tube branching involved in lung morphogenesis	BP
4	14	2.97599695762	-	1.29e-03	GO:0097067	cellular response to thyroid hormone stimulus	BP
4	14	2.97599695762	-	1.29e-03	GO:0043923	positive regulation by host of viral transcription	BP
2	7	2.97599695762	-	7.52e-03	GO:0035356	cellular triglyceride homeostasis	BP
2	7	2.97599695762	-	1.22e-02	GO:0006029	proteoglycan metabolic process	BP
2	7	2.97599695762	-	1.79e-02	GO:0009629	response to gravity	BP
2	7	2.97599695762	-	1.79e-02	GO:2000049	positive regulation of cell-cell adhesion mediated by cadherin	BP
2	7	2.97599695762	-	2.45e-02	GO:0055009	atrial cardiac muscle tissue morphogenesis	BP
2	7	2.97599695762	-	2.45e-02	GO:2000641	regulation of early endosome to late endosome transport	BP
2	7	2.97599695762	-	2.45e-02	GO:2000177	regulation of neural precursor cell proliferation	BP
2	7	2.97599695762	-	2.45e-02	GO:1903071	positive regulation of ER-associated ubiquitin-dependent protein catabolic process	BP
2	7	2.97599695762	-	2.45e-02	GO:0031340	positive regulation of vesicle fusion	BP
2	7	2.97599695762	-	2.45e-02	GO:0032966	negative regulation of collagen biosynthetic process	BP
2	7	2.97599695762	-	2.45e-02	GO:0060290	transdifferentiation	BP
2	7	2.97599695762	-	2.45e-02	GO:0060008	Sertoli cell differentiation	BP
2	7	2.97599695762	-	2.45e-02	GO:0060687	regulation of branching involved in prostate gland morphogenesis	BP
2	7	2.97599695762	-	2.45e-02	GO:2000347	positive regulation of hepatocyte proliferation	BP
2	7	2.97599695762	-	2.45e-02	GO:0061049	cell growth involved in cardiac muscle cell development	BP
10	35	2.97599695762	-	1.59e-07	GO:0001105	RNA polymerase II transcription coactivator activity	MF
2	7	2.97599695762	-	1.79e-02	GO:0001222	transcription corepressor binding	MF
2	7	2.97599695762	-	2.45e-02	GO:0097157	pre-mRNA intronic binding	MF
2	7	2.97599695762	-	2.45e-02	GO:0044389	ubiquitin-like protein ligase binding	MF
2	7	2.97599695762	-	2.45e-02	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	MF
5	18	2.93535497312	-	1.37e-04	GO:0060324	face development	BP
5	18	2.93535497312	-	3.58e-04	GO:0006337	nucleosome disassembly	BP
28	102	2.91828145976	-	2.71e-11	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
6	22	2.90888276176	-	4.03e-05	GO:0007492	endoderm development	BP
3	11	2.90888276176	-	8.77e-04	GO:0070166	enamel mineralization	BP
3	11	2.90888276176	-	3.39e-03	GO:0032703	negative regulation of interleukin-2 production	BP
3	11	2.90888276176	-	3.39e-03	GO:0010867	positive regulation of triglyceride biosynthetic process	BP
3	11	2.90888276176	-	4.72e-03	GO:0090051	negative regulation of cell migration involved in sprouting angiogenesis	BP
3	11	2.90888276176	-	4.72e-03	GO:2000036	regulation of stem cell population maintenance	BP
3	11	2.90888276176	-	4.72e-03	GO:0098911	regulation of ventricular cardiac muscle cell action potential	BP
3	11	2.90888276176	-	4.72e-03	GO:0006476	protein deacetylation	BP
3	11	2.90888276176	-	4.72e-03	GO:0033169	histone H3-K9 demethylation	BP
3	11	2.90888276176	-	6.32e-03	GO:0003279	cardiac septum development	BP
3	11	2.90888276176	-	6.32e-03	GO:1901653	cellular response to peptide	BP
18	66	2.90888276176	-	5.47e-11	GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	MF
3	11	2.90888276176	-	6.32e-03	GO:0004707	MAP kinase activity	MF
3	11	2.90888276176	-	6.32e-03	GO:0008066	glutamate receptor activity	MF
3	11	2.90888276176	-	6.32e-03	GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	MF
8	30	2.87646128407	-	4.68e-06	GO:0090503	RNA phosphodiester bond hydrolysis, exonucleolytic	BP
4	15	2.87646128407	-	1.70e-03	GO:0043982	histone H4-K8 acetylation	BP
4	15	2.87646128407	-	1.70e-03	GO:0043981	histone H4-K5 acetylation	BP
68	255	2.87646128407	-	3.70e-11	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
74	278	2.87386417258	-	4.03e-11	GO:0008134	transcription factor binding	MF
5	19	2.85735246112	-	3.58e-04	GO:0030099	myeloid cell differentiation	BP
10	38	2.85735246112	-	3.96e-07	GO:0001102	RNA polymerase II activating transcription factor binding	MF
6	23	2.84475242434	-	4.03e-05	GO:0055088	lipid homeostasis	BP
6	23	2.84475242434	-	1.01e-04	GO:0045648	positive regulation of erythrocyte differentiation	BP
11	43	2.81651874361	-	2.60e-07	GO:1904837	beta-catenin-TCF complex assembly	BP
45	177	2.80759942592	-	3.20e-11	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	MF
61	243	2.78927671363	-	1.17e-10	GO:0003713	transcription coactivator activity	MF
14	56	2.78335187967	-	6.41e-09	GO:0032922	circadian regulation of gene expression	BP
4	16	2.78335187967	-	9.46e-04	GO:0050767	regulation of neurogenesis	BP
4	16	2.78335187967	-	1.29e-03	GO:0061178	regulation of insulin secretion involved in cellular response to glucose stimulus	BP
4	16	2.78335187967	-	2.21e-03	GO:0030224	monocyte differentiation	BP
3	12	2.78335187967	-	4.72e-03	GO:0043616	keratinocyte proliferation	BP
3	12	2.78335187967	-	4.72e-03	GO:0042592	homeostatic process	BP
3	12	2.78335187967	-	4.72e-03	GO:0071391	cellular response to estrogen stimulus	BP
3	12	2.78335187967	-	6.32e-03	GO:0003215	cardiac right ventricle morphogenesis	BP
3	12	2.78335187967	-	8.20e-03	GO:0021819	layer formation in cerebral cortex	BP
3	12	2.78335187967	-	8.20e-03	GO:0051457	maintenance of protein location in nucleus	BP
3	12	2.78335187967	-	8.20e-03	GO:0035635	entry of bacterium into host cell	BP
3	12	2.78335187967	-	8.20e-03	GO:0060644	mammary gland epithelial cell differentiation	BP
3	12	2.78335187967	-	8.20e-03	GO:0061014	positive regulation of mRNA catabolic process	BP
3	12	2.78335187967	-	8.20e-03	GO:0060444	branching involved in mammary gland duct morphogenesis	BP
2	8	2.78335187967	-	1.22e-02	GO:0071313	cellular response to caffeine	BP
2	8	2.78335187967	-	1.79e-02	GO:0060346	bone trabecula formation	BP
2	8	2.78335187967	-	1.79e-02	GO:1904948	midbrain dopaminergic neuron differentiation	BP
2	8	2.78335187967	-	2.45e-02	GO:0000288	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	BP
2	8	2.78335187967	-	2.45e-02	GO:0003139	secondary heart field specification	BP
2	8	2.78335187967	-	2.45e-02	GO:0040019	positive regulation of embryonic development	BP
2	8	2.78335187967	-	2.45e-02	GO:0015908	fatty acid transport	BP
2	8	2.78335187967	-	2.45e-02	GO:0071316	cellular response to nicotine	BP
2	8	2.78335187967	-	3.19e-02	GO:0045348	positive regulation of MHC class II biosynthetic process	BP
2	8	2.78335187967	-	3.19e-02	GO:0051569	regulation of histone H3-K4 methylation	BP
2	8	2.78335187967	-	3.19e-02	GO:0045647	negative regulation of erythrocyte differentiation	BP
2	8	2.78335187967	-	3.19e-02	GO:0034115	negative regulation of heterotypic cell-cell adhesion	BP
2	8	2.78335187967	-	3.19e-02	GO:1903599	positive regulation of mitophagy	BP
1	4	2.78335187967	-	7.13e-02	GO:1904954	canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	BP
1	4	2.78335187967	-	7.13e-02	GO:0090403	oxidative stress-induced premature senescence	BP
1	4	2.78335187967	-	7.13e-02	GO:0046684	response to pyrethroid	BP
1	4	2.78335187967	-	7.13e-02	GO:0043587	tongue morphogenesis	BP
1	4	2.78335187967	-	7.13e-02	GO:0060214	endocardium formation	BP
1	4	2.78335187967	-	7.13e-02	GO:0021759	globus pallidus development	BP
1	4	2.78335187967	-	7.13e-02	GO:0050994	regulation of lipid catabolic process	BP
1	4	2.78335187967	-	1.05e-01	GO:0036438	maintenance of lens transparency	BP
1	4	2.78335187967	-	1.05e-01	GO:0035616	histone H2B conserved C-terminal lysine deubiquitination	BP
1	4	2.78335187967	-	1.05e-01	GO:0031936	negative regulation of chromatin silencing	BP
1	4	2.78335187967	-	1.05e-01	GO:0048368	lateral mesoderm development	BP
1	4	2.78335187967	-	1.05e-01	GO:0003338	metanephros morphogenesis	BP
1	4	2.78335187967	-	1.05e-01	GO:0061030	epithelial cell differentiation involved in mammary gland alveolus development	BP
1	4	2.78335187967	-	1.05e-01	GO:1904179	positive regulation of adipose tissue development	BP
1	4	2.78335187967	-	1.05e-01	GO:0072676	lymphocyte migration	BP
1	4	2.78335187967	-	1.05e-01	GO:0070857	regulation of bile acid biosynthetic process	BP
1	4	2.78335187967	-	1.05e-01	GO:0003272	endocardial cushion formation	BP
1	4	2.78335187967	-	1.05e-01	GO:1902261	positive regulation of delayed rectifier potassium channel activity	BP
1	4	2.78335187967	-	1.05e-01	GO:0060335	positive regulation of interferon-gamma-mediated signaling pathway	BP
1	4	2.78335187967	-	1.05e-01	GO:0003231	cardiac ventricle development	BP
1	4	2.78335187967	-	1.05e-01	GO:0060429	epithelium development	BP
1	4	2.78335187967	-	1.05e-01	GO:0072221	metanephric distal convoluted tubule development	BP
1	4	2.78335187967	-	1.05e-01	GO:0048808	male genitalia morphogenesis	BP
1	4	2.78335187967	-	1.05e-01	GO:0015842	aminergic neurotransmitter loading into synaptic vesicle	BP
1	4	2.78335187967	-	1.05e-01	GO:0070741	response to interleukin-6	BP
1	4	2.78335187967	-	1.05e-01	GO:1902177	positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
1	4	2.78335187967	-	1.05e-01	GO:0002768	immune response-regulating cell surface receptor signaling pathway	BP
1	4	2.78335187967	-	1.05e-01	GO:1904888	cranial skeletal system development	BP
1	4	2.78335187967	-	1.05e-01	GO:0060486	Clara cell differentiation	BP
1	4	2.78335187967	-	1.05e-01	GO:0090184	positive regulation of kidney development	BP
1	4	2.78335187967	-	1.05e-01	GO:0060971	embryonic heart tube left/right pattern formation	BP
1	4	2.78335187967	-	1.05e-01	GO:0071442	positive regulation of histone H3-K14 acetylation	BP
1	4	2.78335187967	-	1.38e-01	GO:0002455	humoral immune response mediated by circulating immunoglobulin	BP
1	4	2.78335187967	-	1.38e-01	GO:0071801	regulation of podosome assembly	BP
1	4	2.78335187967	-	1.38e-01	GO:2001013	epithelial cell proliferation involved in renal tubule morphogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:0043201	response to leucine	BP
1	4	2.78335187967	-	1.38e-01	GO:0097411	hypoxia-inducible factor-1alpha signaling pathway	BP
1	4	2.78335187967	-	1.38e-01	GO:0035799	ureter maturation	BP
1	4	2.78335187967	-	1.38e-01	GO:0003170	heart valve development	BP
1	4	2.78335187967	-	1.38e-01	GO:1900020	positive regulation of protein kinase C activity	BP
1	4	2.78335187967	-	1.38e-01	GO:1901203	positive regulation of extracellular matrix assembly	BP
1	4	2.78335187967	-	1.38e-01	GO:0072107	positive regulation of ureteric bud formation	BP
1	4	2.78335187967	-	1.38e-01	GO:0072108	positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:0033625	positive regulation of integrin activation	BP
1	4	2.78335187967	-	1.38e-01	GO:0042345	regulation of NF-kappaB import into nucleus	BP
1	4	2.78335187967	-	1.38e-01	GO:0032507	maintenance of protein location in cell	BP
1	4	2.78335187967	-	1.38e-01	GO:0065002	intracellular protein transmembrane transport	BP
1	4	2.78335187967	-	1.38e-01	GO:0002248	connective tissue replacement involved in inflammatory response wound healing	BP
1	4	2.78335187967	-	1.38e-01	GO:0060708	spongiotrophoblast differentiation	BP
1	4	2.78335187967	-	1.38e-01	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	4	2.78335187967	-	1.38e-01	GO:0061428	negative regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
1	4	2.78335187967	-	1.38e-01	GO:0046602	regulation of mitotic centrosome separation	BP
1	4	2.78335187967	-	1.38e-01	GO:0019086	late viral transcription	BP
1	4	2.78335187967	-	1.38e-01	GO:0061333	renal tubule morphogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:0007296	vitellogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:0042063	gliogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:0060421	positive regulation of heart growth	BP
1	4	2.78335187967	-	1.38e-01	GO:0010835	regulation of protein ADP-ribosylation	BP
1	4	2.78335187967	-	1.38e-01	GO:0031670	cellular response to nutrient	BP
1	4	2.78335187967	-	1.38e-01	GO:0070318	positive regulation of G0 to G1 transition	BP
1	4	2.78335187967	-	1.38e-01	GO:0060676	ureteric bud formation	BP
1	4	2.78335187967	-	1.38e-01	GO:2000491	positive regulation of hepatic stellate cell activation	BP
1	4	2.78335187967	-	1.38e-01	GO:0060033	anatomical structure regression	BP
1	4	2.78335187967	-	1.38e-01	GO:0030910	olfactory placode formation	BP
1	4	2.78335187967	-	1.38e-01	GO:1990182	exosomal secretion	BP
1	4	2.78335187967	-	1.38e-01	GO:1903347	negative regulation of bicellular tight junction assembly	BP
1	4	2.78335187967	-	1.38e-01	GO:0090170	regulation of Golgi inheritance	BP
1	4	2.78335187967	-	1.38e-01	GO:1904504	positive regulation of lipophagy	BP
1	4	2.78335187967	-	1.38e-01	GO:1901300	positive regulation of hydrogen peroxide-mediated programmed cell death	BP
1	4	2.78335187967	-	1.38e-01	GO:0007621	negative regulation of female receptivity	BP
1	4	2.78335187967	-	1.38e-01	GO:0051660	establishment of centrosome localization	BP
1	4	2.78335187967	-	1.38e-01	GO:0061419	positive regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
1	4	2.78335187967	-	1.38e-01	GO:0003266	regulation of secondary heart field cardioblast proliferation	BP
1	4	2.78335187967	-	1.38e-01	GO:0010735	positive regulation of transcription via serum response element binding	BP
1	4	2.78335187967	-	1.38e-01	GO:0032417	positive regulation of sodium:proton antiporter activity	BP
1	4	2.78335187967	-	1.38e-01	GO:2000664	positive regulation of interleukin-5 secretion	BP
1	4	2.78335187967	-	1.38e-01	GO:0090240	positive regulation of histone H4 acetylation	BP
1	4	2.78335187967	-	1.38e-01	GO:0010988	regulation of low-density lipoprotein particle clearance	BP
1	4	2.78335187967	-	1.38e-01	GO:0060364	frontal suture morphogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:0006538	glutamate catabolic process	BP
1	4	2.78335187967	-	1.38e-01	GO:0051169	nuclear transport	BP
1	4	2.78335187967	-	1.38e-01	GO:0016071	mRNA metabolic process	BP
1	4	2.78335187967	-	1.38e-01	GO:0010822	positive regulation of mitochondrion organization	BP
1	4	2.78335187967	-	1.38e-01	GO:0031077	post-embryonic camera-type eye development	BP
1	4	2.78335187967	-	1.38e-01	GO:0060298	positive regulation of sarcomere organization	BP
1	4	2.78335187967	-	1.38e-01	GO:2000741	positive regulation of mesenchymal stem cell differentiation	BP
1	4	2.78335187967	-	1.38e-01	GO:0045876	positive regulation of sister chromatid cohesion	BP
1	4	2.78335187967	-	1.38e-01	GO:0035522	monoubiquitinated histone H2A deubiquitination	BP
1	4	2.78335187967	-	1.38e-01	GO:0010463	mesenchymal cell proliferation	BP
1	4	2.78335187967	-	1.38e-01	GO:0034698	response to gonadotropin	BP
1	4	2.78335187967	-	1.38e-01	GO:1902514	regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	BP
1	4	2.78335187967	-	1.38e-01	GO:0060574	intestinal epithelial cell maturation	BP
1	4	2.78335187967	-	1.38e-01	GO:0070836	caveola assembly	BP
1	4	2.78335187967	-	1.38e-01	GO:0022009	central nervous system vasculogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:1904637	cellular response to ionomycin	BP
1	4	2.78335187967	-	1.38e-01	GO:0045629	negative regulation of T-helper 2 cell differentiation	BP
1	4	2.78335187967	-	1.38e-01	GO:0072513	positive regulation of secondary heart field cardioblast proliferation	BP
1	4	2.78335187967	-	1.38e-01	GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation	BP
1	4	2.78335187967	-	1.38e-01	GO:0003253	cardiac neural crest cell migration involved in outflow tract morphogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:0042089	cytokine biosynthetic process	BP
1	4	2.78335187967	-	1.38e-01	GO:0033133	positive regulation of glucokinase activity	BP
1	4	2.78335187967	-	1.38e-01	GO:0048549	positive regulation of pinocytosis	BP
1	4	2.78335187967	-	1.38e-01	GO:0048541	Peyer's patch development	BP
1	4	2.78335187967	-	1.38e-01	GO:0003219	cardiac right ventricle formation	BP
1	4	2.78335187967	-	1.38e-01	GO:0034121	regulation of toll-like receptor signaling pathway	BP
1	4	2.78335187967	-	1.38e-01	GO:0002159	desmosome assembly	BP
1	4	2.78335187967	-	1.38e-01	GO:2000676	positive regulation of type B pancreatic cell apoptotic process	BP
1	4	2.78335187967	-	1.38e-01	GO:2000736	regulation of stem cell differentiation	BP
1	4	2.78335187967	-	1.38e-01	GO:0007100	mitotic centrosome separation	BP
1	4	2.78335187967	-	1.38e-01	GO:1901985	positive regulation of protein acetylation	BP
1	4	2.78335187967	-	1.38e-01	GO:0060351	cartilage development involved in endochondral bone morphogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:0060355	positive regulation of cell adhesion molecule production	BP
1	4	2.78335187967	-	1.38e-01	GO:0051345	positive regulation of hydrolase activity	BP
1	4	2.78335187967	-	1.38e-01	GO:0030050	vesicle transport along actin filament	BP
1	4	2.78335187967	-	1.38e-01	GO:0010626	negative regulation of Schwann cell proliferation	BP
1	4	2.78335187967	-	1.38e-01	GO:1902714	negative regulation of interferon-gamma secretion	BP
1	4	2.78335187967	-	1.38e-01	GO:0038028	insulin receptor signaling pathway via phosphatidylinositol 3-kinase	BP
1	4	2.78335187967	-	1.38e-01	GO:0051385	response to mineralocorticoid	BP
1	4	2.78335187967	-	1.38e-01	GO:0000904	cell morphogenesis involved in differentiation	BP
1	4	2.78335187967	-	1.38e-01	GO:0021764	amygdala development	BP
1	4	2.78335187967	-	1.38e-01	GO:0010499	proteasomal ubiquitin-independent protein catabolic process	BP
1	4	2.78335187967	-	1.38e-01	GO:0048570	notochord morphogenesis	BP
1	4	2.78335187967	-	1.38e-01	GO:0032909	regulation of transforming growth factor beta2 production	BP
2	8	2.78335187967	-	1.79e-02	GO:0032052	bile acid binding	MF
2	8	2.78335187967	-	3.19e-02	GO:0030235	nitric-oxide synthase regulator activity	MF
2	8	2.78335187967	-	3.19e-02	GO:0008140	cAMP response element binding protein binding	MF
2	8	2.78335187967	-	3.19e-02	GO:0001135	transcription factor activity, RNA polymerase II transcription factor recruiting	MF
2	8	2.78335187967	-	3.19e-02	GO:0003680	AT DNA binding	MF
1	4	2.78335187967	-	1.05e-01	GO:0005219	ryanodine-sensitive calcium-release channel activity	MF
1	4	2.78335187967	-	1.05e-01	GO:0048763	calcium-induced calcium release activity	MF
1	4	2.78335187967	-	1.05e-01	GO:0070891	lipoteichoic acid binding	MF
1	4	2.78335187967	-	1.05e-01	GO:0042287	MHC protein binding	MF
1	4	2.78335187967	-	1.05e-01	GO:0005176	ErbB-2 class receptor binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0050815	phosphoserine binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0043208	glycosphingolipid binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0009008	DNA-methyltransferase activity	MF
1	4	2.78335187967	-	1.38e-01	GO:0031014	troponin T binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0005025	transforming growth factor beta receptor activity, type I	MF
1	4	2.78335187967	-	1.38e-01	GO:0048408	epidermal growth factor binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0070851	growth factor receptor binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0030546	receptor activator activity	MF
1	4	2.78335187967	-	1.38e-01	GO:0004945	angiotensin type II receptor activity	MF
1	4	2.78335187967	-	1.38e-01	GO:0097371	MDM2/MDM4 family protein binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0034191	apolipoprotein A-I receptor binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0036033	mediator complex binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0004974	leukotriene receptor activity	MF
1	4	2.78335187967	-	1.38e-01	GO:0005497	androgen binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0003873	6-phosphofructo-2-kinase activity	MF
1	4	2.78335187967	-	1.38e-01	GO:0035312	5'-3' exodeoxyribonuclease activity	MF
1	4	2.78335187967	-	1.38e-01	GO:0001882	nucleoside binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0043125	ErbB-3 class receptor binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0086007	voltage-gated calcium channel activity involved in cardiac muscle cell action potential	MF
1	4	2.78335187967	-	1.38e-01	GO:0004698	calcium-dependent protein kinase C activity	MF
1	4	2.78335187967	-	1.38e-01	GO:0045503	dynein light chain binding	MF
1	4	2.78335187967	-	1.38e-01	GO:0031698	beta-2 adrenergic receptor binding	MF
14	57	2.75781678757	-	2.88e-09	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	MF
11	45	2.75093040198	-	4.71e-08	GO:0035914	skeletal muscle cell differentiation	BP
10	41	2.74772796994	-	5.25e-07	GO:0004402	histone acetyltransferase activity	MF
7	29	2.7327258066	-	1.61e-05	GO:0001569	branching involved in blood vessel morphogenesis	BP
6	25	2.72445819062	-	7.58e-05	GO:0016573	histone acetylation	BP
11	46	2.71922154225	-	1.15e-07	GO:0051591	response to cAMP	BP
5	21	2.71296255178	-	1.94e-04	GO:0071542	dopaminergic neuron differentiation	BP
14	59	2.70806375237	-	1.35e-08	GO:0001047	core promoter binding	MF
18	76	2.70534936767	-	5.47e-11	GO:0007623	circadian rhythm	BP
4	17	2.69588903842	-	1.29e-03	GO:0032331	negative regulation of chondrocyte differentiation	BP
4	17	2.69588903842	-	1.70e-03	GO:0071375	cellular response to peptide hormone stimulus	BP
4	17	2.69588903842	-	2.21e-03	GO:0030225	macrophage differentiation	BP
24	102	2.69588903842	-	5.41e-11	GO:0042826	histone deacetylase binding	MF
4	17	2.69588903842	-	2.80e-03	GO:0071837	HMG box domain binding	MF
14	60	2.68381620612	-	1.06e-08	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	BP
3	13	2.66787466225	-	3.39e-03	GO:0060402	calcium ion transport into cytosol	BP
3	13	2.66787466225	-	8.20e-03	GO:0060413	atrial septum morphogenesis	BP
3	13	2.66787466225	-	1.04e-02	GO:0001678	cellular glucose homeostasis	BP
3	13	2.66787466225	-	1.04e-02	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	BP
3	13	2.66787466225	-	1.04e-02	GO:0048821	erythrocyte development	BP
48	208	2.66787466225	-	1.07e-10	GO:0044212	transcription regulatory region DNA binding	MF
3	13	2.66787466225	-	8.20e-03	GO:0035326	enhancer binding	MF
75	329	2.65022679643	-	8.32e-11	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	MF
7	31	2.63651049134	-	1.61e-05	GO:0035115	embryonic forelimb morphogenesis	BP
26	116	2.62581060269	-	9.76e-11	GO:0001078	transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
8	36	2.61342687823	-	1.78e-05	GO:0071392	cellular response to estradiol stimulus	BP
6	27	2.61342687823	-	1.01e-04	GO:0010575	positive regulation of vascular endothelial growth factor production	BP
6	27	2.61342687823	-	2.19e-04	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	BP
2	9	2.61342687823	-	1.79e-02	GO:0055091	phospholipid homeostasis	BP
2	9	2.61342687823	-	1.79e-02	GO:0048617	embryonic foregut morphogenesis	BP
2	9	2.61342687823	-	2.45e-02	GO:0061072	iris morphogenesis	BP
2	9	2.61342687823	-	2.45e-02	GO:0048643	positive regulation of skeletal muscle tissue development	BP
2	9	2.61342687823	-	3.19e-02	GO:0003208	cardiac ventricle morphogenesis	BP
2	9	2.61342687823	-	3.19e-02	GO:0019953	sexual reproduction	BP
2	9	2.61342687823	-	3.19e-02	GO:0036500	ATF6-mediated unfolded protein response	BP
2	9	2.61342687823	-	3.19e-02	GO:0048660	regulation of smooth muscle cell proliferation	BP
2	9	2.61342687823	-	4.00e-02	GO:2000727	positive regulation of cardiac muscle cell differentiation	BP
2	9	2.61342687823	-	4.00e-02	GO:0010224	response to UV-B	BP
2	9	2.61342687823	-	4.00e-02	GO:2000178	negative regulation of neural precursor cell proliferation	BP
2	9	2.61342687823	-	4.00e-02	GO:0010831	positive regulation of myotube differentiation	BP
2	9	2.61342687823	-	4.00e-02	GO:0043068	positive regulation of programmed cell death	BP
2	9	2.61342687823	-	4.00e-02	GO:0030851	granulocyte differentiation	BP
2	9	2.61342687823	-	4.00e-02	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	BP
2	9	2.61342687823	-	4.00e-02	GO:0033762	response to glucagon	BP
2	9	2.61342687823	-	4.00e-02	GO:0007184	SMAD protein import into nucleus	BP
2	9	2.61342687823	-	4.00e-02	GO:0045080	positive regulation of chemokine biosynthetic process	BP
2	9	2.61342687823	-	4.00e-02	GO:0021895	cerebral cortex neuron differentiation	BP
2	9	2.61342687823	-	4.00e-02	GO:0032000	positive regulation of fatty acid beta-oxidation	BP
2	9	2.61342687823	-	4.00e-02	GO:0043995	histone acetyltransferase activity (H4-K5 specific)	MF
2	9	2.61342687823	-	4.00e-02	GO:0043996	histone acetyltransferase activity (H4-K8 specific)	MF
2	9	2.61342687823	-	4.00e-02	GO:0046972	histone acetyltransferase activity (H4-K16 specific)	MF
7	32	2.59070680173	-	1.22e-04	GO:0070491	repressing transcription factor binding	MF
12	55	2.58695466687	-	2.01e-07	GO:0003712	transcription cofactor activity	MF
5	23	2.5817180185	-	4.71e-04	GO:0009954	proximal/distal pattern formation	BP
3	14	2.56095945834	-	3.39e-03	GO:0021854	hypothalamus development	BP
3	14	2.56095945834	-	4.72e-03	GO:0010839	negative regulation of keratinocyte proliferation	BP
3	14	2.56095945834	-	8.20e-03	GO:0006359	regulation of transcription from RNA polymerase III promoter	BP
3	14	2.56095945834	-	8.20e-03	GO:0001708	cell fate specification	BP
3	14	2.56095945834	-	8.20e-03	GO:2000678	negative regulation of transcription regulatory region DNA binding	BP
3	14	2.56095945834	-	1.04e-02	GO:0014912	negative regulation of smooth muscle cell migration	BP
3	14	2.56095945834	-	1.04e-02	GO:0060749	mammary gland alveolus development	BP
3	14	2.56095945834	-	1.04e-02	GO:0040029	regulation of gene expression, epigenetic	BP
4	19	2.53542436623	-	2.80e-03	GO:0042832	defense response to protozoan	BP
4	19	2.53542436623	-	4.31e-03	GO:0043011	myeloid dendritic cell differentiation	BP
4	19	2.53542436623	-	4.31e-03	GO:0070932	histone H3 deacetylation	BP
104	496	2.52959528743	-	1.28e-10	GO:0045893	positive regulation of transcription, DNA-templated	BP
10	48	2.52031747384	-	2.37e-06	GO:0034097	response to cytokine	BP
5	24	2.52031747384	-	3.58e-04	GO:0030878	thyroid gland development	BP
6	29	2.51033338527	-	4.24e-04	GO:0048662	negative regulation of smooth muscle cell proliferation	BP
3	15	2.46142378479	-	8.20e-03	GO:0035050	embryonic heart tube development	BP
3	15	2.46142378479	-	1.04e-02	GO:0044849	estrous cycle	BP
3	15	2.46142378479	-	1.28e-02	GO:0030330	DNA damage response, signal transduction by p53 class mediator	BP
3	15	2.46142378479	-	1.28e-02	GO:0010608	posttranscriptional regulation of gene expression	BP
3	15	2.46142378479	-	1.56e-02	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BP
3	15	2.46142378479	-	1.56e-02	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	BP
3	15	2.46142378479	-	1.56e-02	GO:2000679	positive regulation of transcription regulatory region DNA binding	BP
3	15	2.46142378479	-	1.56e-02	GO:0051393	alpha-actinin binding	MF
8	40	2.46142378479	-	1.78e-05	GO:0032570	response to progesterone	BP
5	25	2.46142378479	-	1.37e-04	GO:0015721	bile acid and bile salt transport	BP
5	25	2.46142378479	-	1.21e-03	GO:0060612	adipose tissue development	BP
4	20	2.46142378479	-	1.70e-03	GO:0002052	positive regulation of neuroblast proliferation	BP
2	10	2.46142378479	-	3.85e-03	GO:0002430	complement receptor mediated signaling pathway	BP
4	20	2.46142378479	-	4.31e-03	GO:0045662	negative regulation of myoblast differentiation	BP
2	10	2.46142378479	-	1.79e-02	GO:0060174	limb bud formation	BP
2	10	2.46142378479	-	2.45e-02	GO:0045598	regulation of fat cell differentiation	BP
2	10	2.46142378479	-	2.45e-02	GO:0051006	positive regulation of lipoprotein lipase activity	BP
2	10	2.46142378479	-	2.45e-02	GO:0015909	long-chain fatty acid transport	BP
2	10	2.46142378479	-	3.19e-02	GO:0045723	positive regulation of fatty acid biosynthetic process	BP
2	10	2.46142378479	-	3.19e-02	GO:0048048	embryonic eye morphogenesis	BP
2	10	2.46142378479	-	3.19e-02	GO:0060055	angiogenesis involved in wound healing	BP
2	10	2.46142378479	-	4.00e-02	GO:1903204	negative regulation of oxidative stress-induced neuron death	BP
2	10	2.46142378479	-	4.00e-02	GO:0050880	regulation of blood vessel size	BP
2	10	2.46142378479	-	4.00e-02	GO:0000290	deadenylation-dependent decapping of nuclear-transcribed mRNA	BP
2	10	2.46142378479	-	4.00e-02	GO:0003181	atrioventricular valve morphogenesis	BP
2	10	2.46142378479	-	4.00e-02	GO:0007614	short-term memory	BP
2	10	2.46142378479	-	4.00e-02	GO:0045943	positive regulation of transcription from RNA polymerase I promoter	BP
2	10	2.46142378479	-	4.88e-02	GO:0071383	cellular response to steroid hormone stimulus	BP
2	10	2.46142378479	-	4.88e-02	GO:0010225	response to UV-C	BP
2	10	2.46142378479	-	4.88e-02	GO:0033235	positive regulation of protein sumoylation	BP
2	10	2.46142378479	-	4.88e-02	GO:0031065	positive regulation of histone deacetylation	BP
2	10	2.46142378479	-	4.88e-02	GO:1902237	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
2	10	2.46142378479	-	4.88e-02	GO:0042416	dopamine biosynthetic process	BP
2	10	2.46142378479	-	4.88e-02	GO:0031000	response to caffeine	BP
2	10	2.46142378479	-	4.88e-02	GO:0000338	protein deneddylation	BP
1	5	2.46142378479	-	7.13e-02	GO:0070309	lens fiber cell morphogenesis	BP
1	5	2.46142378479	-	7.13e-02	GO:0097070	ductus arteriosus closure	BP
1	5	2.46142378479	-	7.13e-02	GO:0042743	hydrogen peroxide metabolic process	BP
1	5	2.46142378479	-	1.05e-01	GO:2000647	negative regulation of stem cell proliferation	BP
1	5	2.46142378479	-	1.05e-01	GO:0048645	animal organ formation	BP
1	5	2.46142378479	-	1.05e-01	GO:0061743	motor learning	BP
1	5	2.46142378479	-	1.05e-01	GO:0046219	indolalkylamine biosynthetic process	BP
1	5	2.46142378479	-	1.05e-01	GO:1990845	adaptive thermogenesis	BP
1	5	2.46142378479	-	1.05e-01	GO:0030856	regulation of epithelial cell differentiation	BP
1	5	2.46142378479	-	1.05e-01	GO:0046618	drug export	BP
1	5	2.46142378479	-	1.05e-01	GO:0003211	cardiac ventricle formation	BP
1	5	2.46142378479	-	1.05e-01	GO:0030311	poly-N-acetyllactosamine biosynthetic process	BP
1	5	2.46142378479	-	1.38e-01	GO:0048730	epidermis morphogenesis	BP
1	5	2.46142378479	-	1.38e-01	GO:0045347	negative regulation of MHC class II biosynthetic process	BP
1	5	2.46142378479	-	1.38e-01	GO:0060666	dichotomous subdivision of terminal units involved in salivary gland branching	BP
1	5	2.46142378479	-	1.38e-01	GO:0060591	chondroblast differentiation	BP
1	5	2.46142378479	-	1.38e-01	GO:0060510	Type II pneumocyte differentiation	BP
1	5	2.46142378479	-	1.38e-01	GO:0021960	anterior commissure morphogenesis	BP
1	5	2.46142378479	-	1.38e-01	GO:0060136	embryonic process involved in female pregnancy	BP
1	5	2.46142378479	-	1.38e-01	GO:0072602	interleukin-4 secretion	BP
1	5	2.46142378479	-	1.38e-01	GO:0031346	positive regulation of cell projection organization	BP
1	5	2.46142378479	-	1.38e-01	GO:2000987	positive regulation of behavioral fear response	BP
1	5	2.46142378479	-	1.38e-01	GO:0072284	metanephric S-shaped body morphogenesis	BP
1	5	2.46142378479	-	1.38e-01	GO:0031914	negative regulation of synaptic plasticity	BP
1	5	2.46142378479	-	1.38e-01	GO:0043584	nose development	BP
1	5	2.46142378479	-	1.38e-01	GO:0051122	hepoxilin biosynthetic process	BP
1	5	2.46142378479	-	1.38e-01	GO:0019563	glycerol catabolic process	BP
1	5	2.46142378479	-	1.38e-01	GO:0010632	regulation of epithelial cell migration	BP
1	5	2.46142378479	-	1.38e-01	GO:0035881	amacrine cell differentiation	BP
1	5	2.46142378479	-	1.38e-01	GO:0016101	diterpenoid metabolic process	BP
1	5	2.46142378479	-	1.38e-01	GO:0009414	response to water deprivation	BP
1	5	2.46142378479	-	1.38e-01	GO:0072162	metanephric mesenchymal cell differentiation	BP
1	5	2.46142378479	-	1.38e-01	GO:0032224	positive regulation of synaptic transmission, cholinergic	BP
1	5	2.46142378479	-	1.38e-01	GO:2001028	positive regulation of endothelial cell chemotaxis	BP
1	5	2.46142378479	-	1.38e-01	GO:1901727	positive regulation of histone deacetylase activity	BP
1	5	2.46142378479	-	1.38e-01	GO:0086045	membrane depolarization during AV node cell action potential	BP
1	5	2.46142378479	-	1.38e-01	GO:0045542	positive regulation of cholesterol biosynthetic process	BP
1	5	2.46142378479	-	1.38e-01	GO:0072207	metanephric epithelium development	BP
1	5	2.46142378479	-	1.38e-01	GO:0009299	mRNA transcription	BP
1	5	2.46142378479	-	1.38e-01	GO:0043367	CD4-positive, alpha-beta T cell differentiation	BP
1	5	2.46142378479	-	1.38e-01	GO:0014050	negative regulation of glutamate secretion	BP
1	5	2.46142378479	-	1.38e-01	GO:0072178	nephric duct morphogenesis	BP
1	5	2.46142378479	-	1.69e-01	GO:0042541	hemoglobin biosynthetic process	BP
1	5	2.46142378479	-	1.69e-01	GO:0072655	establishment of protein localization to mitochondrion	BP
1	5	2.46142378479	-	1.69e-01	GO:0060964	regulation of gene silencing by miRNA	BP
1	5	2.46142378479	-	1.69e-01	GO:0002074	extraocular skeletal muscle development	BP
1	5	2.46142378479	-	1.69e-01	GO:0061737	leukotriene signaling pathway	BP
1	5	2.46142378479	-	1.69e-01	GO:0030240	skeletal muscle thin filament assembly	BP
1	5	2.46142378479	-	1.69e-01	GO:0035509	negative regulation of myosin-light-chain-phosphatase activity	BP
1	5	2.46142378479	-	1.69e-01	GO:0065004	protein-DNA complex assembly	BP
1	5	2.46142378479	-	1.69e-01	GO:1905007	positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	BP
1	5	2.46142378479	-	1.69e-01	GO:0098735	positive regulation of the force of heart contraction	BP
1	5	2.46142378479	-	1.69e-01	GO:0010715	regulation of extracellular matrix disassembly	BP
1	5	2.46142378479	-	1.69e-01	GO:1902262	apoptotic process involved in blood vessel morphogenesis	BP
1	5	2.46142378479	-	1.69e-01	GO:0031536	positive regulation of exit from mitosis	BP
1	5	2.46142378479	-	1.69e-01	GO:0019640	glucuronate catabolic process to xylulose 5-phosphate	BP
1	5	2.46142378479	-	1.69e-01	GO:0045646	regulation of erythrocyte differentiation	BP
1	5	2.46142378479	-	1.69e-01	GO:0060179	male mating behavior	BP
1	5	2.46142378479	-	1.69e-01	GO:0010830	regulation of myotube differentiation	BP
1	5	2.46142378479	-	1.69e-01	GO:0014031	mesenchymal cell development	BP
1	5	2.46142378479	-	1.69e-01	GO:0038084	vascular endothelial growth factor signaling pathway	BP
1	5	2.46142378479	-	1.69e-01	GO:0032747	positive regulation of interleukin-23 production	BP
1	5	2.46142378479	-	1.69e-01	GO:0048143	astrocyte activation	BP
1	5	2.46142378479	-	1.69e-01	GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
1	5	2.46142378479	-	1.69e-01	GO:0045637	regulation of myeloid cell differentiation	BP
1	5	2.46142378479	-	1.69e-01	GO:0001504	neurotransmitter uptake	BP
1	5	2.46142378479	-	1.69e-01	GO:0034197	triglyceride transport	BP
1	5	2.46142378479	-	1.69e-01	GO:2001171	positive regulation of ATP biosynthetic process	BP
1	5	2.46142378479	-	1.69e-01	GO:0070296	sarcoplasmic reticulum calcium ion transport	BP
1	5	2.46142378479	-	1.69e-01	GO:0072584	caveolin-mediated endocytosis	BP
1	5	2.46142378479	-	1.69e-01	GO:0036035	osteoclast development	BP
1	5	2.46142378479	-	1.69e-01	GO:1902035	positive regulation of hematopoietic stem cell proliferation	BP
1	5	2.46142378479	-	1.69e-01	GO:1903026	negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
1	5	2.46142378479	-	1.69e-01	GO:0071864	positive regulation of cell proliferation in bone marrow	BP
1	5	2.46142378479	-	1.69e-01	GO:0048341	paraxial mesoderm formation	BP
1	5	2.46142378479	-	1.69e-01	GO:1990441	negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
1	5	2.46142378479	-	1.69e-01	GO:0043353	enucleate erythrocyte differentiation	BP
1	5	2.46142378479	-	1.69e-01	GO:0038033	positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	BP
1	5	2.46142378479	-	1.69e-01	GO:0050713	negative regulation of interleukin-1 beta secretion	BP
1	5	2.46142378479	-	1.69e-01	GO:0036336	dendritic cell migration	BP
1	5	2.46142378479	-	1.69e-01	GO:0001887	selenium compound metabolic process	BP
1	5	2.46142378479	-	1.69e-01	GO:0090330	regulation of platelet aggregation	BP
1	5	2.46142378479	-	1.69e-01	GO:0002260	lymphocyte homeostasis	BP
1	5	2.46142378479	-	1.69e-01	GO:0033132	negative regulation of glucokinase activity	BP
1	5	2.46142378479	-	1.69e-01	GO:0060157	urinary bladder development	BP
1	5	2.46142378479	-	1.69e-01	GO:0090188	negative regulation of pancreatic juice secretion	BP
1	5	2.46142378479	-	1.69e-01	GO:2000535	regulation of entry of bacterium into host cell	BP
1	5	2.46142378479	-	1.69e-01	GO:0010991	negative regulation of SMAD protein complex assembly	BP
1	5	2.46142378479	-	1.69e-01	GO:0051344	negative regulation of cyclic-nucleotide phosphodiesterase activity	BP
1	5	2.46142378479	-	1.69e-01	GO:0071681	cellular response to indole-3-methanol	BP
1	5	2.46142378479	-	1.69e-01	GO:0006003	fructose 2,6-bisphosphate metabolic process	BP
1	5	2.46142378479	-	1.69e-01	GO:1903361	protein localization to basolateral plasma membrane	BP
1	5	2.46142378479	-	1.69e-01	GO:0043550	regulation of lipid kinase activity	BP
1	5	2.46142378479	-	1.69e-01	GO:0051534	negative regulation of NFAT protein import into nucleus	BP
1	5	2.46142378479	-	1.69e-01	GO:0010452	histone H3-K36 methylation	BP
1	5	2.46142378479	-	1.69e-01	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	BP
1	5	2.46142378479	-	1.69e-01	GO:0032534	regulation of microvillus assembly	BP
1	5	2.46142378479	-	1.69e-01	GO:0006089	lactate metabolic process	BP
1	5	2.46142378479	-	1.69e-01	GO:0030098	lymphocyte differentiation	BP
2	10	2.46142378479	-	3.19e-02	GO:0001206	transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
1	5	2.46142378479	-	1.05e-01	GO:0008532	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity	MF
1	5	2.46142378479	-	1.38e-01	GO:0061665	SUMO ligase activity	MF
1	5	2.46142378479	-	1.38e-01	GO:0019871	sodium channel inhibitor activity	MF
1	5	2.46142378479	-	1.38e-01	GO:0034596	phosphatidylinositol phosphate 4-phosphatase activity	MF
1	5	2.46142378479	-	1.69e-01	GO:1990239	steroid hormone binding	MF
1	5	2.46142378479	-	1.69e-01	GO:0000975	regulatory region DNA binding	MF
1	5	2.46142378479	-	1.69e-01	GO:0010385	double-stranded methylated DNA binding	MF
1	5	2.46142378479	-	1.69e-01	GO:0004331	fructose-2,6-bisphosphate 2-phosphatase activity	MF
1	5	2.46142378479	-	1.69e-01	GO:0005324	long-chain fatty acid transporter activity	MF
1	5	2.46142378479	-	1.69e-01	GO:0050544	arachidonic acid binding	MF
1	5	2.46142378479	-	1.69e-01	GO:0015277	kainate selective glutamate receptor activity	MF
1	5	2.46142378479	-	1.69e-01	GO:0005134	interleukin-2 receptor binding	MF
1	5	2.46142378479	-	1.69e-01	GO:0034711	inhibin binding	MF
1	5	2.46142378479	-	1.69e-01	GO:0042799	histone methyltransferase activity (H4-K20 specific)	MF
1	5	2.46142378479	-	1.69e-01	GO:0071532	ankyrin repeat binding	MF
1	5	2.46142378479	-	1.69e-01	GO:0070878	primary miRNA binding	MF
1	5	2.46142378479	-	1.69e-01	GO:0043426	MRF binding	MF
69	360	2.40002324012	-	6.14e-11	GO:0043565	sequence-specific DNA binding	MF
8	42	2.3910344569	-	2.25e-05	GO:0032526	response to retinoic acid	BP
4	21	2.3910344569	-	2.80e-03	GO:0001502	cartilage condensation	BP
4	21	2.3910344569	-	3.50e-03	GO:0035902	response to immobilization stress	BP
4	21	2.3910344569	-	3.50e-03	GO:0045672	positive regulation of osteoclast differentiation	BP
4	21	2.3910344569	-	3.50e-03	GO:0046697	decidualization	BP
10	53	2.37735952	-	6.88e-06	GO:0048511	rhythmic process	BP
3	16	2.3683143804	-	1.04e-02	GO:0014850	response to muscle activity	BP
3	16	2.3683143804	-	1.28e-02	GO:0035855	megakaryocyte development	BP
3	16	2.3683143804	-	1.56e-02	GO:2000179	positive regulation of neural precursor cell proliferation	BP
3	16	2.3683143804	-	1.56e-02	GO:0035162	embryonic hemopoiesis	BP
3	16	2.3683143804	-	1.56e-02	GO:0043968	histone H2A acetylation	BP
3	16	2.3683143804	-	1.87e-02	GO:0003203	endocardial cushion morphogenesis	BP
3	16	2.3683143804	-	1.87e-02	GO:0032270	positive regulation of cellular protein metabolic process	BP
3	16	2.3683143804	-	1.87e-02	GO:0010613	positive regulation of cardiac muscle hypertrophy	BP
11	59	2.36014044895	-	6.29e-06	GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	BP
15	81	2.3503924724	-	1.08e-07	GO:0006338	chromatin remodeling	BP
9	49	2.338567037	-	3.39e-05	GO:0042752	regulation of circadian rhythm	BP
14	77	2.32392026104	-	9.66e-08	GO:0009952	anterior/posterior pattern specification	BP
8	44	2.32392026104	-	2.83e-05	GO:0032870	cellular response to hormone stimulus	BP
8	44	2.32392026104	-	1.60e-04	GO:0043525	positive regulation of neuron apoptotic process	BP
6	33	2.32392026104	-	7.55e-04	GO:0045787	positive regulation of cell cycle	BP
4	22	2.32392026104	-	4.31e-03	GO:0010719	negative regulation of epithelial to mesenchymal transition	BP
4	22	2.32392026104	-	6.29e-03	GO:0003148	outflow tract septum morphogenesis	BP
2	11	2.32392026104	-	4.00e-02	GO:0001893	maternal placenta development	BP
2	11	2.32392026104	-	4.00e-02	GO:0042445	hormone metabolic process	BP
2	11	2.32392026104	-	4.88e-02	GO:0001823	mesonephros development	BP
2	11	2.32392026104	-	4.88e-02	GO:0060272	embryonic skeletal joint morphogenesis	BP
2	11	2.32392026104	-	4.88e-02	GO:0060218	hematopoietic stem cell differentiation	BP
2	11	2.32392026104	-	4.88e-02	GO:0045945	positive regulation of transcription from RNA polymerase III promoter	BP
2	11	2.32392026104	-	4.88e-02	GO:0008610	lipid biosynthetic process	BP
2	11	2.32392026104	-	5.83e-02	GO:0030238	male sex determination	BP
2	11	2.32392026104	-	5.83e-02	GO:0060487	lung epithelial cell differentiation	BP
4	22	2.32392026104	-	4.31e-03	GO:1990841	promoter-specific chromatin binding	MF
2	11	2.32392026104	-	5.83e-02	GO:0043522	leucine zipper domain binding	MF
176	981	2.30467417209	-	1.41e-10	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	BP
10	56	2.2979250525	-	4.58e-06	GO:0009612	response to mechanical stimulus	BP
5	28	2.2979250525	-	3.04e-03	GO:0051059	NF-kappaB binding	MF
18	102	2.28085153914	-	5.19e-09	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	BP
3	17	2.28085153914	-	1.28e-02	GO:0030193	regulation of blood coagulation	BP
3	17	2.28085153914	-	1.56e-02	GO:0071354	cellular response to interleukin-6	BP
3	17	2.28085153914	-	1.56e-02	GO:0045926	negative regulation of growth	BP
3	17	2.28085153914	-	1.87e-02	GO:0030325	adrenal gland development	BP
3	17	2.28085153914	-	1.87e-02	GO:0043536	positive regulation of blood vessel endothelial cell migration	BP
4	23	2.25978992362	-	5.24e-03	GO:0031018	endocrine pancreas development	BP
4	23	2.25978992362	-	8.79e-03	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	BP
5	29	2.24729897943	-	2.58e-03	GO:0000060	protein import into nucleus, translocation	BP
6	35	2.23903136345	-	1.47e-03	GO:0070888	E-box binding	MF
7	41	2.23315479711	-	3.79e-04	GO:0007595	lactation	BP
92	545	2.21680141607	-	6.48e-11	GO:0006366	transcription from RNA polymerase II promoter	BP
7	42	2.19838937895	-	1.83e-04	GO:0045599	negative regulation of fat cell differentiation	BP
4	24	2.19838937895	-	7.47e-03	GO:0055007	cardiac muscle cell differentiation	BP
4	24	2.19838937895	-	8.79e-03	GO:0051966	regulation of synaptic transmission, glutamatergic	BP
4	24	2.19838937895	-	1.02e-02	GO:0043388	positive regulation of DNA binding	BP
2	12	2.19838937895	-	4.88e-02	GO:0045670	regulation of osteoclast differentiation	BP
2	12	2.19838937895	-	4.88e-02	GO:0009888	tissue development	BP
2	12	2.19838937895	-	4.88e-02	GO:0008206	bile acid metabolic process	BP
2	12	2.19838937895	-	5.83e-02	GO:0007512	adult heart development	BP
2	12	2.19838937895	-	5.83e-02	GO:0043922	negative regulation by host of viral transcription	BP
2	12	2.19838937895	-	5.83e-02	GO:2000505	regulation of energy homeostasis	BP
2	12	2.19838937895	-	5.83e-02	GO:0060766	negative regulation of androgen receptor signaling pathway	BP
2	12	2.19838937895	-	6.83e-02	GO:0045019	negative regulation of nitric oxide biosynthetic process	BP
2	12	2.19838937895	-	6.83e-02	GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation	BP
2	12	2.19838937895	-	6.83e-02	GO:0032801	receptor catabolic process	BP
2	12	2.19838937895	-	6.83e-02	GO:0016578	histone deubiquitination	BP
2	12	2.19838937895	-	6.83e-02	GO:0045820	negative regulation of glycolytic process	BP
2	12	2.19838937895	-	6.83e-02	GO:0021954	central nervous system neuron development	BP
1	6	2.19838937895	-	7.13e-02	GO:0030540	female genitalia development	BP
1	6	2.19838937895	-	7.13e-02	GO:2000253	positive regulation of feeding behavior	BP
1	6	2.19838937895	-	7.13e-02	GO:0034755	iron ion transmembrane transport	BP
1	6	2.19838937895	-	7.13e-02	GO:2000272	negative regulation of receptor activity	BP
1	6	2.19838937895	-	1.05e-01	GO:0070383	DNA cytosine deamination	BP
1	6	2.19838937895	-	1.05e-01	GO:0051552	flavone metabolic process	BP
1	6	2.19838937895	-	1.05e-01	GO:0032964	collagen biosynthetic process	BP
1	6	2.19838937895	-	1.38e-01	GO:0007341	penetration of zona pellucida	BP
1	6	2.19838937895	-	1.38e-01	GO:0045345	positive regulation of MHC class I biosynthetic process	BP
1	6	2.19838937895	-	1.38e-01	GO:0003416	endochondral bone growth	BP
1	6	2.19838937895	-	1.38e-01	GO:0021930	cerebellar granule cell precursor proliferation	BP
1	6	2.19838937895	-	1.38e-01	GO:2000507	positive regulation of energy homeostasis	BP
1	6	2.19838937895	-	1.38e-01	GO:0048793	pronephros development	BP
1	6	2.19838937895	-	1.38e-01	GO:1900116	extracellular negative regulation of signal transduction	BP
1	6	2.19838937895	-	1.38e-01	GO:0007530	sex determination	BP
1	6	2.19838937895	-	1.69e-01	GO:0003179	heart valve morphogenesis	BP
1	6	2.19838937895	-	1.69e-01	GO:0038092	nodal signaling pathway	BP
1	6	2.19838937895	-	1.69e-01	GO:0032364	oxygen homeostasis	BP
1	6	2.19838937895	-	1.69e-01	GO:0031017	exocrine pancreas development	BP
1	6	2.19838937895	-	1.69e-01	GO:0042536	negative regulation of tumor necrosis factor biosynthetic process	BP
1	6	2.19838937895	-	1.69e-01	GO:0048525	negative regulation of viral process	BP
1	6	2.19838937895	-	1.69e-01	GO:0060372	regulation of atrial cardiac muscle cell membrane repolarization	BP
1	6	2.19838937895	-	1.69e-01	GO:2000553	positive regulation of T-helper 2 cell cytokine production	BP
1	6	2.19838937895	-	1.69e-01	GO:0043620	regulation of DNA-templated transcription in response to stress	BP
1	6	2.19838937895	-	1.69e-01	GO:0048806	genitalia development	BP
1	6	2.19838937895	-	1.69e-01	GO:0046533	negative regulation of photoreceptor cell differentiation	BP
1	6	2.19838937895	-	1.69e-01	GO:0061180	mammary gland epithelium development	BP
1	6	2.19838937895	-	1.69e-01	GO:0048845	venous blood vessel morphogenesis	BP
1	6	2.19838937895	-	1.69e-01	GO:0072540	T-helper 17 cell lineage commitment	BP
1	6	2.19838937895	-	1.69e-01	GO:0002639	positive regulation of immunoglobulin production	BP
1	6	2.19838937895	-	1.69e-01	GO:0060836	lymphatic endothelial cell differentiation	BP
1	6	2.19838937895	-	1.69e-01	GO:0010631	epithelial cell migration	BP
1	6	2.19838937895	-	1.69e-01	GO:0051099	positive regulation of binding	BP
1	6	2.19838937895	-	1.69e-01	GO:0033211	adiponectin-activated signaling pathway	BP
1	6	2.19838937895	-	1.69e-01	GO:0021798	forebrain dorsal/ventral pattern formation	BP
1	6	2.19838937895	-	1.69e-01	GO:0021796	cerebral cortex regionalization	BP
1	6	2.19838937895	-	1.69e-01	GO:0042048	olfactory behavior	BP
1	6	2.19838937895	-	1.69e-01	GO:0044806	G-quadruplex DNA unwinding	BP
1	6	2.19838937895	-	1.69e-01	GO:0060056	mammary gland involution	BP
1	6	2.19838937895	-	1.69e-01	GO:0010960	magnesium ion homeostasis	BP
1	6	2.19838937895	-	1.69e-01	GO:0042421	norepinephrine biosynthetic process	BP
1	6	2.19838937895	-	1.99e-01	GO:0051271	negative regulation of cellular component movement	BP
1	6	2.19838937895	-	1.99e-01	GO:0042092	type 2 immune response	BP
1	6	2.19838937895	-	1.99e-01	GO:0098532	histone H3-K27 trimethylation	BP
1	6	2.19838937895	-	1.99e-01	GO:0010564	regulation of cell cycle process	BP
1	6	2.19838937895	-	1.99e-01	GO:0051101	regulation of DNA binding	BP
1	6	2.19838937895	-	1.99e-01	GO:0001553	luteinization	BP
1	6	2.19838937895	-	1.99e-01	GO:0061037	negative regulation of cartilage development	BP
1	6	2.19838937895	-	1.99e-01	GO:1902533	positive regulation of intracellular signal transduction	BP
1	6	2.19838937895	-	1.99e-01	GO:2000171	negative regulation of dendrite development	BP
1	6	2.19838937895	-	1.99e-01	GO:0050671	positive regulation of lymphocyte proliferation	BP
1	6	2.19838937895	-	1.99e-01	GO:1903715	regulation of aerobic respiration	BP
1	6	2.19838937895	-	1.99e-01	GO:0072307	regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	6	2.19838937895	-	1.99e-01	GO:0051902	negative regulation of mitochondrial depolarization	BP
1	6	2.19838937895	-	1.99e-01	GO:0014033	neural crest cell differentiation	BP
1	6	2.19838937895	-	1.99e-01	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	BP
1	6	2.19838937895	-	1.99e-01	GO:0030031	cell projection assembly	BP
1	6	2.19838937895	-	1.99e-01	GO:0003309	type B pancreatic cell differentiation	BP
1	6	2.19838937895	-	1.99e-01	GO:0010216	maintenance of DNA methylation	BP
1	6	2.19838937895	-	1.99e-01	GO:1903140	regulation of establishment of endothelial barrier	BP
1	6	2.19838937895	-	1.99e-01	GO:0001711	endodermal cell fate commitment	BP
1	6	2.19838937895	-	1.99e-01	GO:0030853	negative regulation of granulocyte differentiation	BP
1	6	2.19838937895	-	1.99e-01	GO:0014842	regulation of skeletal muscle satellite cell proliferation	BP
1	6	2.19838937895	-	1.99e-01	GO:2000318	positive regulation of T-helper 17 type immune response	BP
1	6	2.19838937895	-	1.99e-01	GO:0071371	cellular response to gonadotropin stimulus	BP
1	6	2.19838937895	-	1.99e-01	GO:2000667	positive regulation of interleukin-13 secretion	BP
1	6	2.19838937895	-	1.99e-01	GO:0071638	negative regulation of monocyte chemotactic protein-1 production	BP
1	6	2.19838937895	-	1.99e-01	GO:0003158	endothelium development	BP
1	6	2.19838937895	-	1.99e-01	GO:0060363	cranial suture morphogenesis	BP
1	6	2.19838937895	-	1.99e-01	GO:1901016	regulation of potassium ion transmembrane transporter activity	BP
1	6	2.19838937895	-	1.99e-01	GO:0032754	positive regulation of interleukin-5 production	BP
1	6	2.19838937895	-	1.99e-01	GO:0033601	positive regulation of mammary gland epithelial cell proliferation	BP
1	6	2.19838937895	-	1.99e-01	GO:0035520	monoubiquitinated protein deubiquitination	BP
1	6	2.19838937895	-	1.99e-01	GO:0048667	cell morphogenesis involved in neuron differentiation	BP
1	6	2.19838937895	-	1.99e-01	GO:0060762	regulation of branching involved in mammary gland duct morphogenesis	BP
1	6	2.19838937895	-	1.99e-01	GO:0070244	negative regulation of thymocyte apoptotic process	BP
1	6	2.19838937895	-	1.99e-01	GO:0007182	common-partner SMAD protein phosphorylation	BP
1	6	2.19838937895	-	1.99e-01	GO:0071156	regulation of cell cycle arrest	BP
1	6	2.19838937895	-	1.99e-01	GO:0032873	negative regulation of stress-activated MAPK cascade	BP
1	6	2.19838937895	-	1.99e-01	GO:0090279	regulation of calcium ion import	BP
1	6	2.19838937895	-	1.99e-01	GO:0071870	cellular response to catecholamine stimulus	BP
1	6	2.19838937895	-	1.99e-01	GO:0035065	regulation of histone acetylation	BP
1	6	2.19838937895	-	1.99e-01	GO:0035897	proteolysis in other organism	BP
1	6	2.19838937895	-	1.99e-01	GO:0007435	salivary gland morphogenesis	BP
1	6	2.19838937895	-	1.99e-01	GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	BP
1	6	2.19838937895	-	1.99e-01	GO:0042423	catecholamine biosynthetic process	BP
4	24	2.19838937895	-	1.02e-02	GO:0043425	bHLH transcription factor binding	MF
2	12	2.19838937895	-	4.88e-02	GO:0008331	high voltage-gated calcium channel activity	MF
2	12	2.19838937895	-	6.83e-02	GO:0048185	activin binding	MF
2	12	2.19838937895	-	6.83e-02	GO:0043422	protein kinase B binding	MF
2	12	2.19838937895	-	6.83e-02	GO:0000989	transcription factor activity, transcription factor binding	MF
1	6	2.19838937895	-	1.05e-01	GO:0005381	iron ion transmembrane transporter activity	MF
1	6	2.19838937895	-	1.38e-01	GO:0004969	histamine receptor activity	MF
1	6	2.19838937895	-	1.38e-01	GO:0048019	receptor antagonist activity	MF
1	6	2.19838937895	-	1.69e-01	GO:0030020	extracellular matrix structural constituent conferring tensile strength	MF
1	6	2.19838937895	-	1.99e-01	GO:0043140	ATP-dependent 3'-5' DNA helicase activity	MF
1	6	2.19838937895	-	1.99e-01	GO:0017108	5'-flap endonuclease activity	MF
1	6	2.19838937895	-	1.99e-01	GO:0030275	LRR domain binding	MF
1	6	2.19838937895	-	1.99e-01	GO:0046975	histone methyltransferase activity (H3-K36 specific)	MF
1	6	2.19838937895	-	1.99e-01	GO:0036402	proteasome-activating ATPase activity	MF
3	18	2.19838937895	-	4.72e-03	GO:0023019	signal transduction involved in regulation of gene expression	BP
3	18	2.19838937895	-	2.21e-02	GO:0001894	tissue homeostasis	BP
3	18	2.19838937895	-	2.21e-02	GO:0051412	response to corticosterone	BP
3	18	2.19838937895	-	2.59e-02	GO:0031668	cellular response to extracellular stimulus	BP
33	199	2.19112137849	-	3.78e-11	GO:0003714	transcription corepressor activity	MF
7	43	2.16444204703	-	3.79e-04	GO:0048538	thymus development	BP
5	31	2.15108366417	-	4.81e-03	GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	BP
8	50	2.1394956899	-	1.14e-04	GO:0071277	cellular response to calcium ion	BP
4	25	2.1394956899	-	2.21e-03	GO:0006694	steroid biosynthetic process	BP
4	25	2.1394956899	-	1.19e-02	GO:0071353	cellular response to interleukin-4	BP
11	69	2.13425904153	-	1.05e-05	GO:0045444	fat cell differentiation	BP
7	44	2.13127518309	-	3.79e-04	GO:0003151	outflow tract morphogenesis	BP
7	44	2.13127518309	-	5.25e-04	GO:0007519	skeletal muscle tissue development	BP
10	63	2.12800005106	-	1.74e-05	GO:0043627	response to estrogen	BP
6	38	2.12038686695	-	9.02e-04	GO:0045597	positive regulation of cell differentiation	BP
3	19	2.12038686695	-	1.87e-02	GO:0030220	platelet formation	BP
3	19	2.12038686695	-	2.59e-02	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	BP
3	19	2.12038686695	-	2.59e-02	GO:0010906	regulation of glucose metabolic process	BP
3	19	2.12038686695	-	2.99e-02	GO:0043393	regulation of protein binding	BP
3	19	2.12038686695	-	1.28e-02	GO:0051213	dioxygenase activity	MF
5	32	2.10527997456	-	4.16e-03	GO:0043967	histone H4 acetylation	BP
26	168	2.09147417504	-	6.67e-11	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	MF
110	711	2.09100584358	-	9.70e-11	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	BP
6	39	2.08291216153	-	1.98e-03	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	BP
4	26	2.08291216153	-	7.47e-03	GO:0001958	endochondral ossification	BP
4	26	2.08291216153	-	7.47e-03	GO:0070328	triglyceride homeostasis	BP
4	26	2.08291216153	-	8.79e-03	GO:0021983	pituitary gland development	BP
2	13	2.08291216153	-	4.00e-02	GO:0005513	detection of calcium ion	BP
2	13	2.08291216153	-	4.88e-02	GO:0007398	ectoderm development	BP
2	13	2.08291216153	-	4.88e-02	GO:0014032	neural crest cell development	BP
2	13	2.08291216153	-	4.88e-02	GO:0048665	neuron fate specification	BP
2	13	2.08291216153	-	5.83e-02	GO:0050872	white fat cell differentiation	BP
2	13	2.08291216153	-	5.83e-02	GO:0099133	ATP hydrolysis coupled anion transmembrane transport	BP
2	13	2.08291216153	-	5.83e-02	GO:0048546	digestive tract morphogenesis	BP
2	13	2.08291216153	-	5.83e-02	GO:0046628	positive regulation of insulin receptor signaling pathway	BP
2	13	2.08291216153	-	5.83e-02	GO:0055089	fatty acid homeostasis	BP
2	13	2.08291216153	-	6.83e-02	GO:0006622	protein targeting to lysosome	BP
2	13	2.08291216153	-	6.83e-02	GO:0045651	positive regulation of macrophage differentiation	BP
2	13	2.08291216153	-	6.83e-02	GO:0019395	fatty acid oxidation	BP
2	13	2.08291216153	-	6.83e-02	GO:0051974	negative regulation of telomerase activity	BP
2	13	2.08291216153	-	6.83e-02	GO:0045780	positive regulation of bone resorption	BP
2	13	2.08291216153	-	7.88e-02	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	BP
2	13	2.08291216153	-	7.88e-02	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
2	13	2.08291216153	-	7.88e-02	GO:2001234	negative regulation of apoptotic signaling pathway	BP
2	13	2.08291216153	-	7.88e-02	GO:2000573	positive regulation of DNA biosynthetic process	BP
2	13	2.08291216153	-	7.88e-02	GO:0070986	left/right axis specification	BP
2	13	2.08291216153	-	7.88e-02	GO:0043984	histone H4-K16 acetylation	BP
2	13	2.08291216153	-	7.88e-02	GO:0045821	positive regulation of glycolytic process	BP
2	13	2.08291216153	-	7.88e-02	GO:0035497	cAMP response element binding	MF
12	79	2.06453363222	-	1.30e-05	GO:0008013	beta-catenin binding	MF
125	824	2.06263563715	-	9.90e-11	GO:0003700	transcription factor activity, sequence-specific DNA binding	MF
9	60	2.04638628551	-	1.94e-04	GO:0070301	cellular response to hydrogen peroxide	BP
3	20	2.04638628551	-	1.87e-02	GO:0032753	positive regulation of interleukin-4 production	BP
3	20	2.04638628551	-	1.87e-02	GO:0045987	positive regulation of smooth muscle contraction	BP
3	20	2.04638628551	-	2.21e-02	GO:0034614	cellular response to reactive oxygen species	BP
3	20	2.04638628551	-	2.59e-02	GO:0097150	neuronal stem cell population maintenance	BP
6	40	2.04638628551	-	1.98e-03	GO:0018024	histone-lysine N-methyltransferase activity	MF
3	20	2.04638628551	-	2.99e-02	GO:0000175	3'-5'-exoribonuclease activity	MF
4	27	2.02846437751	-	5.24e-03	GO:0017046	peptide hormone binding	MF
5	34	2.01781713331	-	6.33e-03	GO:0010634	positive regulation of epithelial cell migration	BP
7	48	2.00574430101	-	3.19e-04	GO:0045600	positive regulation of fat cell differentiation	BP
10	70	1.97599695762	-	9.47e-05	GO:0001889	liver development	BP
5	35	1.97599695762	-	5.54e-03	GO:0006641	triglyceride metabolic process	BP
4	28	1.97599695762	-	8.79e-03	GO:0003281	ventricular septum development	BP
4	28	1.97599695762	-	1.02e-02	GO:0048863	stem cell differentiation	BP
4	28	1.97599695762	-	1.76e-02	GO:0045739	positive regulation of DNA repair	BP
3	21	1.97599695762	-	3.43e-02	GO:0030879	mammary gland development	BP
1	7	1.97599695762	-	3.63e-02	GO:0006766	vitamin metabolic process	BP
3	21	1.97599695762	-	3.89e-02	GO:0060045	positive regulation of cardiac muscle cell proliferation	BP
2	14	1.97599695762	-	5.83e-02	GO:0010875	positive regulation of cholesterol efflux	BP
2	14	1.97599695762	-	5.83e-02	GO:0003407	neural retina development	BP
2	14	1.97599695762	-	6.83e-02	GO:0060038	cardiac muscle cell proliferation	BP
2	14	1.97599695762	-	6.83e-02	GO:2000310	regulation of NMDA receptor activity	BP
2	14	1.97599695762	-	6.83e-02	GO:2001275	positive regulation of glucose import in response to insulin stimulus	BP
2	14	1.97599695762	-	7.88e-02	GO:0014898	cardiac muscle hypertrophy in response to stress	BP
2	14	1.97599695762	-	7.88e-02	GO:0042692	muscle cell differentiation	BP
2	14	1.97599695762	-	7.88e-02	GO:0030818	negative regulation of cAMP biosynthetic process	BP
2	14	1.97599695762	-	7.88e-02	GO:0050892	intestinal absorption	BP
2	14	1.97599695762	-	8.98e-02	GO:0043069	negative regulation of programmed cell death	BP
2	14	1.97599695762	-	8.98e-02	GO:0035729	cellular response to hepatocyte growth factor stimulus	BP
1	7	1.97599695762	-	1.05e-01	GO:0006776	vitamin A metabolic process	BP
1	7	1.97599695762	-	1.05e-01	GO:0000160	phosphorelay signal transduction system	BP
1	7	1.97599695762	-	1.38e-01	GO:0001945	lymph vessel development	BP
1	7	1.97599695762	-	1.38e-01	GO:0014807	regulation of somitogenesis	BP
1	7	1.97599695762	-	1.38e-01	GO:2000543	positive regulation of gastrulation	BP
1	7	1.97599695762	-	1.38e-01	GO:0021516	dorsal spinal cord development	BP
1	7	1.97599695762	-	1.69e-01	GO:0043031	negative regulation of macrophage activation	BP
1	7	1.97599695762	-	1.69e-01	GO:0072643	interferon-gamma secretion	BP
1	7	1.97599695762	-	1.69e-01	GO:0034144	negative regulation of toll-like receptor 4 signaling pathway	BP
1	7	1.97599695762	-	1.69e-01	GO:0033135	regulation of peptidyl-serine phosphorylation	BP
1	7	1.97599695762	-	1.69e-01	GO:0035878	nail development	BP
1	7	1.97599695762	-	1.69e-01	GO:0009950	dorsal/ventral axis specification	BP
1	7	1.97599695762	-	1.69e-01	GO:0003344	pericardium morphogenesis	BP
1	7	1.97599695762	-	1.69e-01	GO:0060736	prostate gland growth	BP
1	7	1.97599695762	-	1.69e-01	GO:0032927	positive regulation of activin receptor signaling pathway	BP
1	7	1.97599695762	-	1.69e-01	GO:0042756	drinking behavior	BP
1	7	1.97599695762	-	1.69e-01	GO:0006657	CDP-choline pathway	BP
1	7	1.97599695762	-	1.69e-01	GO:0003085	negative regulation of systemic arterial blood pressure	BP
1	7	1.97599695762	-	1.69e-01	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	BP
1	7	1.97599695762	-	1.69e-01	GO:0036302	atrioventricular canal development	BP
1	7	1.97599695762	-	1.99e-01	GO:0048539	bone marrow development	BP
1	7	1.97599695762	-	1.99e-01	GO:0060998	regulation of dendritic spine development	BP
1	7	1.97599695762	-	1.99e-01	GO:2000617	positive regulation of histone H3-K9 acetylation	BP
1	7	1.97599695762	-	1.99e-01	GO:2000650	negative regulation of sodium ion transmembrane transporter activity	BP
1	7	1.97599695762	-	1.99e-01	GO:0019048	modulation by virus of host morphology or physiology	BP
1	7	1.97599695762	-	1.99e-01	GO:0014037	Schwann cell differentiation	BP
1	7	1.97599695762	-	1.99e-01	GO:0022612	gland morphogenesis	BP
1	7	1.97599695762	-	1.99e-01	GO:0000578	embryonic axis specification	BP
1	7	1.97599695762	-	1.99e-01	GO:0043576	regulation of respiratory gaseous exchange	BP
1	7	1.97599695762	-	1.99e-01	GO:0006475	internal protein amino acid acetylation	BP
1	7	1.97599695762	-	1.99e-01	GO:0001542	ovulation from ovarian follicle	BP
1	7	1.97599695762	-	1.99e-01	GO:0021707	cerebellar granule cell differentiation	BP
1	7	1.97599695762	-	1.99e-01	GO:0051001	negative regulation of nitric-oxide synthase activity	BP
1	7	1.97599695762	-	1.99e-01	GO:0032926	negative regulation of activin receptor signaling pathway	BP
1	7	1.97599695762	-	1.99e-01	GO:1900246	positive regulation of RIG-I signaling pathway	BP
1	7	1.97599695762	-	1.99e-01	GO:2000121	regulation of removal of superoxide radicals	BP
1	7	1.97599695762	-	1.99e-01	GO:0032411	positive regulation of transporter activity	BP
1	7	1.97599695762	-	1.99e-01	GO:0035095	behavioral response to nicotine	BP
1	7	1.97599695762	-	1.99e-01	GO:0060042	retina morphogenesis in camera-type eye	BP
1	7	1.97599695762	-	1.99e-01	GO:0060576	intestinal epithelial cell development	BP
1	7	1.97599695762	-	1.99e-01	GO:0090140	regulation of mitochondrial fission	BP
1	7	1.97599695762	-	1.99e-01	GO:0044539	long-chain fatty acid import	BP
1	7	1.97599695762	-	1.99e-01	GO:0007379	segment specification	BP
1	7	1.97599695762	-	1.99e-01	GO:0051057	positive regulation of small GTPase mediated signal transduction	BP
1	7	1.97599695762	-	1.99e-01	GO:0060972	left/right pattern formation	BP
1	7	1.97599695762	-	1.99e-01	GO:0061298	retina vasculature development in camera-type eye	BP
1	7	1.97599695762	-	1.99e-01	GO:0017121	phospholipid scrambling	BP
1	7	1.97599695762	-	1.99e-01	GO:1903214	regulation of protein targeting to mitochondrion	BP
1	7	1.97599695762	-	1.99e-01	GO:0014902	myotube differentiation	BP
1	7	1.97599695762	-	1.99e-01	GO:0003084	positive regulation of systemic arterial blood pressure	BP
1	7	1.97599695762	-	1.99e-01	GO:0034372	very-low-density lipoprotein particle remodeling	BP
1	7	1.97599695762	-	1.99e-01	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	BP
1	7	1.97599695762	-	1.99e-01	GO:0008366	axon ensheathment	BP
1	7	1.97599695762	-	1.99e-01	GO:0042297	vocal learning	BP
1	7	1.97599695762	-	1.99e-01	GO:0035726	common myeloid progenitor cell proliferation	BP
1	7	1.97599695762	-	1.99e-01	GO:0060017	parathyroid gland development	BP
1	7	1.97599695762	-	1.99e-01	GO:0051574	positive regulation of histone H3-K9 methylation	BP
1	7	1.97599695762	-	1.99e-01	GO:0042129	regulation of T cell proliferation	BP
1	7	1.97599695762	-	1.99e-01	GO:0045617	negative regulation of keratinocyte differentiation	BP
1	7	1.97599695762	-	2.28e-01	GO:0045657	positive regulation of monocyte differentiation	BP
1	7	1.97599695762	-	2.28e-01	GO:0050810	regulation of steroid biosynthetic process	BP
1	7	1.97599695762	-	2.28e-01	GO:0046826	negative regulation of protein export from nucleus	BP
1	7	1.97599695762	-	2.28e-01	GO:0019896	axonal transport of mitochondrion	BP
1	7	1.97599695762	-	2.28e-01	GO:0032736	positive regulation of interleukin-13 production	BP
1	7	1.97599695762	-	2.28e-01	GO:0003337	mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	7	1.97599695762	-	2.28e-01	GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling	BP
1	7	1.97599695762	-	2.28e-01	GO:0031848	protection from non-homologous end joining at telomere	BP
1	7	1.97599695762	-	2.28e-01	GO:0060706	cell differentiation involved in embryonic placenta development	BP
1	7	1.97599695762	-	2.28e-01	GO:0003183	mitral valve morphogenesis	BP
1	7	1.97599695762	-	2.28e-01	GO:0034141	positive regulation of toll-like receptor 3 signaling pathway	BP
1	7	1.97599695762	-	2.28e-01	GO:0043405	regulation of MAP kinase activity	BP
1	7	1.97599695762	-	2.28e-01	GO:0038166	angiotensin-activated signaling pathway	BP
1	7	1.97599695762	-	2.28e-01	GO:0034351	negative regulation of glial cell apoptotic process	BP
1	7	1.97599695762	-	2.28e-01	GO:1901385	regulation of voltage-gated calcium channel activity	BP
1	7	1.97599695762	-	2.28e-01	GO:0030916	otic vesicle formation	BP
1	7	1.97599695762	-	2.28e-01	GO:0002438	acute inflammatory response to antigenic stimulus	BP
1	7	1.97599695762	-	2.28e-01	GO:0060732	positive regulation of inositol phosphate biosynthetic process	BP
1	7	1.97599695762	-	2.28e-01	GO:0014808	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	BP
1	7	1.97599695762	-	2.28e-01	GO:1901841	regulation of high voltage-gated calcium channel activity	BP
1	7	1.97599695762	-	2.28e-01	GO:0071636	positive regulation of transforming growth factor beta production	BP
1	7	1.97599695762	-	2.28e-01	GO:0061157	mRNA destabilization	BP
1	7	1.97599695762	-	2.28e-01	GO:0044321	response to leptin	BP
1	7	1.97599695762	-	2.28e-01	GO:2000394	positive regulation of lamellipodium morphogenesis	BP
1	7	1.97599695762	-	2.28e-01	GO:0051932	synaptic transmission, GABAergic	BP
1	7	1.97599695762	-	2.28e-01	GO:0034616	response to laminar fluid shear stress	BP
1	7	1.97599695762	-	2.28e-01	GO:0031642	negative regulation of myelination	BP
1	7	1.97599695762	-	2.28e-01	GO:0042178	xenobiotic catabolic process	BP
1	7	1.97599695762	-	2.28e-01	GO:0035194	posttranscriptional gene silencing by RNA	BP
1	7	1.97599695762	-	2.28e-01	GO:0032057	negative regulation of translational initiation in response to stress	BP
1	7	1.97599695762	-	2.28e-01	GO:0060575	intestinal epithelial cell differentiation	BP
1	7	1.97599695762	-	2.28e-01	GO:1901838	positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	BP
1	7	1.97599695762	-	2.28e-01	GO:0048702	embryonic neurocranium morphogenesis	BP
1	7	1.97599695762	-	2.28e-01	GO:0032872	regulation of stress-activated MAPK cascade	BP
1	7	1.97599695762	-	2.28e-01	GO:0070417	cellular response to cold	BP
1	7	1.97599695762	-	2.28e-01	GO:0031659	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
1	7	1.97599695762	-	2.28e-01	GO:0038066	p38MAPK cascade	BP
1	7	1.97599695762	-	2.28e-01	GO:0050764	regulation of phagocytosis	BP
1	7	1.97599695762	-	2.28e-01	GO:0010669	epithelial structure maintenance	BP
1	7	1.97599695762	-	2.28e-01	GO:0021952	central nervous system projection neuron axonogenesis	BP
8	56	1.97599695762	-	1.88e-04	GO:0001227	transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
4	28	1.97599695762	-	1.19e-02	GO:0001103	RNA polymerase II repressing transcription factor binding	MF
3	21	1.97599695762	-	3.43e-02	GO:0070412	R-SMAD binding	MF
2	14	1.97599695762	-	6.83e-02	GO:0005504	fatty acid binding	MF
1	7	1.97599695762	-	7.13e-02	GO:0004875	complement receptor activity	MF
2	14	1.97599695762	-	8.98e-02	GO:0034236	protein kinase A catalytic subunit binding	MF
1	7	1.97599695762	-	1.05e-01	GO:0015645	fatty acid ligase activity	MF
1	7	1.97599695762	-	1.05e-01	GO:0004321	fatty-acyl-CoA synthase activity	MF
1	7	1.97599695762	-	1.69e-01	GO:0005501	retinoid binding	MF
1	7	1.97599695762	-	1.99e-01	GO:0001848	complement binding	MF
1	7	1.97599695762	-	2.28e-01	GO:0004970	ionotropic glutamate receptor activity	MF
1	7	1.97599695762	-	2.28e-01	GO:0004691	cAMP-dependent protein kinase activity	MF
8	57	1.95046186551	-	4.00e-04	GO:0060041	retina development in camera-type eye	BP
6	43	1.94204962569	-	3.84e-03	GO:0043966	histone H3 acetylation	BP
5	36	1.93535497312	-	7.21e-03	GO:0048536	spleen development	BP
13	94	1.92920274614	-	1.10e-05	GO:0008584	male gonad development	BP
55	398	1.92808697266	-	3.64e-11	GO:0006357	regulation of transcription from RNA polymerase II promoter	BP
65	471	1.92613644309	-	7.95e-11	GO:0045892	negative regulation of transcription, DNA-templated	BP
4	29	1.92537088455	-	1.55e-02	GO:0060412	ventricular septum morphogenesis	BP
4	29	1.92537088455	-	1.55e-02	GO:0045765	regulation of angiogenesis	BP
10	73	1.91545541568	-	7.17e-05	GO:0050728	negative regulation of inflammatory response	BP
3	22	1.90888276176	-	2.99e-02	GO:0071398	cellular response to fatty acid	BP
3	22	1.90888276176	-	3.43e-02	GO:0046329	negative regulation of JNK cascade	BP
3	22	1.90888276176	-	3.43e-02	GO:0060173	limb development	BP
3	22	1.90888276176	-	4.39e-02	GO:0006306	DNA methylation	BP
5	37	1.89582660893	-	8.17e-03	GO:0048469	cell maturation	BP
5	37	1.89582660893	-	9.21e-03	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	BP
9	67	1.88718769066	-	4.75e-04	GO:0002039	p53 binding	MF
8	60	1.87646128407	-	6.83e-04	GO:0034599	cellular response to oxidative stress	BP
4	30	1.87646128407	-	1.02e-02	GO:0030901	midbrain development	BP
4	30	1.87646128407	-	1.19e-02	GO:0031667	response to nutrient levels	BP
4	30	1.87646128407	-	1.19e-02	GO:0001707	mesoderm formation	BP
2	15	1.87646128407	-	6.83e-02	GO:0030279	negative regulation of ossification	BP
2	15	1.87646128407	-	6.83e-02	GO:0034968	histone lysine methylation	BP
2	15	1.87646128407	-	7.88e-02	GO:0001953	negative regulation of cell-matrix adhesion	BP
2	15	1.87646128407	-	7.88e-02	GO:0002042	cell migration involved in sprouting angiogenesis	BP
2	15	1.87646128407	-	7.88e-02	GO:0034375	high-density lipoprotein particle remodeling	BP
2	15	1.87646128407	-	8.98e-02	GO:0080182	histone H3-K4 trimethylation	BP
2	15	1.87646128407	-	8.98e-02	GO:0043277	apoptotic cell clearance	BP
2	15	1.87646128407	-	8.98e-02	GO:0030502	negative regulation of bone mineralization	BP
2	15	1.87646128407	-	8.98e-02	GO:0000729	DNA double-strand break processing	BP
2	15	1.87646128407	-	8.98e-02	GO:0035024	negative regulation of Rho protein signal transduction	BP
2	15	1.87646128407	-	8.98e-02	GO:0070498	interleukin-1-mediated signaling pathway	BP
2	15	1.87646128407	-	1.01e-01	GO:0051123	RNA polymerase II transcriptional preinitiation complex assembly	BP
2	15	1.87646128407	-	1.01e-01	GO:0051571	positive regulation of histone H3-K4 methylation	BP
4	30	1.87646128407	-	1.99e-02	GO:0051879	Hsp90 protein binding	MF
4	30	1.87646128407	-	1.99e-02	GO:0031492	nucleosomal DNA binding	MF
2	15	1.87646128407	-	7.88e-02	GO:0019789	SUMO transferase activity	MF
2	15	1.87646128407	-	1.01e-01	GO:0004697	protein kinase C activity	MF
15	113	1.87006351287	-	7.11e-06	GO:0071222	cellular response to lipopolysaccharide	BP
5	38	1.85735246112	-	4.16e-03	GO:0001942	hair follicle development	BP
9	69	1.84475242434	-	1.27e-04	GO:0071300	cellular response to retinoic acid	BP
3	23	1.84475242434	-	3.89e-02	GO:0070371	ERK1 and ERK2 cascade	BP
3	23	1.84475242434	-	4.39e-02	GO:0090398	cellular senescence	BP
3	23	1.84475242434	-	4.92e-02	GO:0000715	nucleotide-excision repair, DNA damage recognition	BP
4	31	1.82915556929	-	1.76e-02	GO:0030217	T cell differentiation	BP
4	32	1.78335187967	-	2.23e-02	GO:0070555	response to interleukin-1	BP
4	32	1.78335187967	-	2.49e-02	GO:0042594	response to starvation	BP
3	24	1.78335187967	-	4.39e-02	GO:0042327	positive regulation of phosphorylation	BP
2	16	1.78335187967	-	4.88e-02	GO:0008209	androgen metabolic process	BP
2	16	1.78335187967	-	6.83e-02	GO:0032924	activin receptor signaling pathway	BP
2	16	1.78335187967	-	8.98e-02	GO:0001709	cell fate determination	BP
2	16	1.78335187967	-	8.98e-02	GO:0003222	ventricular trabecula myocardium morphogenesis	BP
2	16	1.78335187967	-	1.01e-01	GO:2000811	negative regulation of anoikis	BP
2	16	1.78335187967	-	1.01e-01	GO:0010259	multicellular organism aging	BP
2	16	1.78335187967	-	1.01e-01	GO:0009416	response to light stimulus	BP
1	8	1.78335187967	-	1.38e-01	GO:2000781	positive regulation of double-strand break repair	BP
1	8	1.78335187967	-	1.38e-01	GO:0006690	icosanoid metabolic process	BP
1	8	1.78335187967	-	1.69e-01	GO:0031666	positive regulation of lipopolysaccharide-mediated signaling pathway	BP
1	8	1.78335187967	-	1.69e-01	GO:0003073	regulation of systemic arterial blood pressure	BP
1	8	1.78335187967	-	1.69e-01	GO:0035865	cellular response to potassium ion	BP
1	8	1.78335187967	-	1.69e-01	GO:0046512	sphingosine biosynthetic process	BP
1	8	1.78335187967	-	1.99e-01	GO:0035137	hindlimb morphogenesis	BP
1	8	1.78335187967	-	1.99e-01	GO:0060137	maternal process involved in parturition	BP
1	8	1.78335187967	-	1.99e-01	GO:0032963	collagen metabolic process	BP
1	8	1.78335187967	-	1.99e-01	GO:0045056	transcytosis	BP
1	8	1.78335187967	-	1.99e-01	GO:0071374	cellular response to parathyroid hormone stimulus	BP
1	8	1.78335187967	-	1.99e-01	GO:0007494	midgut development	BP
1	8	1.78335187967	-	1.99e-01	GO:0002827	positive regulation of T-helper 1 type immune response	BP
1	8	1.78335187967	-	1.99e-01	GO:0032099	negative regulation of appetite	BP
1	8	1.78335187967	-	1.99e-01	GO:0048339	paraxial mesoderm development	BP
1	8	1.78335187967	-	1.99e-01	GO:0035767	endothelial cell chemotaxis	BP
1	8	1.78335187967	-	2.28e-01	GO:0045654	positive regulation of megakaryocyte differentiation	BP
1	8	1.78335187967	-	2.28e-01	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	BP
1	8	1.78335187967	-	2.28e-01	GO:0000012	single strand break repair	BP
1	8	1.78335187967	-	2.28e-01	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	BP
1	8	1.78335187967	-	2.28e-01	GO:0060452	positive regulation of cardiac muscle contraction	BP
1	8	1.78335187967	-	2.28e-01	GO:0060020	Bergmann glial cell differentiation	BP
1	8	1.78335187967	-	2.28e-01	GO:0033629	negative regulation of cell adhesion mediated by integrin	BP
1	8	1.78335187967	-	2.28e-01	GO:0045410	positive regulation of interleukin-6 biosynthetic process	BP
1	8	1.78335187967	-	2.28e-01	GO:0006356	regulation of transcription from RNA polymerase I promoter	BP
1	8	1.78335187967	-	2.28e-01	GO:0034393	positive regulation of smooth muscle cell apoptotic process	BP
1	8	1.78335187967	-	2.28e-01	GO:0048312	intracellular distribution of mitochondria	BP
1	8	1.78335187967	-	2.28e-01	GO:0033993	response to lipid	BP
1	8	1.78335187967	-	2.28e-01	GO:0010470	regulation of gastrulation	BP
1	8	1.78335187967	-	2.28e-01	GO:1901380	negative regulation of potassium ion transmembrane transport	BP
1	8	1.78335187967	-	2.28e-01	GO:0045059	positive thymic T cell selection	BP
1	8	1.78335187967	-	2.28e-01	GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction	BP
1	8	1.78335187967	-	2.28e-01	GO:0071168	protein localization to chromatin	BP
1	8	1.78335187967	-	2.28e-01	GO:0070544	histone H3-K36 demethylation	BP
1	8	1.78335187967	-	2.28e-01	GO:0006729	tetrahydrobiopterin biosynthetic process	BP
1	8	1.78335187967	-	2.28e-01	GO:0000076	DNA replication checkpoint	BP
1	8	1.78335187967	-	2.28e-01	GO:0009062	fatty acid catabolic process	BP
1	8	1.78335187967	-	2.28e-01	GO:1901409	positive regulation of phosphorylation of RNA polymerase II C-terminal domain	BP
1	8	1.78335187967	-	2.28e-01	GO:0010954	positive regulation of protein processing	BP
1	8	1.78335187967	-	2.28e-01	GO:0051963	regulation of synapse assembly	BP
1	8	1.78335187967	-	2.28e-01	GO:0060059	embryonic retina morphogenesis in camera-type eye	BP
1	8	1.78335187967	-	2.28e-01	GO:0016584	nucleosome positioning	BP
1	8	1.78335187967	-	2.28e-01	GO:0035912	dorsal aorta morphogenesis	BP
1	8	1.78335187967	-	2.56e-01	GO:0060100	positive regulation of phagocytosis, engulfment	BP
1	8	1.78335187967	-	2.56e-01	GO:0018026	peptidyl-lysine monomethylation	BP
1	8	1.78335187967	-	2.56e-01	GO:0007097	nuclear migration	BP
1	8	1.78335187967	-	2.56e-01	GO:0050687	negative regulation of defense response to virus	BP
1	8	1.78335187967	-	2.56e-01	GO:0006012	galactose metabolic process	BP
1	8	1.78335187967	-	2.56e-01	GO:0033598	mammary gland epithelial cell proliferation	BP
1	8	1.78335187967	-	2.56e-01	GO:0075713	establishment of integrated proviral latency	BP
1	8	1.78335187967	-	2.56e-01	GO:0001955	blood vessel maturation	BP
1	8	1.78335187967	-	2.56e-01	GO:0032463	negative regulation of protein homooligomerization	BP
1	8	1.78335187967	-	2.56e-01	GO:0060670	branching involved in labyrinthine layer morphogenesis	BP
1	8	1.78335187967	-	2.56e-01	GO:0002674	negative regulation of acute inflammatory response	BP
1	8	1.78335187967	-	2.56e-01	GO:0003300	cardiac muscle hypertrophy	BP
1	8	1.78335187967	-	2.56e-01	GO:0006264	mitochondrial DNA replication	BP
1	8	1.78335187967	-	2.56e-01	GO:0006268	DNA unwinding involved in DNA replication	BP
1	8	1.78335187967	-	2.56e-01	GO:0071548	response to dexamethasone	BP
1	8	1.78335187967	-	2.56e-01	GO:0045630	positive regulation of T-helper 2 cell differentiation	BP
1	8	1.78335187967	-	2.56e-01	GO:0002903	negative regulation of B cell apoptotic process	BP
1	8	1.78335187967	-	2.56e-01	GO:0001960	negative regulation of cytokine-mediated signaling pathway	BP
1	8	1.78335187967	-	2.56e-01	GO:0090073	positive regulation of protein homodimerization activity	BP
1	8	1.78335187967	-	2.56e-01	GO:0042035	regulation of cytokine biosynthetic process	BP
1	8	1.78335187967	-	2.56e-01	GO:0048304	positive regulation of isotype switching to IgG isotypes	BP
1	8	1.78335187967	-	2.56e-01	GO:0007289	spermatid nucleus differentiation	BP
1	8	1.78335187967	-	2.56e-01	GO:2000587	negative regulation of platelet-derived growth factor receptor-beta signaling pathway	BP
1	8	1.78335187967	-	2.56e-01	GO:0007172	signal complex assembly	BP
1	8	1.78335187967	-	2.56e-01	GO:0002011	morphogenesis of an epithelial sheet	BP
1	8	1.78335187967	-	2.56e-01	GO:1900119	positive regulation of execution phase of apoptosis	BP
1	8	1.78335187967	-	2.56e-01	GO:0070206	protein trimerization	BP
1	8	1.78335187967	-	2.56e-01	GO:0035457	cellular response to interferon-alpha	BP
1	8	1.78335187967	-	2.56e-01	GO:0014732	skeletal muscle atrophy	BP
1	8	1.78335187967	-	2.56e-01	GO:2000774	positive regulation of cellular senescence	BP
1	8	1.78335187967	-	2.56e-01	GO:0010498	proteasomal protein catabolic process	BP
1	8	1.78335187967	-	2.56e-01	GO:0060712	spongiotrophoblast layer development	BP
1	8	1.78335187967	-	2.56e-01	GO:0071312	cellular response to alkaloid	BP
46	368	1.78335187967	-	3.99e-11	GO:0003682	chromatin binding	MF
2	16	1.78335187967	-	3.19e-02	GO:0001972	retinoic acid binding	MF
3	24	1.78335187967	-	4.92e-02	GO:0032452	histone demethylase activity	MF
1	8	1.78335187967	-	1.38e-01	GO:0003996	acyl-CoA ligase activity	MF
1	8	1.78335187967	-	1.38e-01	GO:0047760	butyrate-CoA ligase activity	MF
1	8	1.78335187967	-	1.38e-01	GO:0038036	sphingosine-1-phosphate receptor activity	MF
1	8	1.78335187967	-	1.69e-01	GO:0004126	cytidine deaminase activity	MF
1	8	1.78335187967	-	1.69e-01	GO:0019213	deacetylase activity	MF
1	8	1.78335187967	-	1.99e-01	GO:0001162	RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding	MF
1	8	1.78335187967	-	2.28e-01	GO:0017110	nucleoside-diphosphatase activity	MF
1	8	1.78335187967	-	2.28e-01	GO:0008430	selenium binding	MF
1	8	1.78335187967	-	2.28e-01	GO:0051864	histone demethylase activity (H3-K36 specific)	MF
1	8	1.78335187967	-	2.28e-01	GO:0005113	patched binding	MF
1	8	1.78335187967	-	2.28e-01	GO:0102391	decanoate--CoA ligase activity	MF
1	8	1.78335187967	-	2.56e-01	GO:0003857	3-hydroxyacyl-CoA dehydrogenase activity	MF
1	8	1.78335187967	-	2.56e-01	GO:0001164	RNA polymerase I CORE element sequence-specific DNA binding	MF
1	8	1.78335187967	-	2.56e-01	GO:0019215	intermediate filament binding	MF
1	8	1.78335187967	-	2.56e-01	GO:0032183	SUMO binding	MF
9	73	1.76345232224	-	8.34e-04	GO:0001843	neural tube closure	BP
7	57	1.75781678757	-	1.62e-03	GO:0045669	positive regulation of osteoblast differentiation	BP
5	41	1.74772796994	-	7.21e-03	GO:0009725	response to hormone	BP
5	41	1.74772796994	-	8.17e-03	GO:0043010	camera-type eye development	BP
5	41	1.74772796994	-	9.21e-03	GO:0007566	embryo implantation	BP
5	41	1.74772796994	-	1.29e-02	GO:0045740	positive regulation of DNA replication	BP
5	41	1.74772796994	-	1.43e-02	GO:0030218	erythrocyte differentiation	BP
12	99	1.73895776032	-	5.43e-05	GO:0001764	neuron migration	BP
4	33	1.73895776032	-	1.76e-02	GO:0003007	heart morphogenesis	BP
7	58	1.7327258066	-	1.83e-03	GO:0021766	hippocampus development	BP
13	108	1.72890409565	-	5.23e-05	GO:0009615	response to virus	BP
3	25	1.72445819062	-	2.99e-02	GO:0060349	bone morphogenesis	BP
3	25	1.72445819062	-	3.43e-02	GO:0051899	membrane depolarization	BP
3	25	1.72445819062	-	4.92e-02	GO:0002053	positive regulation of mesenchymal cell proliferation	BP
3	25	1.72445819062	-	5.47e-02	GO:0055010	ventricular cardiac muscle tissue morphogenesis	BP
3	25	1.72445819062	-	5.47e-02	GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity	BP
3	25	1.72445819062	-	6.06e-02	GO:0051149	positive regulation of muscle cell differentiation	BP
2	17	1.69588903842	-	7.88e-02	GO:0009948	anterior/posterior axis specification	BP
2	17	1.69588903842	-	7.88e-02	GO:0048514	blood vessel morphogenesis	BP
2	17	1.69588903842	-	8.98e-02	GO:0043651	linoleic acid metabolic process	BP
2	17	1.69588903842	-	8.98e-02	GO:0030301	cholesterol transport	BP
2	17	1.69588903842	-	8.98e-02	GO:0045582	positive regulation of T cell differentiation	BP
2	17	1.69588903842	-	8.98e-02	GO:0042462	eye photoreceptor cell development	BP
2	17	1.69588903842	-	1.01e-01	GO:0045956	positive regulation of calcium ion-dependent exocytosis	BP
2	17	1.69588903842	-	1.01e-01	GO:0048488	synaptic vesicle endocytosis	BP
2	17	1.69588903842	-	1.01e-01	GO:0043691	reverse cholesterol transport	BP
2	17	1.69588903842	-	1.01e-01	GO:0001702	gastrulation with mouth forming second	BP
2	17	1.69588903842	-	1.01e-01	GO:1901800	positive regulation of proteasomal protein catabolic process	BP
2	17	1.69588903842	-	1.01e-01	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	BP
2	17	1.69588903842	-	1.13e-01	GO:0048854	brain morphogenesis	BP
2	17	1.69588903842	-	1.13e-01	GO:0021772	olfactory bulb development	BP
2	17	1.69588903842	-	1.13e-01	GO:0048814	regulation of dendrite morphogenesis	BP
2	17	1.69588903842	-	1.13e-01	GO:2000778	positive regulation of interleukin-6 secretion	BP
2	17	1.69588903842	-	7.88e-02	GO:0008301	DNA binding, bending	MF
5	43	1.67901521986	-	1.91e-02	GO:0034644	cellular response to UV	BP
5	43	1.67901521986	-	1.29e-02	GO:0046332	SMAD binding	MF
3	26	1.66787466225	-	4.39e-02	GO:0019216	regulation of lipid metabolic process	BP
3	26	1.66787466225	-	4.92e-02	GO:0048709	oligodendrocyte differentiation	BP
3	26	1.66787466225	-	5.47e-02	GO:2000352	negative regulation of endothelial cell apoptotic process	BP
3	26	1.66787466225	-	6.67e-02	GO:0045931	positive regulation of mitotic cell cycle	BP
4	35	1.65406886273	-	3.06e-02	GO:0045786	negative regulation of cell cycle	BP
5	44	1.64584835592	-	7.21e-03	GO:0048666	neuron development	BP
6	53	1.64039392583	-	7.49e-03	GO:0071333	cellular response to glucose stimulus	BP
18	159	1.64039392583	-	8.38e-06	GO:0001666	response to hypoxia	BP
6	54	1.61342687823	-	5.45e-03	GO:0000902	cell morphogenesis	BP
6	54	1.61342687823	-	9.13e-03	GO:0006325	chromatin organization	BP
5	45	1.61342687823	-	9.21e-03	GO:0008015	blood circulation	BP
5	45	1.61342687823	-	1.43e-02	GO:0071363	cellular response to growth factor stimulus	BP
5	45	1.61342687823	-	1.91e-02	GO:0031100	animal organ regeneration	BP
5	45	1.61342687823	-	1.91e-02	GO:0010595	positive regulation of endothelial cell migration	BP
4	36	1.61342687823	-	2.23e-02	GO:0001568	blood vessel development	BP
3	27	1.61342687823	-	2.99e-02	GO:0009755	hormone-mediated signaling pathway	BP
3	27	1.61342687823	-	3.43e-02	GO:0001755	neural crest cell migration	BP
3	27	1.61342687823	-	3.89e-02	GO:0030534	adult behavior	BP
2	18	1.61342687823	-	6.83e-02	GO:0010460	positive regulation of heart rate	BP
2	18	1.61342687823	-	6.83e-02	GO:0007141	male meiosis I	BP
3	27	1.61342687823	-	7.31e-02	GO:0009314	response to radiation	BP
2	18	1.61342687823	-	8.98e-02	GO:0060037	pharyngeal system development	BP
2	18	1.61342687823	-	1.01e-01	GO:0002076	osteoblast development	BP
2	18	1.61342687823	-	1.01e-01	GO:1903506	regulation of nucleic acid-templated transcription	BP
2	18	1.61342687823	-	1.01e-01	GO:0006970	response to osmotic stress	BP
2	18	1.61342687823	-	1.13e-01	GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	BP
2	18	1.61342687823	-	1.25e-01	GO:0035066	positive regulation of histone acetylation	BP
2	18	1.61342687823	-	1.38e-01	GO:0043523	regulation of neuron apoptotic process	BP
2	18	1.61342687823	-	1.38e-01	GO:0035904	aorta development	BP
1	9	1.61342687823	-	1.38e-01	GO:0090181	regulation of cholesterol metabolic process	BP
1	9	1.61342687823	-	1.69e-01	GO:0046549	retinal cone cell development	BP
1	9	1.61342687823	-	1.69e-01	GO:0097186	amelogenesis	BP
1	9	1.61342687823	-	1.69e-01	GO:0051205	protein insertion into membrane	BP
1	9	1.61342687823	-	1.69e-01	GO:0043583	ear development	BP
1	9	1.61342687823	-	1.69e-01	GO:0070286	axonemal dynein complex assembly	BP
1	9	1.61342687823	-	1.99e-01	GO:0060287	epithelial cilium movement involved in determination of left/right asymmetry	BP
1	9	1.61342687823	-	1.99e-01	GO:0060586	multicellular organismal iron ion homeostasis	BP
1	9	1.61342687823	-	1.99e-01	GO:0002315	marginal zone B cell differentiation	BP
1	9	1.61342687823	-	1.99e-01	GO:0009972	cytidine deamination	BP
1	9	1.61342687823	-	2.28e-01	GO:0046548	retinal rod cell development	BP
1	9	1.61342687823	-	2.28e-01	GO:0061549	sympathetic ganglion development	BP
1	9	1.61342687823	-	2.28e-01	GO:0060039	pericardium development	BP
1	9	1.61342687823	-	2.28e-01	GO:0007599	hemostasis	BP
1	9	1.61342687823	-	2.28e-01	GO:0042698	ovulation cycle	BP
1	9	1.61342687823	-	2.28e-01	GO:0010907	positive regulation of glucose metabolic process	BP
1	9	1.61342687823	-	2.28e-01	GO:0072358	cardiovascular system development	BP
1	9	1.61342687823	-	2.28e-01	GO:0045124	regulation of bone resorption	BP
1	9	1.61342687823	-	2.28e-01	GO:0035313	wound healing, spreading of epidermal cells	BP
1	9	1.61342687823	-	2.28e-01	GO:0046620	regulation of organ growth	BP
1	9	1.61342687823	-	2.28e-01	GO:1900017	positive regulation of cytokine production involved in inflammatory response	BP
1	9	1.61342687823	-	2.28e-01	GO:0055086	nucleobase-containing small molecule metabolic process	BP
1	9	1.61342687823	-	2.56e-01	GO:0090197	positive regulation of chemokine secretion	BP
1	9	1.61342687823	-	2.56e-01	GO:0045899	positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
1	9	1.61342687823	-	2.56e-01	GO:1900027	regulation of ruffle assembly	BP
1	9	1.61342687823	-	2.56e-01	GO:0060068	vagina development	BP
1	9	1.61342687823	-	2.56e-01	GO:0060231	mesenchymal to epithelial transition	BP
1	9	1.61342687823	-	2.56e-01	GO:0051983	regulation of chromosome segregation	BP
1	9	1.61342687823	-	2.56e-01	GO:1901223	negative regulation of NIK/NF-kappaB signaling	BP
1	9	1.61342687823	-	2.56e-01	GO:0042908	xenobiotic transport	BP
1	9	1.61342687823	-	2.56e-01	GO:0042754	negative regulation of circadian rhythm	BP
1	9	1.61342687823	-	2.56e-01	GO:0009410	response to xenobiotic stimulus	BP
1	9	1.61342687823	-	2.56e-01	GO:2000059	negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
1	9	1.61342687823	-	2.56e-01	GO:0072089	stem cell proliferation	BP
1	9	1.61342687823	-	2.56e-01	GO:0042088	T-helper 1 type immune response	BP
1	9	1.61342687823	-	2.56e-01	GO:0050795	regulation of behavior	BP
1	9	1.61342687823	-	2.56e-01	GO:0050862	positive regulation of T cell receptor signaling pathway	BP
1	9	1.61342687823	-	2.56e-01	GO:0070493	thrombin-activated receptor signaling pathway	BP
1	9	1.61342687823	-	2.83e-01	GO:0060261	positive regulation of transcription initiation from RNA polymerase II promoter	BP
1	9	1.61342687823	-	2.83e-01	GO:0001771	immunological synapse formation	BP
1	9	1.61342687823	-	2.83e-01	GO:0043030	regulation of macrophage activation	BP
1	9	1.61342687823	-	2.83e-01	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	BP
1	9	1.61342687823	-	2.83e-01	GO:0034405	response to fluid shear stress	BP
1	9	1.61342687823	-	2.83e-01	GO:0048489	synaptic vesicle transport	BP
1	9	1.61342687823	-	2.83e-01	GO:0008354	germ cell migration	BP
1	9	1.61342687823	-	2.83e-01	GO:0034063	stress granule assembly	BP
1	9	1.61342687823	-	2.83e-01	GO:0050774	negative regulation of dendrite morphogenesis	BP
1	9	1.61342687823	-	2.83e-01	GO:0010761	fibroblast migration	BP
1	9	1.61342687823	-	2.83e-01	GO:0006390	transcription from mitochondrial promoter	BP
1	9	1.61342687823	-	2.83e-01	GO:0034145	positive regulation of toll-like receptor 4 signaling pathway	BP
1	9	1.61342687823	-	2.83e-01	GO:0050807	regulation of synapse organization	BP
1	9	1.61342687823	-	2.83e-01	GO:0006000	fructose metabolic process	BP
1	9	1.61342687823	-	2.83e-01	GO:2000008	regulation of protein localization to cell surface	BP
1	9	1.61342687823	-	2.83e-01	GO:0051593	response to folic acid	BP
1	9	1.61342687823	-	2.83e-01	GO:0010944	negative regulation of transcription by competitive promoter binding	BP
1	9	1.61342687823	-	2.83e-01	GO:1904706	negative regulation of vascular smooth muscle cell proliferation	BP
1	9	1.61342687823	-	2.83e-01	GO:0010863	positive regulation of phospholipase C activity	BP
1	9	1.61342687823	-	2.83e-01	GO:0033160	positive regulation of protein import into nucleus, translocation	BP
1	9	1.61342687823	-	2.83e-01	GO:0044320	cellular response to leptin stimulus	BP
1	9	1.61342687823	-	2.83e-01	GO:0043589	skin morphogenesis	BP
1	9	1.61342687823	-	2.83e-01	GO:0035563	positive regulation of chromatin binding	BP
1	9	1.61342687823	-	2.83e-01	GO:0070933	histone H4 deacetylation	BP
1	9	1.61342687823	-	2.83e-01	GO:0035456	response to interferon-beta	BP
1	9	1.61342687823	-	2.83e-01	GO:0032688	negative regulation of interferon-beta production	BP
1	9	1.61342687823	-	2.83e-01	GO:0034333	adherens junction assembly	BP
1	9	1.61342687823	-	2.83e-01	GO:0022407	regulation of cell-cell adhesion	BP
1	9	1.61342687823	-	2.83e-01	GO:0060711	labyrinthine layer development	BP
1	9	1.61342687823	-	2.83e-01	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
2	18	1.61342687823	-	4.88e-02	GO:0016409	palmitoyltransferase activity	MF
2	18	1.61342687823	-	1.01e-01	GO:0005319	lipid transporter activity	MF
2	18	1.61342687823	-	1.25e-01	GO:0070577	lysine-acetylated histone binding	MF
1	9	1.61342687823	-	2.28e-01	GO:0017111	nucleoside-triphosphatase activity	MF
1	9	1.61342687823	-	2.28e-01	GO:0016918	retinal binding	MF
1	9	1.61342687823	-	2.28e-01	GO:0071933	Arp2/3 complex binding	MF
1	9	1.61342687823	-	2.56e-01	GO:0001191	transcriptional repressor activity, RNA polymerase II transcription factor binding	MF
1	9	1.61342687823	-	2.83e-01	GO:0016595	glutamate binding	MF
1	9	1.61342687823	-	2.83e-01	GO:0048027	mRNA 5'-UTR binding	MF
1	9	1.61342687823	-	2.83e-01	GO:0030957	Tat protein binding	MF
1	9	1.61342687823	-	2.83e-01	GO:0001075	transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly	MF
1	9	1.61342687823	-	2.83e-01	GO:0005522	profilin binding	MF
1	9	1.61342687823	-	2.83e-01	GO:0017081	chloride channel regulator activity	MF
1	9	1.61342687823	-	2.83e-01	GO:0004716	signal transducer, downstream of receptor, with protein tyrosine kinase activity	MF
1	9	1.61342687823	-	2.83e-01	GO:0045505	dynein intermediate chain binding	MF
6	55	1.58695466687	-	6.08e-03	GO:0042475	odontogenesis of dentin-containing tooth	BP
5	46	1.5817180185	-	1.29e-02	GO:1903507	negative regulation of nucleic acid-templated transcription	BP
7	65	1.5683389887	-	3.97e-03	GO:0050796	regulation of insulin secretion	BP
3	28	1.56095945834	-	6.06e-02	GO:0001937	negative regulation of endothelial cell proliferation	BP
3	28	1.56095945834	-	7.98e-02	GO:0032008	positive regulation of TOR signaling	BP
8	75	1.55453318918	-	4.85e-03	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
4	38	1.53542436623	-	1.02e-02	GO:0009409	response to cold	BP
6	57	1.53542436623	-	1.31e-02	GO:0048661	positive regulation of smooth muscle cell proliferation	BP
4	38	1.53542436623	-	3.70e-02	GO:0021549	cerebellum development	BP
4	38	1.53542436623	-	4.05e-02	GO:0038128	ERBB2 signaling pathway	BP
2	19	1.53542436623	-	5.83e-02	GO:0018345	protein palmitoylation	BP
2	19	1.53542436623	-	1.13e-01	GO:0032332	positive regulation of chondrocyte differentiation	BP
2	19	1.53542436623	-	1.25e-01	GO:0008589	regulation of smoothened signaling pathway	BP
2	19	1.53542436623	-	1.25e-01	GO:0051968	positive regulation of synaptic transmission, glutamatergic	BP
2	19	1.53542436623	-	1.38e-01	GO:0045453	bone resorption	BP
2	19	1.53542436623	-	1.38e-01	GO:0043153	entrainment of circadian clock by photoperiod	BP
2	19	1.53542436623	-	1.38e-01	GO:0046716	muscle cell cellular homeostasis	BP
5	48	1.52031747384	-	2.29e-02	GO:0019827	stem cell population maintenance	BP
10	96	1.52031747384	-	2.32e-03	GO:0047485	protein N-terminus binding	MF
8	77	1.51656533898	-	4.09e-03	GO:0032869	cellular response to insulin stimulus	BP
6	58	1.51033338527	-	1.31e-02	GO:0017148	negative regulation of translation	BP
3	29	1.51033338527	-	4.39e-02	GO:0002088	lens development in camera-type eye	BP
3	29	1.51033338527	-	5.47e-02	GO:0048167	regulation of synaptic plasticity	BP
3	29	1.51033338527	-	7.31e-02	GO:0042149	cellular response to glucose starvation	BP
3	29	1.51033338527	-	7.31e-02	GO:0034198	cellular response to amino acid starvation	BP
3	29	1.51033338527	-	8.67e-02	GO:0000278	mitotic cell cycle	BP
3	29	1.51033338527	-	8.67e-02	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
10	97	1.50536713237	-	1.30e-03	GO:0051726	regulation of cell cycle	BP
4	39	1.49794966081	-	3.70e-02	GO:0043434	response to peptide hormone	BP
6	59	1.48567133103	-	1.00e-02	GO:0050727	regulation of inflammatory response	BP
7	69	1.48218234495	-	6.99e-03	GO:0001938	positive regulation of endothelial cell proliferation	BP
32	319	1.46593926591	-	6.96e-08	GO:0019899	enzyme binding	MF
3	30	1.46142378479	-	5.47e-02	GO:0050873	brown fat cell differentiation	BP
3	30	1.46142378479	-	6.06e-02	GO:0071773	cellular response to BMP stimulus	BP
3	30	1.46142378479	-	7.31e-02	GO:0007259	JAK-STAT cascade	BP
8	80	1.46142378479	-	3.42e-03	GO:0035264	multicellular organism growth	BP
5	50	1.46142378479	-	2.29e-02	GO:0048146	positive regulation of fibroblast proliferation	BP
5	50	1.46142378479	-	2.94e-02	GO:0071560	cellular response to transforming growth factor beta stimulus	BP
4	40	1.46142378479	-	3.06e-02	GO:0048704	embryonic skeletal system morphogenesis	BP
5	50	1.46142378479	-	3.18e-02	GO:0032481	positive regulation of type I interferon production	BP
4	40	1.46142378479	-	5.19e-02	GO:0045429	positive regulation of nitric oxide biosynthetic process	BP
2	20	1.46142378479	-	6.83e-02	GO:0055074	calcium ion homeostasis	BP
2	20	1.46142378479	-	8.98e-02	GO:0001659	temperature homeostasis	BP
2	20	1.46142378479	-	1.01e-01	GO:0031016	pancreas development	BP
2	20	1.46142378479	-	1.50e-01	GO:0045861	negative regulation of proteolysis	BP
2	20	1.46142378479	-	1.63e-01	GO:0045663	positive regulation of myoblast differentiation	BP
2	20	1.46142378479	-	1.63e-01	GO:0071526	semaphorin-plexin signaling pathway	BP
1	10	1.46142378479	-	1.69e-01	GO:0046470	phosphatidylcholine metabolic process	BP
1	10	1.46142378479	-	1.99e-01	GO:0007168	receptor guanylyl cyclase signaling pathway	BP
1	10	1.46142378479	-	1.99e-01	GO:0007567	parturition	BP
1	10	1.46142378479	-	1.99e-01	GO:0002021	response to dietary excess	BP
1	10	1.46142378479	-	2.28e-01	GO:0048935	peripheral nervous system neuron development	BP
1	10	1.46142378479	-	2.28e-01	GO:0043586	tongue development	BP
1	10	1.46142378479	-	2.28e-01	GO:0032525	somite rostral/caudal axis specification	BP
1	10	1.46142378479	-	2.56e-01	GO:2000648	positive regulation of stem cell proliferation	BP
1	10	1.46142378479	-	2.56e-01	GO:0048096	chromatin-mediated maintenance of transcription	BP
1	10	1.46142378479	-	2.56e-01	GO:0060411	cardiac septum morphogenesis	BP
1	10	1.46142378479	-	2.56e-01	GO:0035136	forelimb morphogenesis	BP
1	10	1.46142378479	-	2.56e-01	GO:0007216	G-protein coupled glutamate receptor signaling pathway	BP
1	10	1.46142378479	-	2.56e-01	GO:0033674	positive regulation of kinase activity	BP
1	10	1.46142378479	-	2.56e-01	GO:0090501	RNA phosphodiester bond hydrolysis	BP
1	10	1.46142378479	-	2.56e-01	GO:0021702	cerebellar Purkinje cell differentiation	BP
1	10	1.46142378479	-	2.56e-01	GO:0022038	corpus callosum development	BP
1	10	1.46142378479	-	2.56e-01	GO:0031953	negative regulation of protein autophosphorylation	BP
1	10	1.46142378479	-	2.56e-01	GO:0043267	negative regulation of potassium ion transport	BP
1	10	1.46142378479	-	2.56e-01	GO:0021904	dorsal/ventral neural tube patterning	BP
1	10	1.46142378479	-	2.83e-01	GO:1903206	negative regulation of hydrogen peroxide-induced cell death	BP
1	10	1.46142378479	-	2.83e-01	GO:0033234	negative regulation of protein sumoylation	BP
1	10	1.46142378479	-	2.83e-01	GO:1903078	positive regulation of protein localization to plasma membrane	BP
1	10	1.46142378479	-	2.83e-01	GO:0010820	positive regulation of T cell chemotaxis	BP
1	10	1.46142378479	-	2.83e-01	GO:0060044	negative regulation of cardiac muscle cell proliferation	BP
1	10	1.46142378479	-	2.83e-01	GO:0045475	locomotor rhythm	BP
1	10	1.46142378479	-	2.83e-01	GO:0060484	lung-associated mesenchyme development	BP
1	10	1.46142378479	-	3.09e-01	GO:0071803	positive regulation of podosome assembly	BP
1	10	1.46142378479	-	3.09e-01	GO:0042053	regulation of dopamine metabolic process	BP
1	10	1.46142378479	-	3.09e-01	GO:0006983	ER overload response	BP
1	10	1.46142378479	-	3.09e-01	GO:0050678	regulation of epithelial cell proliferation	BP
1	10	1.46142378479	-	3.09e-01	GO:0060546	negative regulation of necroptotic process	BP
1	10	1.46142378479	-	3.09e-01	GO:0043306	positive regulation of mast cell degranulation	BP
1	10	1.46142378479	-	3.09e-01	GO:0043114	regulation of vascular permeability	BP
1	10	1.46142378479	-	3.09e-01	GO:0090136	epithelial cell-cell adhesion	BP
1	10	1.46142378479	-	3.09e-01	GO:0001759	organ induction	BP
1	10	1.46142378479	-	3.09e-01	GO:0071372	cellular response to follicle-stimulating hormone stimulus	BP
1	10	1.46142378479	-	3.09e-01	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	BP
1	10	1.46142378479	-	3.09e-01	GO:0060009	Sertoli cell development	BP
1	10	1.46142378479	-	3.09e-01	GO:0060252	positive regulation of glial cell proliferation	BP
1	10	1.46142378479	-	3.09e-01	GO:2000637	positive regulation of gene silencing by miRNA	BP
1	10	1.46142378479	-	3.09e-01	GO:0032930	positive regulation of superoxide anion generation	BP
1	10	1.46142378479	-	3.09e-01	GO:2001020	regulation of response to DNA damage stimulus	BP
1	10	1.46142378479	-	3.09e-01	GO:0033197	response to vitamin E	BP
1	10	1.46142378479	-	3.09e-01	GO:2000772	regulation of cellular senescence	BP
1	10	1.46142378479	-	3.09e-01	GO:2000773	negative regulation of cellular senescence	BP
1	10	1.46142378479	-	3.09e-01	GO:0051024	positive regulation of immunoglobulin secretion	BP
1	10	1.46142378479	-	3.09e-01	GO:2000146	negative regulation of cell motility	BP
2	20	1.46142378479	-	1.50e-01	GO:0030159	receptor signaling complex scaffold activity	MF
1	10	1.46142378479	-	1.99e-01	GO:0017128	phospholipid scramblase activity	MF
1	10	1.46142378479	-	1.99e-01	GO:0004791	thioredoxin-disulfide reductase activity	MF
1	10	1.46142378479	-	1.99e-01	GO:0030215	semaphorin receptor binding	MF
1	10	1.46142378479	-	1.99e-01	GO:0000900	translation repressor activity, nucleic acid binding	MF
1	10	1.46142378479	-	2.83e-01	GO:0043142	single-stranded DNA-dependent ATPase activity	MF
1	10	1.46142378479	-	2.83e-01	GO:0051428	peptide hormone receptor binding	MF
1	10	1.46142378479	-	2.83e-01	GO:0016504	peptidase activator activity	MF
1	10	1.46142378479	-	3.09e-01	GO:0042805	actinin binding	MF
1	10	1.46142378479	-	3.09e-01	GO:0045294	alpha-catenin binding	MF
1	10	1.46142378479	-	3.09e-01	GO:0070016	armadillo repeat domain binding	MF
1	10	1.46142378479	-	3.09e-01	GO:0034452	dynactin binding	MF
11	111	1.44836763196	-	5.88e-04	GO:0007219	Notch signaling pathway	BP
11	111	1.44836763196	-	6.44e-04	GO:0045766	positive regulation of angiogenesis	BP
11	111	1.44836763196	-	1.37e-03	GO:0016569	covalent chromatin modification	BP
7	71	1.44095968223	-	8.30e-03	GO:0060333	interferon-gamma-mediated signaling pathway	BP
7	71	1.44095968223	-	9.02e-03	GO:0071347	cellular response to interleukin-1	BP
6	61	1.43757704283	-	1.00e-02	GO:0042632	cholesterol homeostasis	BP
17	173	1.43618649329	-	5.66e-05	GO:0001701	in utero embryonic development	BP
5	51	1.43285463259	-	2.71e-02	GO:0035064	methylated histone binding	MF
7	73	1.40088224285	-	6.99e-03	GO:0008144	drug binding	MF
6	63	1.3910344569	-	1.20e-02	GO:0008203	cholesterol metabolic process	BP
2	21	1.3910344569	-	1.01e-01	GO:0045333	cellular respiration	BP
2	21	1.3910344569	-	1.25e-01	GO:0045671	negative regulation of osteoclast differentiation	BP
2	21	1.3910344569	-	1.50e-01	GO:0048870	cell motility	BP
2	21	1.3910344569	-	1.63e-01	GO:0090103	cochlea morphogenesis	BP
2	21	1.3910344569	-	1.76e-01	GO:0051403	stress-activated MAPK cascade	BP
2	21	1.3910344569	-	1.76e-01	GO:0030316	osteoclast differentiation	BP
2	21	1.3910344569	-	1.13e-01	GO:0031210	phosphatidylcholine binding	MF
2	21	1.3910344569	-	1.76e-01	GO:0017025	TBP-class protein binding	MF
11	116	1.38480250318	-	1.73e-03	GO:0030308	negative regulation of cell growth	BP
5	53	1.37735952	-	7.21e-03	GO:0042472	inner ear morphogenesis	BP
6	64	1.3683143804	-	1.20e-02	GO:0060337	type I interferon signaling pathway	BP
3	32	1.3683143804	-	6.67e-02	GO:0030513	positive regulation of BMP signaling pathway	BP
3	32	1.3683143804	-	1.09e-01	GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway	BP
7	75	1.36188811124	-	3.23e-03	GO:0045666	positive regulation of neuron differentiation	BP
9	97	1.35336403893	-	2.40e-03	GO:0030182	neuron differentiation	BP
9	97	1.35336403893	-	4.94e-03	GO:0071456	cellular response to hypoxia	BP
35	379	1.34658085845	-	2.00e-08	GO:0008285	negative regulation of cell proliferation	BP
7	77	1.32392026104	-	6.40e-03	GO:0030324	lung development	BP
7	77	1.32392026104	-	9.78e-03	GO:0060070	canonical Wnt signaling pathway	BP
6	66	1.32392026104	-	1.83e-02	GO:0009749	response to glucose	BP
5	55	1.32392026104	-	2.71e-02	GO:0001570	vasculogenesis	BP
5	55	1.32392026104	-	2.94e-02	GO:0050680	negative regulation of epithelial cell proliferation	BP
4	44	1.32392026104	-	3.70e-02	GO:0006342	chromatin silencing	BP
4	44	1.32392026104	-	6.05e-02	GO:0006094	gluconeogenesis	BP
3	33	1.32392026104	-	8.67e-02	GO:0002931	response to ischemia	BP
3	33	1.32392026104	-	9.38e-02	GO:0007585	respiratory gaseous exchange	BP
3	33	1.32392026104	-	1.01e-01	GO:0001974	blood vessel remodeling	BP
1	11	1.32392026104	-	1.05e-01	GO:0060285	cilium-dependent cell motility	BP
3	33	1.32392026104	-	1.09e-01	GO:0051973	positive regulation of telomerase activity	BP
2	22	1.32392026104	-	1.13e-01	GO:0019915	lipid storage	BP
3	33	1.32392026104	-	1.17e-01	GO:0043928	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	BP
1	11	1.32392026104	-	1.38e-01	GO:0006071	glycerol metabolic process	BP
2	22	1.32392026104	-	1.50e-01	GO:0001816	cytokine production	BP
2	22	1.32392026104	-	1.63e-01	GO:0035924	cellular response to vascular endothelial growth factor stimulus	BP
2	22	1.32392026104	-	1.63e-01	GO:1904886	beta-catenin destruction complex disassembly	BP
1	11	1.32392026104	-	1.69e-01	GO:0006590	thyroid hormone generation	BP
1	11	1.32392026104	-	1.69e-01	GO:0010529	negative regulation of transposition	BP
2	22	1.32392026104	-	1.76e-01	GO:0005978	glycogen biosynthetic process	BP
1	11	1.32392026104	-	2.28e-01	GO:0006702	androgen biosynthetic process	BP
1	11	1.32392026104	-	2.28e-01	GO:0008406	gonad development	BP
1	11	1.32392026104	-	2.28e-01	GO:0048703	embryonic viscerocranium morphogenesis	BP
1	11	1.32392026104	-	2.28e-01	GO:0042551	neuron maturation	BP
1	11	1.32392026104	-	2.28e-01	GO:0002064	epithelial cell development	BP
1	11	1.32392026104	-	2.56e-01	GO:0000050	urea cycle	BP
1	11	1.32392026104	-	2.56e-01	GO:0010524	positive regulation of calcium ion transport into cytosol	BP
1	11	1.32392026104	-	2.56e-01	GO:0006707	cholesterol catabolic process	BP
1	11	1.32392026104	-	2.56e-01	GO:0045603	positive regulation of endothelial cell differentiation	BP
1	11	1.32392026104	-	2.56e-01	GO:0002089	lens morphogenesis in camera-type eye	BP
1	11	1.32392026104	-	2.56e-01	GO:0045446	endothelial cell differentiation	BP
1	11	1.32392026104	-	2.56e-01	GO:0006346	methylation-dependent chromatin silencing	BP
1	11	1.32392026104	-	2.56e-01	GO:0060294	cilium movement involved in cell motility	BP
1	11	1.32392026104	-	2.56e-01	GO:0001655	urogenital system development	BP
1	11	1.32392026104	-	2.83e-01	GO:0010389	regulation of G2/M transition of mitotic cell cycle	BP
1	11	1.32392026104	-	2.83e-01	GO:0030431	sleep	BP
1	11	1.32392026104	-	2.83e-01	GO:0070365	hepatocyte differentiation	BP
1	11	1.32392026104	-	2.83e-01	GO:0043666	regulation of phosphoprotein phosphatase activity	BP
1	11	1.32392026104	-	2.83e-01	GO:0022409	positive regulation of cell-cell adhesion	BP
1	11	1.32392026104	-	2.83e-01	GO:0072520	seminiferous tubule development	BP
1	11	1.32392026104	-	2.83e-01	GO:0019371	cyclooxygenase pathway	BP
1	11	1.32392026104	-	3.09e-01	GO:0048484	enteric nervous system development	BP
1	11	1.32392026104	-	3.09e-01	GO:0032206	positive regulation of telomere maintenance	BP
1	11	1.32392026104	-	3.09e-01	GO:0055015	ventricular cardiac muscle cell development	BP
1	11	1.32392026104	-	3.09e-01	GO:0030033	microvillus assembly	BP
1	11	1.32392026104	-	3.09e-01	GO:0048715	negative regulation of oligodendrocyte differentiation	BP
1	11	1.32392026104	-	3.09e-01	GO:0006937	regulation of muscle contraction	BP
1	11	1.32392026104	-	3.09e-01	GO:0021756	striatum development	BP
1	11	1.32392026104	-	3.09e-01	GO:0019068	virion assembly	BP
1	11	1.32392026104	-	3.09e-01	GO:0035413	positive regulation of catenin import into nucleus	BP
1	11	1.32392026104	-	3.09e-01	GO:0048333	mesodermal cell differentiation	BP
1	11	1.32392026104	-	3.09e-01	GO:0000002	mitochondrial genome maintenance	BP
1	11	1.32392026104	-	3.09e-01	GO:0043517	positive regulation of DNA damage response, signal transduction by p53 class mediator	BP
1	11	1.32392026104	-	3.09e-01	GO:0032211	negative regulation of telomere maintenance via telomerase	BP
1	11	1.32392026104	-	3.34e-01	GO:0043249	erythrocyte maturation	BP
1	11	1.32392026104	-	3.34e-01	GO:0042347	negative regulation of NF-kappaB import into nucleus	BP
1	11	1.32392026104	-	3.34e-01	GO:0010884	positive regulation of lipid storage	BP
1	11	1.32392026104	-	3.34e-01	GO:0032786	positive regulation of DNA-templated transcription, elongation	BP
1	11	1.32392026104	-	3.34e-01	GO:0010955	negative regulation of protein processing	BP
1	11	1.32392026104	-	3.34e-01	GO:0032700	negative regulation of interleukin-17 production	BP
1	11	1.32392026104	-	3.34e-01	GO:0006266	DNA ligation	BP
1	11	1.32392026104	-	3.34e-01	GO:0060544	regulation of necroptotic process	BP
1	11	1.32392026104	-	3.34e-01	GO:0032495	response to muramyl dipeptide	BP
1	11	1.32392026104	-	3.34e-01	GO:0035970	peptidyl-threonine dephosphorylation	BP
1	11	1.32392026104	-	3.34e-01	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	BP
1	11	1.32392026104	-	3.34e-01	GO:0060765	regulation of androgen receptor signaling pathway	BP
1	11	1.32392026104	-	3.34e-01	GO:0042511	positive regulation of tyrosine phosphorylation of Stat1 protein	BP
1	11	1.32392026104	-	3.34e-01	GO:0045667	regulation of osteoblast differentiation	BP
1	11	1.32392026104	-	3.34e-01	GO:0061001	regulation of dendritic spine morphogenesis	BP
1	11	1.32392026104	-	3.34e-01	GO:0051382	kinetochore assembly	BP
1	11	1.32392026104	-	2.28e-01	GO:0015278	calcium-release channel activity	MF
1	11	1.32392026104	-	2.56e-01	GO:0042301	phosphate ion binding	MF
1	11	1.32392026104	-	2.56e-01	GO:0043394	proteoglycan binding	MF
1	11	1.32392026104	-	2.83e-01	GO:0005548	phospholipid transporter activity	MF
1	11	1.32392026104	-	2.83e-01	GO:0043225	ATPase-coupled anion transmembrane transporter activity	MF
1	11	1.32392026104	-	3.09e-01	GO:0048407	platelet-derived growth factor binding	MF
1	11	1.32392026104	-	3.09e-01	GO:0050786	RAGE receptor binding	MF
1	11	1.32392026104	-	3.34e-01	GO:0017154	semaphorin receptor activity	MF
1	11	1.32392026104	-	3.34e-01	GO:0030371	translation repressor activity	MF
1	11	1.32392026104	-	3.34e-01	GO:0070410	co-SMAD binding	MF
1	11	1.32392026104	-	3.34e-01	GO:0070411	I-SMAD binding	MF
15	165	1.32392026104	-	2.35e-04	GO:0007507	heart development	BP
8	89	1.30761844871	-	1.04e-02	GO:0007179	transforming growth factor beta receptor signaling pathway	BP
4	45	1.29149878334	-	5.19e-02	GO:0030900	forebrain development	BP
3	34	1.28085153914	-	8.67e-02	GO:0048813	dendrite morphogenesis	BP
3	34	1.28085153914	-	1.09e-01	GO:0001837	epithelial to mesenchymal transition	BP
3	34	1.28085153914	-	1.25e-01	GO:1990090	cellular response to nerve growth factor stimulus	BP
112	1271	1.27895848673	-	1.79e-10	GO:0006355	regulation of transcription, DNA-templated	BP
8	91	1.27555723948	-	5.27e-03	GO:0009653	anatomical structure morphogenesis	BP
8	91	1.27555723948	-	9.70e-03	GO:0032355	response to estradiol	BP
5	57	1.2723899604	-	2.49e-02	GO:0001947	heart looping	BP
18	206	1.26677635393	-	3.90e-04	GO:0019904	protein domain specific binding	MF
2	23	1.25978992362	-	1.76e-01	GO:0048675	axon extension	BP
2	23	1.25978992362	-	2.03e-01	GO:0030866	cortical actin cytoskeleton organization	BP
2	23	1.25978992362	-	2.03e-01	GO:0043044	ATP-dependent chromatin remodeling	BP
4	46	1.25978992362	-	2.23e-02	GO:0005044	scavenger receptor activity	MF
2	23	1.25978992362	-	1.89e-01	GO:0030332	cyclin binding	MF
9	104	1.25283716298	-	3.36e-03	GO:0010468	regulation of gene expression	BP
11	129	1.23155624289	-	3.75e-03	GO:0043524	negative regulation of neuron apoptotic process	BP
11	131	1.20936049677	-	5.14e-03	GO:0010629	negative regulation of gene expression	BP
5	60	1.19838937895	-	6.25e-02	GO:0007059	chromosome segregation	BP
4	48	1.19838937895	-	7.46e-02	GO:0009267	cellular response to starvation	BP
4	48	1.19838937895	-	9.02e-02	GO:0042542	response to hydrogen peroxide	BP
2	24	1.19838937895	-	1.50e-01	GO:0048589	developmental growth	BP
2	24	1.19838937895	-	1.76e-01	GO:0008306	associative learning	BP
2	24	1.19838937895	-	1.89e-01	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	BP
2	24	1.19838937895	-	1.89e-01	GO:0051602	response to electrical stimulus	BP
1	12	1.19838937895	-	1.99e-01	GO:0042738	exogenous drug catabolic process	BP
1	12	1.19838937895	-	1.99e-01	GO:0003376	sphingosine-1-phosphate signaling pathway	BP
2	24	1.19838937895	-	2.16e-01	GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway	BP
2	24	1.19838937895	-	2.16e-01	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	BP
1	12	1.19838937895	-	2.28e-01	GO:0086012	membrane depolarization during cardiac muscle cell action potential	BP
1	12	1.19838937895	-	2.28e-01	GO:0042574	retinal metabolic process	BP
1	12	1.19838937895	-	2.56e-01	GO:0034374	low-density lipoprotein particle remodeling	BP
1	12	1.19838937895	-	2.83e-01	GO:0010759	positive regulation of macrophage chemotaxis	BP
1	12	1.19838937895	-	2.83e-01	GO:0046834	lipid phosphorylation	BP
1	12	1.19838937895	-	2.83e-01	GO:0030277	maintenance of gastrointestinal epithelium	BP
1	12	1.19838937895	-	2.83e-01	GO:0007041	lysosomal transport	BP
1	12	1.19838937895	-	3.09e-01	GO:0045078	positive regulation of interferon-gamma biosynthetic process	BP
1	12	1.19838937895	-	3.09e-01	GO:0010447	response to acidic pH	BP
1	12	1.19838937895	-	3.09e-01	GO:0001706	endoderm formation	BP
1	12	1.19838937895	-	3.09e-01	GO:0021846	cell proliferation in forebrain	BP
1	12	1.19838937895	-	3.09e-01	GO:0030278	regulation of ossification	BP
1	12	1.19838937895	-	3.09e-01	GO:0002009	morphogenesis of an epithelium	BP
1	12	1.19838937895	-	3.09e-01	GO:0097028	dendritic cell differentiation	BP
1	12	1.19838937895	-	3.09e-01	GO:0045995	regulation of embryonic development	BP
1	12	1.19838937895	-	3.34e-01	GO:0001736	establishment of planar polarity	BP
1	12	1.19838937895	-	3.34e-01	GO:0001946	lymphangiogenesis	BP
1	12	1.19838937895	-	3.34e-01	GO:0060707	trophoblast giant cell differentiation	BP
1	12	1.19838937895	-	3.34e-01	GO:0060425	lung morphogenesis	BP
1	12	1.19838937895	-	3.34e-01	GO:0086004	regulation of cardiac muscle cell contraction	BP
1	12	1.19838937895	-	3.34e-01	GO:0071361	cellular response to ethanol	BP
1	12	1.19838937895	-	3.34e-01	GO:0071360	cellular response to exogenous dsRNA	BP
1	12	1.19838937895	-	3.34e-01	GO:0030212	hyaluronan metabolic process	BP
1	12	1.19838937895	-	3.59e-01	GO:0055003	cardiac myofibril assembly	BP
1	12	1.19838937895	-	3.59e-01	GO:0055008	cardiac muscle tissue morphogenesis	BP
1	12	1.19838937895	-	3.59e-01	GO:0047496	vesicle transport along microtubule	BP
1	12	1.19838937895	-	3.59e-01	GO:0045724	positive regulation of cilium assembly	BP
1	12	1.19838937895	-	3.59e-01	GO:2000484	positive regulation of interleukin-8 secretion	BP
1	12	1.19838937895	-	3.59e-01	GO:0007252	I-kappaB phosphorylation	BP
1	12	1.19838937895	-	3.59e-01	GO:0035278	miRNA mediated inhibition of translation	BP
1	12	1.19838937895	-	3.59e-01	GO:0033630	positive regulation of cell adhesion mediated by integrin	BP
1	12	1.19838937895	-	3.59e-01	GO:0090179	planar cell polarity pathway involved in neural tube closure	BP
1	12	1.19838937895	-	3.59e-01	GO:0048712	negative regulation of astrocyte differentiation	BP
1	12	1.19838937895	-	3.59e-01	GO:0061099	negative regulation of protein tyrosine kinase activity	BP
1	12	1.19838937895	-	3.59e-01	GO:0042994	cytoplasmic sequestering of transcription factor	BP
1	12	1.19838937895	-	3.59e-01	GO:0040007	growth	BP
1	12	1.19838937895	-	3.59e-01	GO:0090656	t-circle formation	BP
1	12	1.19838937895	-	1.69e-01	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	MF
2	24	1.19838937895	-	1.76e-01	GO:0005246	calcium channel regulator activity	MF
1	12	1.19838937895	-	2.28e-01	GO:0004065	arylsulfatase activity	MF
1	12	1.19838937895	-	3.09e-01	GO:0003906	DNA-(apurinic or apyrimidinic site) lyase activity	MF
1	12	1.19838937895	-	3.34e-01	GO:0050321	tau-protein kinase activity	MF
1	12	1.19838937895	-	3.59e-01	GO:0004708	MAP kinase kinase activity	MF
1	12	1.19838937895	-	3.59e-01	GO:0004861	cyclin-dependent protein serine/threonine kinase inhibitor activity	MF
3	36	1.19838937895	-	8.67e-02	GO:0002062	chondrocyte differentiation	BP
146	1762	1.19017822963	-	1.39e-10	GO:0006351	transcription, DNA-templated	BP
9	109	1.18509255634	-	8.63e-03	GO:0071356	cellular response to tumor necrosis factor	BP
125	1518	1.18118008892	-	1.54e-10	GO:0003677	DNA binding	MF
6	73	1.17848982152	-	2.83e-02	GO:0007005	mitochondrion organization	BP
6	73	1.17848982152	-	4.64e-02	GO:0006283	transcription-coupled nucleotide-excision repair	BP
4	49	1.16864203556	-	8.49e-02	GO:0004386	helicase activity	MF
7	86	1.16444204703	-	4.39e-03	GO:0006805	xenobiotic metabolic process	BP
3	37	1.15886101477	-	1.17e-01	GO:0007611	learning or memory	BP
3	37	1.15886101477	-	1.25e-01	GO:0071902	positive regulation of protein serine/threonine kinase activity	BP
3	37	1.15886101477	-	1.33e-01	GO:0071364	cellular response to epidermal growth factor stimulus	BP
3	37	1.15886101477	-	1.50e-01	GO:0004407	histone deacetylase activity	MF
11	136	1.15532065706	-	2.01e-03	GO:0001501	skeletal system development	BP
20	249	1.14527804249	-	2.08e-04	GO:0010628	positive regulation of gene expression	BP
10	125	1.1394956899	-	1.41e-02	GO:1901796	regulation of signal transduction by p53 class mediator	BP
4	50	1.1394956899	-	8.49e-02	GO:0071407	cellular response to organic cyclic compound	BP
2	25	1.1394956899	-	1.50e-01	GO:0032689	negative regulation of interferon-gamma production	BP
2	25	1.1394956899	-	1.63e-01	GO:0050715	positive regulation of cytokine secretion	BP
2	25	1.1394956899	-	1.76e-01	GO:0045930	negative regulation of mitotic cell cycle	BP
2	25	1.1394956899	-	1.89e-01	GO:0050772	positive regulation of axonogenesis	BP
2	25	1.1394956899	-	2.16e-01	GO:0032757	positive regulation of interleukin-8 production	BP
2	25	1.1394956899	-	2.16e-01	GO:0060976	coronary vasculature development	BP
6	75	1.1394956899	-	3.89e-02	GO:0019900	kinase binding	MF
2	25	1.1394956899	-	2.30e-01	GO:0046875	ephrin receptor binding	MF
9	113	1.1330979187	-	4.59e-03	GO:0007417	central nervous system development	BP
5	63	1.12800005106	-	4.56e-02	GO:0032868	response to insulin	BP
5	63	1.12800005106	-	4.56e-02	GO:0031647	regulation of protein stability	BP
3	38	1.12038686695	-	1.01e-01	GO:0001657	ureteric bud development	BP
3	38	1.12038686695	-	1.09e-01	GO:0030199	collagen fibril organization	BP
3	38	1.12038686695	-	1.50e-01	GO:0030155	regulation of cell adhesion	BP
3	38	1.12038686695	-	6.67e-02	GO:0005245	voltage-gated calcium channel activity	MF
4	51	1.1109265377	-	9.02e-02	GO:0040008	regulation of growth	BP
36	460	1.10778683017	-	4.70e-07	GO:0046982	protein heterodimerization activity	MF
5	64	1.10527997456	-	5.88e-02	GO:0035019	somatic stem cell population maintenance	BP
3	39	1.08291216153	-	1.01e-01	GO:0030326	embryonic limb morphogenesis	BP
3	39	1.08291216153	-	1.17e-01	GO:0045071	negative regulation of viral genome replication	BP
3	39	1.08291216153	-	1.50e-01	GO:0007223	Wnt signaling pathway, calcium modulating pathway	BP
3	39	1.08291216153	-	8.67e-02	GO:0042626	ATPase activity, coupled to transmembrane movement of substances	MF
5	65	1.08291216153	-	4.26e-02	GO:0030183	B cell differentiation	BP
4	52	1.08291216153	-	6.97e-02	GO:0008344	adult locomotory behavior	BP
2	26	1.08291216153	-	1.50e-01	GO:0060338	regulation of type I interferon-mediated signaling pathway	BP
2	26	1.08291216153	-	1.76e-01	GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus	BP
2	26	1.08291216153	-	2.03e-01	GO:0033077	T cell differentiation in thymus	BP
2	26	1.08291216153	-	2.03e-01	GO:0032715	negative regulation of interleukin-6 production	BP
1	13	1.08291216153	-	2.28e-01	GO:0021527	spinal cord association neuron differentiation	BP
2	26	1.08291216153	-	2.30e-01	GO:0000732	strand displacement	BP
2	26	1.08291216153	-	2.30e-01	GO:0050999	regulation of nitric-oxide synthase activity	BP
2	26	1.08291216153	-	2.43e-01	GO:0051225	spindle assembly	BP
1	13	1.08291216153	-	2.56e-01	GO:0048599	oocyte development	BP
1	13	1.08291216153	-	2.56e-01	GO:0006957	complement activation, alternative pathway	BP
1	13	1.08291216153	-	2.83e-01	GO:0001516	prostaglandin biosynthetic process	BP
1	13	1.08291216153	-	2.83e-01	GO:0072001	renal system development	BP
1	13	1.08291216153	-	2.83e-01	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	BP
1	13	1.08291216153	-	3.09e-01	GO:0002087	regulation of respiratory gaseous exchange by neurological system process	BP
1	13	1.08291216153	-	3.09e-01	GO:0060389	pathway-restricted SMAD protein phosphorylation	BP
1	13	1.08291216153	-	3.34e-01	GO:0050806	positive regulation of synaptic transmission	BP
1	13	1.08291216153	-	3.34e-01	GO:0071425	hematopoietic stem cell proliferation	BP
1	13	1.08291216153	-	3.34e-01	GO:0007171	activation of transmembrane receptor protein tyrosine kinase activity	BP
1	13	1.08291216153	-	3.34e-01	GO:0003016	respiratory system process	BP
1	13	1.08291216153	-	3.34e-01	GO:0036109	alpha-linolenic acid metabolic process	BP
1	13	1.08291216153	-	3.59e-01	GO:0035909	aorta morphogenesis	BP
1	13	1.08291216153	-	3.59e-01	GO:0033962	cytoplasmic mRNA processing body assembly	BP
1	13	1.08291216153	-	3.59e-01	GO:0016226	iron-sulfur cluster assembly	BP
1	13	1.08291216153	-	3.59e-01	GO:0006883	cellular sodium ion homeostasis	BP
1	13	1.08291216153	-	3.59e-01	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP
1	13	1.08291216153	-	3.59e-01	GO:0071285	cellular response to lithium ion	BP
1	13	1.08291216153	-	3.59e-01	GO:0010952	positive regulation of peptidase activity	BP
1	13	1.08291216153	-	3.59e-01	GO:0002526	acute inflammatory response	BP
1	13	1.08291216153	-	3.59e-01	GO:0071872	cellular response to epinephrine stimulus	BP
1	13	1.08291216153	-	3.59e-01	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
1	13	1.08291216153	-	3.82e-01	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	BP
1	13	1.08291216153	-	3.82e-01	GO:0070306	lens fiber cell differentiation	BP
1	13	1.08291216153	-	3.82e-01	GO:0032784	regulation of DNA-templated transcription, elongation	BP
1	13	1.08291216153	-	3.82e-01	GO:0045579	positive regulation of B cell differentiation	BP
1	13	1.08291216153	-	3.82e-01	GO:0042176	regulation of protein catabolic process	BP
1	13	1.08291216153	-	3.82e-01	GO:0006809	nitric oxide biosynthetic process	BP
1	13	1.08291216153	-	3.82e-01	GO:0035418	protein localization to synapse	BP
1	13	1.08291216153	-	3.82e-01	GO:0045088	regulation of innate immune response	BP
1	13	1.08291216153	-	3.82e-01	GO:0002756	MyD88-independent toll-like receptor signaling pathway	BP
1	13	1.08291216153	-	2.28e-01	GO:0019841	retinol binding	MF
2	26	1.08291216153	-	2.43e-01	GO:0051721	protein phosphatase 2A binding	MF
1	13	1.08291216153	-	2.83e-01	GO:0070403	NAD+ binding	MF
1	13	1.08291216153	-	3.09e-01	GO:0004467	long-chain fatty acid-CoA ligase activity	MF
1	13	1.08291216153	-	3.09e-01	GO:0003995	acyl-CoA dehydrogenase activity	MF
1	13	1.08291216153	-	3.09e-01	GO:0004527	exonuclease activity	MF
1	13	1.08291216153	-	3.09e-01	GO:0004518	nuclease activity	MF
1	13	1.08291216153	-	3.82e-01	GO:0001784	phosphotyrosine binding	MF
14	183	1.07500696345	-	1.86e-03	GO:0042981	regulation of apoptotic process	BP
23	301	1.07329415897	-	1.77e-04	GO:0042493	response to drug	BP
13	171	1.06593908293	-	2.87e-03	GO:0042127	regulation of cell proliferation	BP
13	171	1.06593908293	-	1.02e-02	GO:0008022	protein C-terminus binding	MF
10	133	1.04999753906	-	2.94e-02	GO:0051092	positive regulation of NF-kappaB transcription factor activity	BP
3	40	1.04638628551	-	1.50e-01	GO:0032024	positive regulation of insulin secretion	BP
3	40	1.04638628551	-	1.50e-01	GO:0097191	extrinsic apoptotic signaling pathway	BP
3	40	1.04638628551	-	1.77e-01	GO:0010508	positive regulation of autophagy	BP
11	147	1.04311115347	-	2.01e-03	GO:0046983	protein dimerization activity	MF
5	67	1.0391907841	-	7.01e-02	GO:0032088	negative regulation of NF-kappaB transcription factor activity	BP
82	1102	1.03499537572	-	1.56e-10	GO:0008270	zinc ion binding	MF
2	27	1.02846437751	-	1.13e-01	GO:0007389	pattern specification process	BP
2	27	1.02846437751	-	1.89e-01	GO:0042476	odontogenesis	BP
2	27	1.02846437751	-	2.30e-01	GO:0001662	behavioral fear response	BP
2	27	1.02846437751	-	2.43e-01	GO:0090314	positive regulation of protein targeting to membrane	BP
2	27	1.02846437751	-	2.43e-01	GO:0043392	negative regulation of DNA binding	BP
2	27	1.02846437751	-	2.57e-01	GO:0043278	response to morphine	BP
2	27	1.02846437751	-	1.01e-01	GO:0019706	protein-cysteine S-palmitoyltransferase activity	MF
2	27	1.02846437751	-	2.03e-01	GO:0004693	cyclin-dependent protein serine/threonine kinase activity	MF
2	27	1.02846437751	-	2.16e-01	GO:0001106	RNA polymerase II transcription corepressor activity	MF
3	41	1.01076237578	-	1.50e-01	GO:0030968	endoplasmic reticulum unfolded protein response	BP
3	41	1.01076237578	-	1.59e-01	GO:0014823	response to activity	BP
7	96	1.00574430101	-	3.28e-02	GO:0042593	glucose homeostasis	BP
4	55	1.00199216615	-	9.02e-02	GO:0042733	embryonic digit morphogenesis	BP
4	55	1.00199216615	-	9.02e-02	GO:0045665	negative regulation of neuron differentiation	BP
9	124	0.999080570729	-	1.86e-02	GO:0002223	stimulatory C-type lectin receptor signaling pathway	BP
3	42	0.975996957616	-	1.17e-01	GO:0050885	neuromuscular process controlling balance	BP
3	42	0.975996957616	-	1.17e-01	GO:0001658	branching involved in ureteric bud morphogenesis	BP
2	28	0.975996957616	-	1.63e-01	GO:0007194	negative regulation of adenylate cyclase activity	BP
2	28	0.975996957616	-	1.76e-01	GO:0030449	regulation of complement activation	BP
2	28	0.975996957616	-	1.76e-01	GO:0006520	cellular amino acid metabolic process	BP
3	42	0.975996957616	-	1.77e-01	GO:1901215	negative regulation of neuron death	BP
3	42	0.975996957616	-	1.86e-01	GO:0000302	response to reactive oxygen species	BP
1	14	0.975996957616	-	1.99e-01	GO:0006790	sulfur compound metabolic process	BP
2	28	0.975996957616	-	2.43e-01	GO:0007528	neuromuscular junction development	BP
1	14	0.975996957616	-	2.56e-01	GO:0046928	regulation of neurotransmitter secretion	BP
1	14	0.975996957616	-	2.56e-01	GO:0051967	negative regulation of synaptic transmission, glutamatergic	BP
2	28	0.975996957616	-	2.70e-01	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	BP
2	28	0.975996957616	-	2.70e-01	GO:0010332	response to gamma radiation	BP
1	14	0.975996957616	-	2.83e-01	GO:0051604	protein maturation	BP
1	14	0.975996957616	-	3.09e-01	GO:0003382	epithelial cell morphogenesis	BP
1	14	0.975996957616	-	3.09e-01	GO:0031103	axon regeneration	BP
1	14	0.975996957616	-	3.09e-01	GO:0002063	chondrocyte development	BP
1	14	0.975996957616	-	3.34e-01	GO:0043303	mast cell degranulation	BP
1	14	0.975996957616	-	3.34e-01	GO:0045947	negative regulation of translational initiation	BP
1	14	0.975996957616	-	3.59e-01	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	BP
1	14	0.975996957616	-	3.59e-01	GO:0050965	detection of temperature stimulus involved in sensory perception of pain	BP
1	14	0.975996957616	-	3.59e-01	GO:0043409	negative regulation of MAPK cascade	BP
1	14	0.975996957616	-	3.59e-01	GO:1901185	negative regulation of ERBB signaling pathway	BP
1	14	0.975996957616	-	3.59e-01	GO:0034356	NAD biosynthesis via nicotinamide riboside salvage pathway	BP
1	14	0.975996957616	-	3.59e-01	GO:0030517	negative regulation of axon extension	BP
1	14	0.975996957616	-	3.59e-01	GO:0042325	regulation of phosphorylation	BP
1	14	0.975996957616	-	3.82e-01	GO:0044130	negative regulation of growth of symbiont in host	BP
1	14	0.975996957616	-	3.82e-01	GO:0006940	regulation of smooth muscle contraction	BP
1	14	0.975996957616	-	3.82e-01	GO:0001817	regulation of cytokine production	BP
1	14	0.975996957616	-	3.82e-01	GO:0032743	positive regulation of interleukin-2 production	BP
1	14	0.975996957616	-	3.82e-01	GO:0030194	positive regulation of blood coagulation	BP
1	14	0.975996957616	-	3.82e-01	GO:0070528	protein kinase C signaling	BP
1	14	0.975996957616	-	4.04e-01	GO:0001774	microglial cell activation	BP
1	14	0.975996957616	-	4.04e-01	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	BP
1	14	0.975996957616	-	4.04e-01	GO:0042953	lipoprotein transport	BP
1	14	0.975996957616	-	4.04e-01	GO:0042993	positive regulation of transcription factor import into nucleus	BP
1	14	0.975996957616	-	4.04e-01	GO:2000353	positive regulation of endothelial cell apoptotic process	BP
1	14	0.975996957616	-	4.04e-01	GO:0022904	respiratory electron transport chain	BP
1	14	0.975996957616	-	4.04e-01	GO:0000380	alternative mRNA splicing, via spliceosome	BP
3	42	0.975996957616	-	1.17e-01	GO:0015485	cholesterol binding	MF
1	14	0.975996957616	-	1.99e-01	GO:0008188	neuropeptide receptor activity	MF
1	14	0.975996957616	-	2.56e-01	GO:0008499	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity	MF
1	14	0.975996957616	-	3.59e-01	GO:0008528	G-protein coupled peptide receptor activity	MF
1	14	0.975996957616	-	3.82e-01	GO:0005095	GTPase inhibitor activity	MF
1	14	0.975996957616	-	3.82e-01	GO:0004438	phosphatidylinositol-3-phosphatase activity	MF
1	14	0.975996957616	-	3.82e-01	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	MF
1	14	0.975996957616	-	4.04e-01	GO:0031432	titin binding	MF
1	14	0.975996957616	-	4.04e-01	GO:0031434	mitogen-activated protein kinase kinase binding	MF
1	14	0.975996957616	-	4.04e-01	GO:0070182	DNA polymerase binding	MF
1	14	0.975996957616	-	4.04e-01	GO:0070063	RNA polymerase binding	MF
1	14	0.975996957616	-	4.04e-01	GO:0035198	miRNA binding	MF
1	14	0.975996957616	-	4.04e-01	GO:0005528	FK506 binding	MF
6	85	0.958923444258	-	3.89e-02	GO:0009887	animal organ morphogenesis	BP
6	85	0.958923444258	-	4.13e-02	GO:0007565	female pregnancy	BP
4	57	0.950461865509	-	6.05e-02	GO:0007338	single fertilization	BP
6	86	0.942049625693	-	4.38e-02	GO:0007517	muscle organ development	BP
3	43	0.942049625693	-	1.09e-01	GO:0045165	cell fate commitment	BP
3	43	0.942049625693	-	1.17e-01	GO:0001756	somitogenesis	BP
4	58	0.925370884546	-	9.58e-02	GO:0051216	cartilage development	BP
4	58	0.925370884546	-	1.13e-01	GO:0016525	negative regulation of angiogenesis	BP
2	29	0.925370884546	-	1.50e-01	GO:0048477	oogenesis	BP
2	29	0.925370884546	-	2.16e-01	GO:0060325	face morphogenesis	BP
2	29	0.925370884546	-	2.16e-01	GO:0019933	cAMP-mediated signaling	BP
2	29	0.925370884546	-	2.30e-01	GO:0001654	eye development	BP
2	29	0.925370884546	-	2.43e-01	GO:0007281	germ cell development	BP
2	29	0.925370884546	-	2.43e-01	GO:0010033	response to organic substance	BP
2	29	0.925370884546	-	2.57e-01	GO:1903146	regulation of mitophagy	BP
2	29	0.925370884546	-	2.57e-01	GO:0034504	protein localization to nucleus	BP
2	29	0.925370884546	-	2.57e-01	GO:0006284	base-excision repair	BP
2	29	0.925370884546	-	2.70e-01	GO:0048147	negative regulation of fibroblast proliferation	BP
2	29	0.925370884546	-	2.43e-01	GO:0008234	cysteine-type peptidase activity	MF
2	29	0.925370884546	-	2.70e-01	GO:0042169	SH2 domain binding	MF
2	29	0.925370884546	-	2.84e-01	GO:0008094	DNA-dependent ATPase activity	MF
3	44	0.908882761758	-	1.09e-01	GO:0061337	cardiac conduction	BP
3	44	0.908882761758	-	1.25e-01	GO:0006631	fatty acid metabolic process	BP
4	59	0.900708830312	-	1.01e-01	GO:0050679	positive regulation of epithelial cell proliferation	BP
4	59	0.900708830312	-	1.26e-01	GO:0032092	positive regulation of protein binding	BP
4	59	0.900708830312	-	1.52e-01	GO:0007249	I-kappaB kinase/NF-kappaB signaling	BP
5	74	0.895826608932	-	8.68e-02	GO:0042060	wound healing	BP
30	444	0.895826608932	-	1.62e-04	GO:0043066	negative regulation of apoptotic process	BP
5	75	0.876461284066	-	5.20e-02	GO:0001503	ossification	BP
4	60	0.876461284066	-	1.52e-01	GO:0030334	regulation of cell migration	BP
2	30	0.876461284066	-	2.70e-01	GO:0042177	negative regulation of protein catabolic process	BP
2	30	0.876461284066	-	2.70e-01	GO:0001932	regulation of protein phosphorylation	BP
1	15	0.876461284066	-	2.83e-01	GO:0001963	synaptic transmission, dopaminergic	BP
1	15	0.876461284066	-	2.83e-01	GO:2000311	regulation of AMPA receptor activity	BP
2	30	0.876461284066	-	2.84e-01	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	BP
1	15	0.876461284066	-	3.09e-01	GO:0035082	axoneme assembly	BP
1	15	0.876461284066	-	3.34e-01	GO:0007340	acrosome reaction	BP
1	15	0.876461284066	-	3.59e-01	GO:0051276	chromosome organization	BP
1	15	0.876461284066	-	3.59e-01	GO:0008585	female gonad development	BP
1	15	0.876461284066	-	3.59e-01	GO:0048485	sympathetic nervous system development	BP
1	15	0.876461284066	-	3.59e-01	GO:0086005	ventricular cardiac muscle cell action potential	BP
1	15	0.876461284066	-	3.59e-01	GO:0006750	glutathione biosynthetic process	BP
1	15	0.876461284066	-	3.82e-01	GO:0060347	heart trabecula formation	BP
1	15	0.876461284066	-	3.82e-01	GO:0032793	positive regulation of CREB transcription factor activity	BP
1	15	0.876461284066	-	4.04e-01	GO:0048872	homeostasis of number of cells	BP
1	15	0.876461284066	-	4.04e-01	GO:0031573	intra-S DNA damage checkpoint	BP
1	15	0.876461284066	-	4.04e-01	GO:0032469	endoplasmic reticulum calcium ion homeostasis	BP
1	15	0.876461284066	-	4.04e-01	GO:2000251	positive regulation of actin cytoskeleton reorganization	BP
1	15	0.876461284066	-	4.04e-01	GO:0051044	positive regulation of membrane protein ectodomain proteolysis	BP
1	15	0.876461284066	-	4.04e-01	GO:0030490	maturation of SSU-rRNA	BP
1	15	0.876461284066	-	4.04e-01	GO:0060397	JAK-STAT cascade involved in growth hormone signaling pathway	BP
1	15	0.876461284066	-	4.04e-01	GO:0034162	toll-like receptor 9 signaling pathway	BP
1	15	0.876461284066	-	4.04e-01	GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
1	15	0.876461284066	-	4.04e-01	GO:0035458	cellular response to interferon-beta	BP
1	15	0.876461284066	-	4.26e-01	GO:0051895	negative regulation of focal adhesion assembly	BP
1	15	0.876461284066	-	4.26e-01	GO:0046328	regulation of JNK cascade	BP
1	15	0.876461284066	-	4.26e-01	GO:1903543	positive regulation of exosomal secretion	BP
1	15	0.876461284066	-	4.26e-01	GO:0031929	TOR signaling	BP
1	15	0.876461284066	-	4.26e-01	GO:1902187	negative regulation of viral release from host cell	BP
1	15	0.876461284066	-	4.26e-01	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
1	15	0.876461284066	-	4.26e-01	GO:0045190	isotype switching	BP
1	15	0.876461284066	-	4.26e-01	GO:0007215	glutamate receptor signaling pathway	BP
1	15	0.876461284066	-	4.26e-01	GO:0001935	endothelial cell proliferation	BP
1	15	0.876461284066	-	4.26e-01	GO:0048011	neurotrophin TRK receptor signaling pathway	BP
1	15	0.876461284066	-	3.82e-01	GO:0017091	AU-rich element binding	MF
1	15	0.876461284066	-	4.26e-01	GO:0070742	C2H2 zinc finger domain binding	MF
3	45	0.876461284066	-	4.39e-02	GO:0045596	negative regulation of cell differentiation	BP
3	45	0.876461284066	-	1.17e-01	GO:0006633	fatty acid biosynthetic process	BP
3	45	0.876461284066	-	1.86e-01	GO:0014070	response to organic cyclic compound	BP
3	45	0.876461284066	-	1.68e-01	GO:0003730	mRNA 3'-UTR binding	MF
5	76	0.857352461118	-	8.24e-02	GO:0060021	palate development	BP
5	76	0.857352461118	-	1.05e-01	GO:0051117	ATPase binding	MF
8	122	0.852614542111	-	1.64e-02	GO:0006629	lipid metabolic process	BP
3	46	0.844752424338	-	1.77e-01	GO:0010506	regulation of autophagy	BP
3	46	0.844752424338	-	1.86e-01	GO:0071230	cellular response to amino acid stimulus	BP
3	46	0.844752424338	-	1.95e-01	GO:0008542	visual learning	BP
9	139	0.834335808393	-	4.80e-02	GO:0007050	cell cycle arrest	BP
4	62	0.829155569287	-	1.01e-01	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	BP
4	62	0.829155569287	-	1.52e-01	GO:0035690	cellular response to drug	BP
2	31	0.829155569287	-	2.16e-01	GO:0045907	positive regulation of vasoconstriction	BP
2	31	0.829155569287	-	2.43e-01	GO:0009953	dorsal/ventral pattern formation	BP
2	31	0.829155569287	-	2.43e-01	GO:0019882	antigen processing and presentation	BP
2	31	0.829155569287	-	2.70e-01	GO:0032007	negative regulation of TOR signaling	BP
4	62	0.829155569287	-	2.88e-01	GO:0045815	positive regulation of gene expression, epigenetic	BP
2	31	0.829155569287	-	2.98e-01	GO:0006383	transcription from RNA polymerase III promoter	BP
2	31	0.829155569287	-	3.11e-01	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	BP
2	31	0.829155569287	-	2.84e-01	GO:0008536	Ran GTPase binding	MF
7	109	0.822522476955	-	1.08e-01	GO:0000082	G1/S transition of mitotic cell cycle	BP
12	187	0.821419920508	-	1.49e-02	GO:0007420	brain development	BP
3	47	0.813725528718	-	2.24e-01	GO:0038083	peptidyl-tyrosine autophosphorylation	BP
13	204	0.811366255844	-	2.67e-02	GO:0006974	cellular response to DNA damage stimulus	BP
4	63	0.806071956174	-	2.88e-01	GO:0019903	protein phosphatase binding	MF
10	159	0.792397019277	-	4.32e-02	GO:0090090	negative regulation of canonical Wnt signaling pathway	BP
4	64	0.783351879674	-	1.66e-01	GO:0018107	peptidyl-threonine phosphorylation	BP
4	64	0.783351879674	-	1.73e-01	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	BP
2	32	0.783351879674	-	1.89e-01	GO:0042100	B cell proliferation	BP
2	32	0.783351879674	-	2.03e-01	GO:0051480	regulation of cytosolic calcium ion concentration	BP
2	32	0.783351879674	-	2.30e-01	GO:0007498	mesoderm development	BP
2	32	0.783351879674	-	2.43e-01	GO:0008016	regulation of heart contraction	BP
2	32	0.783351879674	-	2.70e-01	GO:0002027	regulation of heart rate	BP
2	32	0.783351879674	-	2.84e-01	GO:0070830	bicellular tight junction assembly	BP
2	32	0.783351879674	-	2.84e-01	GO:0071479	cellular response to ionizing radiation	BP
2	32	0.783351879674	-	3.11e-01	GO:0045773	positive regulation of axon extension	BP
2	32	0.783351879674	-	3.11e-01	GO:0071549	cellular response to dexamethasone stimulus	BP
2	32	0.783351879674	-	3.25e-01	GO:0070911	global genome nucleotide-excision repair	BP
2	32	0.783351879674	-	3.25e-01	GO:0097421	liver regeneration	BP
2	32	0.783351879674	-	3.25e-01	GO:0032212	positive regulation of telomere maintenance via telomerase	BP
1	16	0.783351879674	-	3.34e-01	GO:0048566	embryonic digestive tract development	BP
1	16	0.783351879674	-	3.34e-01	GO:0097009	energy homeostasis	BP
1	16	0.783351879674	-	3.34e-01	GO:0086002	cardiac muscle cell action potential involved in contraction	BP
1	16	0.783351879674	-	3.59e-01	GO:0019372	lipoxygenase pathway	BP
1	16	0.783351879674	-	3.82e-01	GO:0021522	spinal cord motor neuron differentiation	BP
1	16	0.783351879674	-	3.82e-01	GO:0010975	regulation of neuron projection development	BP
1	16	0.783351879674	-	3.82e-01	GO:0048714	positive regulation of oligodendrocyte differentiation	BP
1	16	0.783351879674	-	3.82e-01	GO:0070509	calcium ion import	BP
1	16	0.783351879674	-	4.04e-01	GO:0031293	membrane protein intracellular domain proteolysis	BP
1	16	0.783351879674	-	4.04e-01	GO:0061036	positive regulation of cartilage development	BP
1	16	0.783351879674	-	4.04e-01	GO:0060292	long term synaptic depression	BP
1	16	0.783351879674	-	4.04e-01	GO:0090026	positive regulation of monocyte chemotaxis	BP
1	16	0.783351879674	-	4.26e-01	GO:0048535	lymph node development	BP
1	16	0.783351879674	-	4.26e-01	GO:0032479	regulation of type I interferon production	BP
1	16	0.783351879674	-	4.26e-01	GO:0006349	regulation of gene expression by genetic imprinting	BP
1	16	0.783351879674	-	4.26e-01	GO:0071732	cellular response to nitric oxide	BP
1	16	0.783351879674	-	4.26e-01	GO:0010744	positive regulation of macrophage derived foam cell differentiation	BP
1	16	0.783351879674	-	4.47e-01	GO:0034142	toll-like receptor 4 signaling pathway	BP
1	16	0.783351879674	-	4.47e-01	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	BP
1	16	0.783351879674	-	4.47e-01	GO:0000132	establishment of mitotic spindle orientation	BP
1	16	0.783351879674	-	4.47e-01	GO:0007020	microtubule nucleation	BP
1	16	0.783351879674	-	3.82e-01	GO:0004540	ribonuclease activity	MF
1	16	0.783351879674	-	4.04e-01	GO:0008574	ATP-dependent microtubule motor activity, plus-end-directed	MF
1	16	0.783351879674	-	4.26e-01	GO:0050431	transforming growth factor beta binding	MF
1	16	0.783351879674	-	4.47e-01	GO:0050750	low-density lipoprotein particle receptor binding	MF
1	16	0.783351879674	-	4.47e-01	GO:0050998	nitric-oxide synthase binding	MF
9	148	0.743823515487	-	9.90e-02	GO:0050852	T cell receptor signaling pathway	BP
6	99	0.738957760316	-	1.44e-01	GO:0031175	neuron projection development	BP
2	33	0.738957760316	-	2.70e-01	GO:0050808	synapse organization	BP
2	33	0.738957760316	-	3.11e-01	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
2	33	0.738957760316	-	3.25e-01	GO:0010718	positive regulation of epithelial to mesenchymal transition	BP
13	215	0.735598748226	-	2.62e-02	GO:0001525	angiogenesis	BP
11	182	0.734988858113	-	5.08e-02	GO:0007596	blood coagulation	BP
3	50	0.72445819062	-	2.14e-01	GO:0006091	generation of precursor metabolites and energy	BP
27	453	0.714872141791	-	1.21e-03	GO:0008284	positive regulation of cell proliferation	BP
4	68	0.695889038424	-	1.52e-01	GO:0006310	DNA recombination	BP
1	17	0.695889038424	-	2.56e-01	GO:0050908	detection of light stimulus involved in visual perception	BP
2	34	0.695889038424	-	2.70e-01	GO:0030501	positive regulation of bone mineralization	BP
4	68	0.695889038424	-	2.88e-01	GO:0034976	response to endoplasmic reticulum stress	BP
1	17	0.695889038424	-	3.09e-01	GO:0015012	heparan sulfate proteoglycan biosynthetic process	BP
1	17	0.695889038424	-	3.34e-01	GO:0007276	gamete generation	BP
1	17	0.695889038424	-	3.34e-01	GO:0042310	vasoconstriction	BP
2	34	0.695889038424	-	3.51e-01	GO:0000731	DNA synthesis involved in DNA repair	BP
1	17	0.695889038424	-	3.82e-01	GO:0001556	oocyte maturation	BP
1	17	0.695889038424	-	4.04e-01	GO:0030902	hindbrain development	BP
1	17	0.695889038424	-	4.04e-01	GO:0050804	modulation of synaptic transmission	BP
1	17	0.695889038424	-	4.04e-01	GO:0021537	telencephalon development	BP
1	17	0.695889038424	-	4.04e-01	GO:0007043	cell-cell junction assembly	BP
1	17	0.695889038424	-	4.04e-01	GO:2000377	regulation of reactive oxygen species metabolic process	BP
1	17	0.695889038424	-	4.26e-01	GO:0010804	negative regulation of tumor necrosis factor-mediated signaling pathway	BP
1	17	0.695889038424	-	4.26e-01	GO:0071380	cellular response to prostaglandin E stimulus	BP
1	17	0.695889038424	-	4.26e-01	GO:0010880	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	BP
1	17	0.695889038424	-	4.26e-01	GO:0034199	activation of protein kinase A activity	BP
1	17	0.695889038424	-	4.26e-01	GO:0032722	positive regulation of chemokine production	BP
1	17	0.695889038424	-	4.47e-01	GO:0031589	cell-substrate adhesion	BP
1	17	0.695889038424	-	4.47e-01	GO:1904355	positive regulation of telomere capping	BP
1	17	0.695889038424	-	4.47e-01	GO:0006261	DNA-dependent DNA replication	BP
1	17	0.695889038424	-	4.47e-01	GO:0032418	lysosome localization	BP
1	17	0.695889038424	-	4.47e-01	GO:0016571	histone methylation	BP
1	17	0.695889038424	-	4.47e-01	GO:2000114	regulation of establishment of cell polarity	BP
1	17	0.695889038424	-	4.67e-01	GO:0031333	negative regulation of protein complex assembly	BP
1	17	0.695889038424	-	4.67e-01	GO:0010039	response to iron ion	BP
2	34	0.695889038424	-	2.16e-01	GO:0017080	sodium channel regulator activity	MF
1	17	0.695889038424	-	3.82e-01	GO:0017049	GTP-Rho binding	MF
1	17	0.695889038424	-	3.82e-01	GO:0017127	cholesterol transporter activity	MF
1	17	0.695889038424	-	4.26e-01	GO:0016279	protein-lysine N-methyltransferase activity	MF
1	17	0.695889038424	-	4.47e-01	GO:0034237	protein kinase A regulatory subunit binding	MF
22	377	0.684362785043	-	1.33e-02	GO:0019901	protein kinase binding	MF
11	189	0.68054107409	-	5.60e-02	GO:0005516	calmodulin binding	MF
4	69	0.674827422896	-	3.04e-01	GO:0097190	apoptotic signaling pathway	BP
3	52	0.667874662254	-	1.86e-01	GO:0042157	lipoprotein metabolic process	BP
3	52	0.667874662254	-	2.63e-01	GO:0006417	regulation of translation	BP
11	191	0.665354670276	-	1.03e-01	GO:0004672	protein kinase activity	MF
2	35	0.654068862729	-	2.57e-01	GO:0051321	meiotic cell cycle	BP
2	35	0.654068862729	-	2.57e-01	GO:0086091	regulation of heart rate by cardiac conduction	BP
2	35	0.654068862729	-	2.70e-01	GO:0001890	placenta development	BP
4	70	0.654068862729	-	3.19e-01	GO:0042795	snRNA transcription from RNA polymerase II promoter	BP
2	35	0.654068862729	-	3.51e-01	GO:0031648	protein destabilization	BP
4	70	0.654068862729	-	2.96e-01	GO:0003690	double-stranded DNA binding	MF
3	53	0.640393925832	-	4.34e-01	GO:0050729	positive regulation of inflammatory response	BP
3	53	0.640393925832	-	4.29e-01	GO:0004702	signal transducer, downstream of receptor, with serine/threonine kinase activity	MF
10	179	0.621464197297	-	8.02e-03	GO:0003676	nucleic acid binding	MF
3	54	0.613426878232	-	1.33e-01	GO:0019730	antimicrobial humoral response	BP
4	72	0.613426878232	-	2.85e-01	GO:0006816	calcium ion transport	BP
2	36	0.613426878232	-	3.11e-01	GO:0051209	release of sequestered calcium ion into cytosol	BP
1	18	0.613426878232	-	3.59e-01	GO:0036342	post-anal tail morphogenesis	BP
2	36	0.613426878232	-	3.65e-01	GO:0006953	acute-phase response	BP
1	18	0.613426878232	-	4.04e-01	GO:1903861	positive regulation of dendrite extension	BP
1	18	0.613426878232	-	4.04e-01	GO:0048557	embryonic digestive tract morphogenesis	BP
1	18	0.613426878232	-	4.04e-01	GO:0035249	synaptic transmission, glutamatergic	BP
1	18	0.613426878232	-	4.04e-01	GO:0010596	negative regulation of endothelial cell migration	BP
1	18	0.613426878232	-	4.26e-01	GO:0042267	natural killer cell mediated cytotoxicity	BP
1	18	0.613426878232	-	4.26e-01	GO:0035584	calcium-mediated signaling using intracellular calcium source	BP
1	18	0.613426878232	-	4.26e-01	GO:0016079	synaptic vesicle exocytosis	BP
1	18	0.613426878232	-	4.26e-01	GO:0030318	melanocyte differentiation	BP
1	18	0.613426878232	-	4.26e-01	GO:0061436	establishment of skin barrier	BP
3	54	0.613426878232	-	4.29e-01	GO:0051592	response to calcium ion	BP
3	54	0.613426878232	-	4.43e-01	GO:0045732	positive regulation of protein catabolic process	BP
1	18	0.613426878232	-	4.47e-01	GO:0036120	cellular response to platelet-derived growth factor stimulus	BP
1	18	0.613426878232	-	4.47e-01	GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	BP
1	18	0.613426878232	-	4.67e-01	GO:2000249	regulation of actin cytoskeleton reorganization	BP
1	18	0.613426878232	-	4.67e-01	GO:0007250	activation of NF-kappaB-inducing kinase activity	BP
1	18	0.613426878232	-	4.67e-01	GO:1902236	negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
1	18	0.613426878232	-	4.67e-01	GO:0008045	motor neuron axon guidance	BP
1	18	0.613426878232	-	4.86e-01	GO:0006913	nucleocytoplasmic transport	BP
1	18	0.613426878232	-	4.86e-01	GO:0045807	positive regulation of endocytosis	BP
1	18	0.613426878232	-	4.86e-01	GO:1904380	endoplasmic reticulum mannose trimming	BP
1	18	0.613426878232	-	4.86e-01	GO:0002026	regulation of the force of heart contraction	BP
1	18	0.613426878232	-	2.56e-01	GO:0004745	retinol dehydrogenase activity	MF
1	18	0.613426878232	-	3.59e-01	GO:0016746	transferase activity, transferring acyl groups	MF
1	18	0.613426878232	-	3.82e-01	GO:0043395	heparan sulfate proteoglycan binding	MF
1	18	0.613426878232	-	4.04e-01	GO:0016209	antioxidant activity	MF
1	18	0.613426878232	-	4.04e-01	GO:0016706	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors	MF
1	18	0.613426878232	-	4.26e-01	GO:0005545	1-phosphatidylinositol binding	MF
1	18	0.613426878232	-	4.86e-01	GO:0003678	DNA helicase activity	MF
1	18	0.613426878232	-	4.86e-01	GO:0005234	extracellular-glutamate-gated ion channel activity	MF
1	18	0.613426878232	-	4.86e-01	GO:0051019	mitogen-activated protein kinase binding	MF
9	162	0.613426878232	-	1.17e-01	GO:0007568	aging	BP
9	163	0.604548726885	-	5.37e-02	GO:0051607	defense response to virus	BP
6	109	0.600130055618	-	1.68e-01	GO:0044325	ion channel binding	MF
4	73	0.593527320794	-	7.96e-02	GO:0030216	keratinocyte differentiation	BP
3	55	0.586954666871	-	1.77e-01	GO:0007368	determination of left/right symmetry	BP
6	110	0.586954666871	-	2.81e-01	GO:0031047	gene silencing by RNA	BP
3	55	0.586954666871	-	4.29e-01	GO:0008104	protein localization	BP
3	55	0.586954666871	-	4.38e-01	GO:0007173	epidermal growth factor receptor signaling pathway	BP
3	55	0.586954666871	-	4.38e-01	GO:0070373	negative regulation of ERK1 and ERK2 cascade	BP
7	129	0.579479546308	-	4.98e-02	GO:0007605	sensory perception of sound	BP
9	166	0.578237449769	-	2.05e-01	GO:0046777	protein autophosphorylation	BP
11	203	0.577447581126	-	1.22e-01	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	BP
2	37	0.573898514045	-	3.38e-01	GO:0051898	negative regulation of protein kinase B signaling	BP
2	37	0.573898514045	-	3.78e-01	GO:0030890	positive regulation of B cell proliferation	BP
2	37	0.573898514045	-	3.91e-01	GO:0031623	receptor internalization	BP
21	389	0.572042957467	-	2.28e-03	GO:0007283	spermatogenesis	BP
5	93	0.566121163453	-	2.34e-01	GO:0030336	negative regulation of cell migration	BP
19	354	0.563673843035	-	4.89e-02	GO:0008283	cell proliferation	BP
3	56	0.560959458338	-	4.48e-01	GO:0032091	negative regulation of protein binding	BP
7	132	0.546312682373	-	2.19e-01	GO:0050821	protein stabilization	BP
3	57	0.53542436623	-	1.95e-01	GO:0060395	SMAD protein signal transduction	BP
3	57	0.53542436623	-	1.95e-01	GO:0006959	humoral immune response	BP
2	38	0.53542436623	-	2.03e-01	GO:0048468	cell development	BP
1	19	0.53542436623	-	2.83e-01	GO:0033141	positive regulation of peptidyl-serine phosphorylation of STAT protein	BP
6	114	0.53542436623	-	2.91e-01	GO:0006461	protein complex assembly	BP
1	19	0.53542436623	-	3.34e-01	GO:0030539	male genitalia development	BP
1	19	0.53542436623	-	3.82e-01	GO:0019226	transmission of nerve impulse	BP
1	19	0.53542436623	-	4.04e-01	GO:0048148	behavioral response to cocaine	BP
1	19	0.53542436623	-	4.04e-01	GO:0033198	response to ATP	BP
1	19	0.53542436623	-	4.26e-01	GO:0060384	innervation	BP
1	19	0.53542436623	-	4.47e-01	GO:0032502	developmental process	BP
1	19	0.53542436623	-	4.67e-01	GO:0055117	regulation of cardiac muscle contraction	BP
1	19	0.53542436623	-	4.67e-01	GO:0014911	positive regulation of smooth muscle cell migration	BP
1	19	0.53542436623	-	4.67e-01	GO:0031290	retinal ganglion cell axon guidance	BP
1	19	0.53542436623	-	4.67e-01	GO:0002230	positive regulation of defense response to virus by host	BP
1	19	0.53542436623	-	4.86e-01	GO:0046597	negative regulation of viral entry into host cell	BP
1	19	0.53542436623	-	5.05e-01	GO:0070987	error-free translesion synthesis	BP
1	19	0.53542436623	-	3.34e-01	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	MF
1	19	0.53542436623	-	4.47e-01	GO:0016597	amino acid binding	MF
3	57	0.53542436623	-	4.48e-01	GO:0003684	damaged DNA binding	MF
1	19	0.53542436623	-	4.86e-01	GO:0017075	syntaxin-1 binding	MF
1	19	0.53542436623	-	5.05e-01	GO:0004709	MAP kinase kinase kinase activity	MF
1	19	0.53542436623	-	5.05e-01	GO:0070064	proline-rich region binding	MF
4	77	0.516565338979	-	3.19e-01	GO:0030674	protein binding, bridging	MF
3	58	0.510333385268	-	2.24e-01	GO:0006952	defense response	BP
9	175	0.502065769284	-	1.17e-01	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP
4	78	0.497949660812	-	1.66e-01	GO:0008544	epidermis development	BP
2	39	0.497949660812	-	2.98e-01	GO:0050890	cognition	BP
2	39	0.497949660812	-	3.25e-01	GO:0050829	defense response to Gram-negative bacterium	BP
2	39	0.497949660812	-	3.65e-01	GO:0009968	negative regulation of signal transduction	BP
3	59	0.485671331033	-	1.50e-01	GO:0016266	O-glycan processing	BP
3	60	0.461423784787	-	2.53e-01	GO:0006968	cellular defense response	BP
3	60	0.461423784787	-	4.63e-01	GO:0021987	cerebral cortex development	BP
23	460	0.461423784787	-	4.50e-03	GO:0007275	multicellular organism development	BP
1	20	0.461423784787	-	3.59e-01	GO:0043046	DNA methylation involved in gamete generation	BP
1	20	0.461423784787	-	3.82e-01	GO:0043687	post-translational protein modification	BP
1	20	0.461423784787	-	4.26e-01	GO:0042474	middle ear morphogenesis	BP
1	20	0.461423784787	-	4.47e-01	GO:0034314	Arp2/3 complex-mediated actin nucleation	BP
1	20	0.461423784787	-	4.47e-01	GO:0007520	myoblast fusion	BP
1	20	0.461423784787	-	4.47e-01	GO:0060716	labyrinthine layer blood vessel development	BP
1	20	0.461423784787	-	4.67e-01	GO:0006401	RNA catabolic process	BP
1	20	0.461423784787	-	4.86e-01	GO:0042346	positive regulation of NF-kappaB import into nucleus	BP
1	20	0.461423784787	-	4.86e-01	GO:0006783	heme biosynthetic process	BP
1	20	0.461423784787	-	4.86e-01	GO:0043113	receptor clustering	BP
1	20	0.461423784787	-	5.05e-01	GO:0007051	spindle organization	BP
1	20	0.461423784787	-	5.05e-01	GO:0042276	error-prone translesion synthesis	BP
1	20	0.461423784787	-	5.23e-01	GO:1900182	positive regulation of protein localization to nucleus	BP
1	20	0.461423784787	-	5.23e-01	GO:0001836	release of cytochrome c from mitochondria	BP
1	20	0.461423784787	-	5.23e-01	GO:0008361	regulation of cell size	BP
1	20	0.461423784787	-	4.04e-01	GO:0004198	calcium-dependent cysteine-type endopeptidase activity	MF
1	20	0.461423784787	-	4.26e-01	GO:0005112	Notch binding	MF
1	20	0.461423784787	-	4.67e-01	GO:0051018	protein kinase A binding	MF
1	20	0.461423784787	-	4.86e-01	GO:0043539	protein serine/threonine kinase activator activity	MF
8	162	0.443501876789	-	1.75e-01	GO:0032496	response to lipopolysaccharide	BP
14	284	0.440959682227	-	1.93e-01	GO:0031625	ubiquitin protein ligase binding	MF
13	266	0.428509162314	-	1.75e-01	GO:0000165	MAPK cascade	BP
2	41	0.425799875056	-	2.70e-01	GO:0022008	neurogenesis	BP
2	41	0.425799875056	-	3.25e-01	GO:0048839	inner ear development	BP
4	82	0.425799875056	-	3.40e-01	GO:0051897	positive regulation of protein kinase B signaling	BP
2	41	0.425799875056	-	6.52e-01	GO:0032947	protein complex scaffold	MF
3	62	0.414118070008	-	1.86e-01	GO:0007200	phospholipase C-activating G-protein coupled receptor signaling pathway	BP
3	62	0.414118070008	-	4.53e-01	GO:0051289	protein homotetramerization	BP
3	62	0.414118070008	-	4.63e-01	GO:0051384	response to glucocorticoid	BP
23	476	0.412096072423	-	5.21e-03	GO:0030154	cell differentiation	BP
13	270	0.406976000764	-	1.59e-01	GO:0016579	protein deubiquitination	BP
2	42	0.391034456895	-	2.84e-01	GO:0030148	sphingolipid biosynthetic process	BP
4	84	0.391034456895	-	3.35e-01	GO:0001822	kidney development	BP
2	42	0.391034456895	-	3.51e-01	GO:0001541	ovarian follicle development	BP
1	21	0.391034456895	-	3.82e-01	GO:0007369	gastrulation	BP
1	21	0.391034456895	-	3.82e-01	GO:0032094	response to food	BP
1	21	0.391034456895	-	4.04e-01	GO:0014059	regulation of dopamine secretion	BP
1	21	0.391034456895	-	4.26e-01	GO:0006637	acyl-CoA metabolic process	BP
3	63	0.391034456895	-	4.53e-01	GO:0009611	response to wounding	BP
1	21	0.391034456895	-	4.67e-01	GO:0030162	regulation of proteolysis	BP
1	21	0.391034456895	-	4.86e-01	GO:0001676	long-chain fatty acid metabolic process	BP
1	21	0.391034456895	-	4.86e-01	GO:0048844	artery morphogenesis	BP
1	21	0.391034456895	-	5.05e-01	GO:0001782	B cell homeostasis	BP
1	21	0.391034456895	-	5.23e-01	GO:0051000	positive regulation of nitric-oxide synthase activity	BP
1	21	0.391034456895	-	5.23e-01	GO:0050769	positive regulation of neurogenesis	BP
1	21	0.391034456895	-	5.40e-01	GO:0050718	positive regulation of interleukin-1 beta secretion	BP
2	42	0.391034456895	-	6.56e-01	GO:0006986	response to unfolded protein	BP
2	42	0.391034456895	-	6.61e-01	GO:0031397	negative regulation of protein ubiquitination	BP
2	42	0.391034456895	-	6.61e-01	GO:0045785	positive regulation of cell adhesion	BP
1	21	0.391034456895	-	4.47e-01	GO:0001530	lipopolysaccharide binding	MF
2	42	0.391034456895	-	6.49e-01	GO:0048365	Rac GTPase binding	MF
3	64	0.368314380395	-	4.93e-01	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
33	706	0.364221625761	-	1.98e-02	GO:0042803	protein homodimerization activity	MF
2	43	0.357087124972	-	6.49e-01	GO:0042110	T cell activation	BP
8	174	0.340408383825	-	2.62e-01	GO:0007411	axon guidance	BP
1	22	0.323920261037	-	1.69e-01	GO:0098664	G-protein coupled serotonin receptor signaling pathway	BP
2	44	0.323920261037	-	3.38e-01	GO:0006879	cellular iron ion homeostasis	BP
2	44	0.323920261037	-	3.91e-01	GO:0030178	negative regulation of Wnt signaling pathway	BP
1	22	0.323920261037	-	4.26e-01	GO:0017158	regulation of calcium ion-dependent exocytosis	BP
1	22	0.323920261037	-	4.86e-01	GO:0017157	regulation of exocytosis	BP
1	22	0.323920261037	-	5.05e-01	GO:0015914	phospholipid transport	BP
1	22	0.323920261037	-	5.05e-01	GO:0008652	cellular amino acid biosynthetic process	BP
1	22	0.323920261037	-	5.40e-01	GO:0046835	carbohydrate phosphorylation	BP
1	22	0.323920261037	-	5.40e-01	GO:0006607	NLS-bearing protein import into nucleus	BP
1	22	0.323920261037	-	5.40e-01	GO:0031954	positive regulation of protein autophosphorylation	BP
1	22	0.323920261037	-	5.40e-01	GO:0048278	vesicle docking	BP
1	22	0.323920261037	-	5.40e-01	GO:0071480	cellular response to gamma radiation	BP
1	22	0.323920261037	-	5.57e-01	GO:0016050	vesicle organization	BP
1	22	0.323920261037	-	5.57e-01	GO:0048568	embryonic organ development	BP
1	22	0.323920261037	-	5.57e-01	GO:0000717	nucleotide-excision repair, DNA duplex unwinding	BP
2	44	0.323920261037	-	6.49e-01	GO:0023014	signal transduction by protein phosphorylation	BP
2	44	0.323920261037	-	6.56e-01	GO:0032508	DNA duplex unwinding	BP
2	44	0.323920261037	-	6.65e-01	GO:0016575	histone deacetylation	BP
2	44	0.323920261037	-	6.65e-01	GO:0032760	positive regulation of tumor necrosis factor production	BP
1	22	0.323920261037	-	5.23e-01	GO:0050699	WW domain binding	MF
1	22	0.323920261037	-	5.40e-01	GO:0035255	ionotropic glutamate receptor binding	MF
9	199	0.316652260573	-	4.93e-02	GO:0007601	visual perception	BP
9	200	0.309420691342	-	4.30e-01	GO:0032403	protein complex binding	MF
4	89	0.307618448708	-	3.04e-01	GO:0007160	cell-matrix adhesion	BP
7	156	0.305304582869	-	3.73e-01	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	BP
3	67	0.302225189937	-	5.18e-01	GO:0038061	NIK/NF-kappaB signaling	BP
13	292	0.293967038935	-	3.37e-01	GO:0016032	viral process	BP
2	45	0.291498783344	-	3.51e-01	GO:0019722	calcium-mediated signaling	BP
2	45	0.291498783344	-	6.52e-01	GO:0060048	cardiac muscle contraction	BP
2	45	0.291498783344	-	6.61e-01	GO:0005080	protein kinase C binding	MF
13	294	0.284119252979	-	3.21e-01	GO:0043065	positive regulation of apoptotic process	BP
3	68	0.280851539145	-	5.18e-01	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
4	91	0.275557239475	-	3.46e-01	GO:0009636	response to toxic substance	BP
4	92	0.259789923617	-	3.70e-01	GO:0016337	single organismal cell-cell adhesion	BP
1	23	0.259789923617	-	4.47e-01	GO:0046856	phosphatidylinositol dephosphorylation	BP
3	69	0.259789923617	-	4.48e-01	GO:0060079	excitatory postsynaptic potential	BP
1	23	0.259789923617	-	4.67e-01	GO:0009617	response to bacterium	BP
1	23	0.259789923617	-	4.86e-01	GO:0032967	positive regulation of collagen biosynthetic process	BP
1	23	0.259789923617	-	5.23e-01	GO:0006259	DNA metabolic process	BP
1	23	0.259789923617	-	5.40e-01	GO:0034394	protein localization to cell surface	BP
1	23	0.259789923617	-	5.57e-01	GO:0000083	regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
1	23	0.259789923617	-	5.57e-01	GO:0003009	skeletal muscle contraction	BP
1	23	0.259789923617	-	5.57e-01	GO:2000378	negative regulation of reactive oxygen species metabolic process	BP
1	23	0.259789923617	-	5.73e-01	GO:0006297	nucleotide-excision repair, DNA gap filling	BP
2	46	0.259789923617	-	6.84e-01	GO:0016241	regulation of macroautophagy	BP
1	23	0.259789923617	-	5.23e-01	GO:0017134	fibroblast growth factor binding	MF
1	23	0.259789923617	-	5.73e-01	GO:0030295	protein kinase activator activity	MF
9	208	0.252837162975	-	3.23e-01	GO:0004871	signal transducer activity	MF
3	70	0.23903136345	-	4.69e-01	GO:0009791	post-embryonic development	BP
2	47	0.228763027996	-	3.51e-01	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	BP
2	47	0.228763027996	-	6.61e-01	GO:0048812	neuron projection morphogenesis	BP
2	47	0.228763027996	-	6.84e-01	GO:0036297	interstrand cross-link repair	BP
2	47	0.228763027996	-	3.51e-01	GO:0005544	calcium-dependent phospholipid binding	MF
2	47	0.228763027996	-	6.65e-01	GO:0003774	motor activity	MF
3	71	0.218567260891	-	7.42e-01	GO:0048010	vascular endothelial growth factor receptor signaling pathway	BP
7	166	0.215667370385	-	5.02e-01	GO:0016477	cell migration	BP
1	24	0.198389378953	-	4.47e-01	GO:0019369	arachidonic acid metabolic process	BP
1	24	0.198389378953	-	4.67e-01	GO:0002376	immune system process	BP
1	24	0.198389378953	-	4.67e-01	GO:0008654	phospholipid biosynthetic process	BP
1	24	0.198389378953	-	4.86e-01	GO:0090102	cochlea development	BP
1	24	0.198389378953	-	5.05e-01	GO:0006182	cGMP biosynthetic process	BP
7	168	0.198389378953	-	5.16e-01	GO:0030335	positive regulation of cell migration	BP
1	24	0.198389378953	-	5.23e-01	GO:0014003	oligodendrocyte development	BP
1	24	0.198389378953	-	5.23e-01	GO:0007214	gamma-aminobutyric acid signaling pathway	BP
1	24	0.198389378953	-	5.40e-01	GO:0033344	cholesterol efflux	BP
1	24	0.198389378953	-	5.57e-01	GO:0042113	B cell activation	BP
1	24	0.198389378953	-	5.57e-01	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	BP
1	24	0.198389378953	-	5.57e-01	GO:0071345	cellular response to cytokine stimulus	BP
1	24	0.198389378953	-	5.57e-01	GO:0033137	negative regulation of peptidyl-serine phosphorylation	BP
1	24	0.198389378953	-	5.57e-01	GO:0002040	sprouting angiogenesis	BP
1	24	0.198389378953	-	5.57e-01	GO:0071158	positive regulation of cell cycle arrest	BP
1	24	0.198389378953	-	5.89e-01	GO:0016239	positive regulation of macroautophagy	BP
1	24	0.198389378953	-	5.89e-01	GO:0035235	ionotropic glutamate receptor signaling pathway	BP
1	24	0.198389378953	-	5.89e-01	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	BP
5	120	0.198389378953	-	6.09e-01	GO:0090263	positive regulation of canonical Wnt signaling pathway	BP
5	120	0.198389378953	-	6.13e-01	GO:0033209	tumor necrosis factor-mediated signaling pathway	BP
2	48	0.198389378953	-	6.56e-01	GO:0035176	social behavior	BP
2	48	0.198389378953	-	6.74e-01	GO:0060548	negative regulation of cell death	BP
2	48	0.198389378953	-	6.93e-01	GO:0007254	JNK cascade	BP
2	48	0.198389378953	-	6.52e-01	GO:0030145	manganese ion binding	MF
3	72	0.198389378953	-	7.36e-01	GO:0043410	positive regulation of MAPK cascade	BP
6	145	0.18840529038	-	6.46e-01	GO:0018105	peptidyl-serine phosphorylation	BP
5	121	0.186416737287	-	6.11e-01	GO:0004713	protein tyrosine kinase activity	MF
3	73	0.178489821515	-	5.12e-01	GO:0045454	cell redox homeostasis	BP
2	49	0.168642035559	-	6.98e-01	GO:0045814	negative regulation of gene expression, epigenetic	BP
8	196	0.168642035559	-	2.66e-01	GO:0004872	receptor activity	MF
2	49	0.168642035559	-	6.70e-01	GO:0097110	scaffold protein binding	MF
2	49	0.168642035559	-	6.84e-01	GO:0043621	protein self-association	MF
3	74	0.158861014766	-	7.44e-01	GO:0071260	cellular response to mechanical stimulus	BP
1	25	0.139495689899	-	4.04e-01	GO:0007602	phototransduction	BP
1	25	0.139495689899	-	5.05e-01	GO:0045880	positive regulation of smoothened signaling pathway	BP
1	25	0.139495689899	-	5.23e-01	GO:0019433	triglyceride catabolic process	BP
1	25	0.139495689899	-	5.23e-01	GO:0007202	activation of phospholipase C activity	BP
1	25	0.139495689899	-	5.57e-01	GO:0043473	pigmentation	BP
1	25	0.139495689899	-	5.73e-01	GO:0043542	endothelial cell migration	BP
1	25	0.139495689899	-	5.89e-01	GO:0006096	glycolytic process	BP
1	25	0.139495689899	-	6.04e-01	GO:0032735	positive regulation of interleukin-12 production	BP
1	25	0.139495689899	-	6.04e-01	GO:0000188	inactivation of MAPK activity	BP
2	50	0.139495689899	-	6.56e-01	GO:0006906	vesicle fusion	BP
3	75	0.139495689899	-	7.44e-01	GO:0016925	protein sumoylation	BP
1	25	0.139495689899	-	2.56e-01	GO:0030594	neurotransmitter receptor activity	MF
1	25	0.139495689899	-	5.89e-01	GO:0043014	alpha-tubulin binding	MF
3	76	0.120386866952	-	4.99e-01	GO:0043085	positive regulation of catalytic activity	BP
4	102	0.110926537703	-	5.70e-01	GO:0001649	osteoblast differentiation	BP
2	51	0.110926537703	-	6.79e-01	GO:0045860	positive regulation of protein kinase activity	BP
4	102	0.110926537703	-	7.85e-01	GO:0043488	regulation of mRNA stability	BP
2	51	0.110926537703	-	6.93e-01	GO:0004715	non-membrane spanning protein tyrosine kinase activity	MF
2	51	0.110926537703	-	7.03e-01	GO:0003743	translation initiation factor activity	MF
3	77	0.1015278397	-	4.99e-01	GO:0031295	T cell costimulation	BP
3	77	0.1015278397	-	5.05e-01	GO:0005543	phospholipid binding	MF
3	77	0.1015278397	-	5.18e-01	GO:0016301	kinase activity	MF
43	1106	0.0984809641414	-	3.01e-02	GO:0007165	signal transduction	BP
3	78	0.082912161533	-	4.53e-01	GO:0090305	nucleic acid phosphodiester bond hydrolysis	BP
1	26	0.082912161533	-	4.67e-01	GO:0019432	triglyceride biosynthetic process	BP
1	26	0.082912161533	-	5.73e-01	GO:0014065	phosphatidylinositol 3-kinase signaling	BP
1	26	0.082912161533	-	5.89e-01	GO:0032148	activation of protein kinase B activity	BP
1	26	0.082912161533	-	6.04e-01	GO:0008089	anterograde axonal transport	BP
1	26	0.082912161533	-	6.18e-01	GO:0045070	positive regulation of viral genome replication	BP
1	26	0.082912161533	-	6.18e-01	GO:0061621	canonical glycolysis	BP
1	26	0.082912161533	-	6.18e-01	GO:0032728	positive regulation of interferon-beta production	BP
1	26	0.082912161533	-	4.67e-01	GO:0042605	peptide antigen binding	MF
1	26	0.082912161533	-	5.40e-01	GO:0019838	growth factor binding	MF
7	183	0.0750069634476	-	6.82e-01	GO:0061630	ubiquitin protein ligase activity	MF
12	314	0.0736936315036	-	2.05e-01	GO:0007399	nervous system development	BP
2	53	0.0554314251108	-	3.51e-01	GO:0030317	flagellated sperm motility	BP
2	53	0.0554314251108	-	6.74e-01	GO:0007612	learning	BP
3	80	0.0463862855078	-	7.42e-01	GO:0007229	integrin-mediated signaling pathway	BP
6	161	0.0373975022806	-	6.53e-01	GO:0006397	mRNA processing	BP
1	27	0.0284643775106	-	4.86e-01	GO:0050832	defense response to fungus	BP
3	81	0.0284643775106	-	4.87e-01	GO:0030509	BMP signaling pathway	BP
1	27	0.0284643775106	-	5.05e-01	GO:0006699	bile acid biosynthetic process	BP
1	27	0.0284643775106	-	5.23e-01	GO:0045746	negative regulation of Notch signaling pathway	BP
1	27	0.0284643775106	-	5.40e-01	GO:0031069	hair follicle morphogenesis	BP
1	27	0.0284643775106	-	5.73e-01	GO:0001656	metanephros development	BP
1	27	0.0284643775106	-	5.73e-01	GO:0016358	dendrite development	BP
1	27	0.0284643775106	-	5.89e-01	GO:0090023	positive regulation of neutrophil chemotaxis	BP
1	27	0.0284643775106	-	6.04e-01	GO:0001975	response to amphetamine	BP
1	27	0.0284643775106	-	6.18e-01	GO:0035329	hippo signaling	BP
1	27	0.0284643775106	-	6.18e-01	GO:0048008	platelet-derived growth factor receptor signaling pathway	BP
1	27	0.0284643775106	-	6.18e-01	GO:0051603	proteolysis involved in cellular protein catabolic process	BP
2	54	0.0284643775106	-	6.93e-01	GO:0043406	positive regulation of MAP kinase activity	BP
2	54	0.0284643775106	-	6.98e-01	GO:0030097	hemopoiesis	BP
3	81	0.0284643775106	-	4.53e-01	GO:0036459	thiol-dependent ubiquitinyl hydrolase activity	MF
1	27	0.0284643775106	-	6.04e-01	GO:0001968	fibronectin binding	MF
2	54	0.0284643775106	-	7.09e-01	GO:0004197	cysteine-type endopeptidase activity	MF
16	434	0.0218006472296	-	1.16e-01	GO:0045087	innate immune response	BP
326	8884	0.0150863563581	-	7.55e-02	GO:0005515	protein binding	MF
2	55	0.00199216614939	-	6.70e-01	GO:1903779	regulation of cardiac conduction	BP
2	55	0.00199216614939	-	3.65e-01	GO:0003824	catalytic activity	MF
1	28	-0.0240030423836	-	5.23e-01	GO:0048791	calcium ion-regulated exocytosis of neurotransmitter	BP
1	28	-0.0240030423836	-	5.57e-01	GO:0007628	adult walking behavior	BP
1	28	-0.0240030423836	-	6.04e-01	GO:0000422	mitophagy	BP
1	28	-0.0240030423836	-	6.04e-01	GO:2000145	regulation of cell motility	BP
1	28	-0.0240030423836	-	6.18e-01	GO:0051491	positive regulation of filopodium assembly	BP
2	56	-0.0240030423836	-	7.19e-01	GO:0036498	IRE1-mediated unfolded protein response	BP
1	28	-0.0240030423836	-	1.00e+00	GO:0014047	glutamate secretion	BP
1	28	-0.0240030423836	-	1.00e+00	GO:0090004	positive regulation of establishment of protein localization to plasma membrane	BP
1	28	-0.0240030423836	-	1.00e+00	GO:0019058	viral life cycle	BP
1	28	-0.0240030423836	-	1.00e+00	GO:0000077	DNA damage checkpoint	BP
1	28	-0.0240030423836	-	1.00e+00	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	BP
1	28	-0.0240030423836	-	2.83e-01	GO:0004993	G-protein coupled serotonin receptor activity	MF
1	28	-0.0240030423836	-	5.73e-01	GO:0008139	nuclear localization sequence binding	MF
2	56	-0.0240030423836	-	7.03e-01	GO:0004722	protein serine/threonine phosphatase activity	MF
1	28	-0.0240030423836	-	1.00e+00	GO:0017048	Rho GTPase binding	MF
69	1943	-0.0321938491331	-	8.10e-03	GO:0046872	metal ion binding	MF
5	141	-0.0342713778374	-	8.15e-01	GO:0006260	DNA replication	BP
3	85	-0.0410765557425	-	7.44e-01	GO:0006874	cellular calcium ion homeostasis	BP
12	344	-0.0579503743069	-	8.80e-01	GO:0004674	protein serine/threonine kinase activity	MF
6	174	-0.0746291154535	-	2.83e-01	GO:0002250	adaptive immune response	BP
1	29	-0.0746291154535	-	4.26e-01	GO:0042572	retinol metabolic process	BP
1	29	-0.0746291154535	-	4.26e-01	GO:0018146	keratan sulfate biosynthetic process	BP
1	29	-0.0746291154535	-	5.40e-01	GO:0030163	protein catabolic process	BP
1	29	-0.0746291154535	-	5.40e-01	GO:0030203	glycosaminoglycan metabolic process	BP
1	29	-0.0746291154535	-	5.73e-01	GO:0044344	cellular response to fibroblast growth factor stimulus	BP
1	29	-0.0746291154535	-	5.73e-01	GO:0045776	negative regulation of blood pressure	BP
1	29	-0.0746291154535	-	5.73e-01	GO:0051017	actin filament bundle assembly	BP
1	29	-0.0746291154535	-	6.04e-01	GO:0045595	regulation of cell differentiation	BP
1	29	-0.0746291154535	-	6.18e-01	GO:0006400	tRNA modification	BP
1	29	-0.0746291154535	-	6.18e-01	GO:0021915	neural tube development	BP
2	58	-0.0746291154535	-	6.98e-01	GO:0043087	regulation of GTPase activity	BP
2	58	-0.0746291154535	-	7.03e-01	GO:0042102	positive regulation of T cell proliferation	BP
1	29	-0.0746291154535	-	1.00e+00	GO:0006513	protein monoubiquitination	BP
1	29	-0.0746291154535	-	1.00e+00	GO:0006294	nucleotide-excision repair, preincision complex assembly	BP
2	58	-0.0746291154535	-	1.00e+00	GO:0010972	negative regulation of G2/M transition of mitotic cell cycle	BP
1	29	-0.0746291154535	-	1.00e+00	GO:0046627	negative regulation of insulin receptor signaling pathway	BP
1	29	-0.0746291154535	-	1.00e+00	GO:0090307	mitotic spindle assembly	BP
1	29	-0.0746291154535	-	4.26e-01	GO:0005184	neuropeptide hormone activity	MF
2	58	-0.0746291154535	-	6.79e-01	GO:0050660	flavin adenine dinucleotide binding	MF
1	29	-0.0746291154535	-	1.00e+00	GO:0004712	protein serine/threonine/tyrosine kinase activity	MF
2	59	-0.0992911696878	-	1.00e+00	GO:0031398	positive regulation of protein ubiquitination	BP
2	59	-0.0992911696878	-	1.00e+00	GO:0001933	negative regulation of protein phosphorylation	BP
6	179	-0.115501396869	-	8.24e-01	GO:0016055	Wnt signaling pathway	BP
7	210	-0.123538715934	-	5.12e-01	GO:0007268	chemical synaptic transmission	BP
1	30	-0.123538715934	-	5.40e-01	GO:0046676	negative regulation of insulin secretion	BP
1	30	-0.123538715934	-	5.89e-01	GO:0048873	homeostasis of number of cells within a tissue	BP
1	30	-0.123538715934	-	5.89e-01	GO:0099132	ATP hydrolysis coupled cation transmembrane transport	BP
1	30	-0.123538715934	-	6.18e-01	GO:2000379	positive regulation of reactive oxygen species metabolic process	BP
2	60	-0.123538715934	-	7.09e-01	GO:0051291	protein heterooligomerization	BP
1	30	-0.123538715934	-	1.00e+00	GO:0006362	transcription elongation from RNA polymerase I promoter	BP
1	30	-0.123538715934	-	1.00e+00	GO:0046326	positive regulation of glucose import	BP
1	30	-0.123538715934	-	1.00e+00	GO:0007052	mitotic spindle organization	BP
1	30	-0.123538715934	-	1.00e+00	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	BP
1	30	-0.123538715934	-	1.00e+00	GO:0007616	long-term memory	BP
1	30	-0.123538715934	-	1.00e+00	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	BP
2	60	-0.123538715934	-	6.98e-01	GO:0005518	collagen binding	MF
2	60	-0.123538715934	-	7.19e-01	GO:0048306	calcium-dependent protein binding	MF
1	30	-0.123538715934	-	1.00e+00	GO:0005164	tumor necrosis factor receptor binding	MF
1	30	-0.123538715934	-	1.00e+00	GO:0032266	phosphatidylinositol-3-phosphate binding	MF
1	30	-0.123538715934	-	1.00e+00	GO:0004714	transmembrane receptor protein tyrosine kinase activity	MF
3	90	-0.123538715934	-	1.00e+00	GO:0002020	protease binding	MF
6	181	-0.131531506688	-	4.70e-01	GO:0038095	Fc-epsilon receptor signaling pathway	BP
2	61	-0.147385457889	-	6.61e-01	GO:0006869	lipid transport	BP
12	366	-0.147385457889	-	6.36e-01	GO:0006954	inflammatory response	BP
5	153	-0.152107868131	-	1.00e+00	GO:0018108	peptidyl-tyrosine phosphorylation	BP
3	93	-0.170844430713	-	1.00e+00	GO:0060071	Wnt signaling pathway, planar cell polarity pathway	BP
1	31	-0.170844430713	-	5.89e-01	GO:0048565	digestive tract development	BP
1	31	-0.170844430713	-	6.04e-01	GO:0048286	lung alveolus development	BP
2	62	-0.170844430713	-	6.56e-01	GO:0007416	synapse assembly	BP
1	31	-0.170844430713	-	1.00e+00	GO:0006363	termination of RNA polymerase I transcription	BP
1	31	-0.170844430713	-	1.00e+00	GO:0043200	response to amino acid	BP
1	31	-0.170844430713	-	1.00e+00	GO:0031663	lipopolysaccharide-mediated signaling pathway	BP
1	31	-0.170844430713	-	1.00e+00	GO:0042220	response to cocaine	BP
1	31	-0.170844430713	-	1.00e+00	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	31	-0.170844430713	-	1.00e+00	GO:0006352	DNA-templated transcription, initiation	BP
2	62	-0.170844430713	-	1.00e+00	GO:0006302	double-strand break repair	BP
1	31	-0.170844430713	-	1.00e+00	GO:0021510	spinal cord development	BP
2	62	-0.170844430713	-	6.84e-01	GO:0008237	metallopeptidase activity	MF
1	31	-0.170844430713	-	1.00e+00	GO:0005158	insulin receptor binding	MF
14	435	-0.174164789004	-	1.00e+00	GO:0006468	protein phosphorylation	BP
17	529	-0.17630919119	-	1.00e+00	GO:0006915	apoptotic process	BP
5	157	-0.18934077433	-	1.15e-01	GO:0042742	defense response to bacterium	BP
2	63	-0.193928043826	-	6.52e-01	GO:0007586	digestion	BP
2	63	-0.193928043826	-	1.00e+00	GO:0006303	double-strand break repair via nonhomologous end joining	BP
13	410	-0.19568850169	-	1.00e+00	GO:0016567	protein ubiquitination	BP
4	127	-0.205332807098	-	7.81e-01	GO:0007204	positive regulation of cytosolic calcium ion concentration	BP
4	127	-0.205332807098	-	1.00e+00	GO:0001934	positive regulation of protein phosphorylation	BP
4	127	-0.205332807098	-	5.38e-01	GO:0020037	heme binding	MF
4	127	-0.205332807098	-	7.85e-01	GO:0008289	lipid binding	MF
1	32	-0.216648120326	-	5.73e-01	GO:0043588	skin development	BP
2	64	-0.216648120326	-	1.00e+00	GO:0008217	regulation of blood pressure	BP
1	32	-0.216648120326	-	1.00e+00	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	BP
1	32	-0.216648120326	-	1.00e+00	GO:0040018	positive regulation of multicellular organism growth	BP
1	32	-0.216648120326	-	1.00e+00	GO:0010507	negative regulation of autophagy	BP
1	32	-0.216648120326	-	1.00e+00	GO:0003091	renal water homeostasis	BP
1	32	-0.216648120326	-	1.00e+00	GO:0002755	MyD88-dependent toll-like receptor signaling pathway	BP
1	32	-0.216648120326	-	1.00e+00	GO:0000722	telomere maintenance via recombination	BP
1	32	-0.216648120326	-	1.00e+00	GO:0016791	phosphatase activity	MF
4	129	-0.227875375749	-	1.00e+00	GO:0042787	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
2	65	-0.239015933354	-	7.03e-01	GO:0030574	collagen catabolic process	BP
23	756	-0.25532858849	-	6.08e-01	GO:0042802	identical protein binding	MF
1	33	-0.261042239684	-	5.57e-01	GO:0006656	phosphatidylcholine biosynthetic process	BP
3	99	-0.261042239684	-	7.67e-01	GO:0016310	phosphorylation	BP
1	33	-0.261042239684	-	1.00e+00	GO:0006361	transcription initiation from RNA polymerase I promoter	BP
2	66	-0.261042239684	-	1.00e+00	GO:0072659	protein localization to plasma membrane	BP
1	33	-0.261042239684	-	1.00e+00	GO:0008219	cell death	BP
2	66	-0.261042239684	-	1.00e+00	GO:0030855	epithelial cell differentiation	BP
1	33	-0.261042239684	-	1.00e+00	GO:0042130	negative regulation of T cell proliferation	BP
1	33	-0.261042239684	-	1.00e+00	GO:0032480	negative regulation of type I interferon production	BP
1	33	-0.261042239684	-	1.00e+00	GO:0043491	protein kinase B signaling	BP
1	33	-0.261042239684	-	6.04e-01	GO:0016874	ligase activity	MF
1	33	-0.261042239684	-	6.18e-01	GO:0004866	endopeptidase inhibitor activity	MF
2	66	-0.261042239684	-	7.03e-01	GO:0003777	microtubule motor activity	MF
1	33	-0.261042239684	-	1.00e+00	GO:0051219	phosphoprotein binding	MF
3	100	-0.27554180938	-	1.00e+00	GO:0006979	response to oxidative stress	BP
3	100	-0.27554180938	-	7.70e-01	GO:0005178	integrin binding	MF
3	101	-0.289897102357	-	4.53e-01	GO:0007218	neuropeptide signaling pathway	BP
6	203	-0.29702153679	-	4.78e-01	GO:0050900	leukocyte migration	BP
1	34	-0.304110961576	-	6.04e-01	GO:0015276	ligand-gated ion channel activity	MF
2	68	-0.304110961576	-	6.93e-01	GO:0005262	calcium channel activity	MF
1	34	-0.304110961576	-	1.00e+00	GO:0048487	beta-tubulin binding	MF
1	34	-0.304110961576	-	1.00e+00	GO:0031624	ubiquitin conjugating enzyme binding	MF
4	138	-0.325172577104	-	1.00e+00	GO:0051015	actin filament binding	MF
3	104	-0.332125337746	-	1.00e+00	GO:0045471	response to ethanol	BP
42	1469	-0.344949378103	-	5.82e-01	GO:0005524	ATP binding	MF
1	35	-0.345931137271	-	5.89e-01	GO:0045494	photoreceptor cell maintenance	BP
2	70	-0.345931137271	-	6.61e-01	GO:0042391	regulation of membrane potential	BP
3	105	-0.345931137271	-	1.00e+00	GO:0006914	autophagy	BP
1	35	-0.345931137271	-	1.00e+00	GO:1901998	toxin transport	BP
1	35	-0.345931137271	-	1.00e+00	GO:0070534	protein K63-linked ubiquitination	BP
1	35	-0.345931137271	-	1.00e+00	GO:0019985	translesion synthesis	BP
1	35	-0.345931137271	-	1.00e+00	GO:0043407	negative regulation of MAP kinase activity	BP
2	70	-0.345931137271	-	1.00e+00	GO:0001558	regulation of cell growth	BP
2	71	-0.366395239831	-	1.00e+00	GO:0098869	cellular oxidant detoxification	BP
2	71	-0.366395239831	-	1.00e+00	GO:0007584	response to nutrient	BP
2	71	-0.366395239831	-	1.00e+00	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP
1	36	-0.386573121768	-	1.00e+00	GO:0045859	regulation of protein kinase activity	BP
1	36	-0.386573121768	-	1.00e+00	GO:0051402	neuron apoptotic process	BP
1	36	-0.386573121768	-	1.00e+00	GO:0032467	positive regulation of cytokinesis	BP
1	36	-0.386573121768	-	1.00e+00	GO:0030177	positive regulation of Wnt signaling pathway	BP
1	36	-0.386573121768	-	1.00e+00	GO:0042769	DNA damage response, detection of DNA damage	BP
1	36	-0.386573121768	-	1.00e+00	GO:0006479	protein methylation	BP
2	72	-0.386573121768	-	1.00e+00	GO:0031146	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	BP
1	36	-0.386573121768	-	1.00e+00	GO:0006605	protein targeting	BP
1	36	-0.386573121768	-	1.00e+00	GO:0015758	glucose transport	BP
1	36	-0.386573121768	-	1.00e+00	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	BP
1	36	-0.386573121768	-	1.00e+00	GO:0000723	telomere maintenance	BP
1	36	-0.386573121768	-	1.00e+00	GO:0032720	negative regulation of tumor necrosis factor production	BP
2	72	-0.386573121768	-	1.00e+00	GO:0051436	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
1	36	-0.386573121768	-	4.47e-01	GO:0004497	monooxygenase activity	MF
1	36	-0.386573121768	-	6.18e-01	GO:0008138	protein tyrosine/serine/threonine phosphatase activity	MF
1	36	-0.386573121768	-	1.00e+00	GO:0005547	phosphatidylinositol-3,4,5-trisphosphate binding	MF
3	110	-0.413045333129	-	1.00e+00	GO:0030168	platelet activation	BP
3	110	-0.413045333129	-	1.00e+00	GO:0006334	nucleosome assembly	BP
1	37	-0.426101485955	-	5.57e-01	GO:0009566	fertilization	BP
1	37	-0.426101485955	-	1.00e+00	GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	BP
1	37	-0.426101485955	-	1.00e+00	GO:0034446	substrate adhesion-dependent cell spreading	BP
1	37	-0.426101485955	-	1.00e+00	GO:0008202	steroid metabolic process	BP
1	37	-0.426101485955	-	1.00e+00	GO:0034332	adherens junction organization	BP
1	37	-0.426101485955	-	1.00e+00	GO:0001786	phosphatidylserine binding	MF
5	188	-0.449308877116	-	1.00e+00	GO:0030198	extracellular matrix organization	BP
1	38	-0.46457563377	-	1.00e+00	GO:0006289	nucleotide-excision repair	BP
1	38	-0.46457563377	-	1.00e+00	GO:0030049	muscle filament sliding	BP
2	76	-0.46457563377	-	1.00e+00	GO:1900034	regulation of cellular response to heat	BP
1	38	-0.46457563377	-	1.00e+00	GO:0009790	embryo development	BP
1	38	-0.46457563377	-	1.00e+00	GO:0045214	sarcomere organization	BP
2	76	-0.46457563377	-	1.00e+00	GO:0002479	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	BP
1	38	-0.46457563377	-	1.00e+00	GO:0033683	nucleotide-excision repair, DNA incision	BP
2	76	-0.46457563377	-	1.00e+00	GO:0008286	insulin receptor signaling pathway	BP
1	38	-0.46457563377	-	5.89e-01	GO:0004519	endonuclease activity	MF
2	76	-0.46457563377	-	1.00e+00	GO:0008233	peptidase activity	MF
2	77	-0.483434661021	-	1.00e+00	GO:0051437	positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition	BP
2	77	-0.483434661021	-	1.00e+00	GO:0004843	thiol-dependent ubiquitin-specific protease activity	MF
9	349	-0.493806345093	-	7.52e-01	GO:0005102	receptor binding	MF
1	39	-0.502050339188	-	5.73e-01	GO:0007631	feeding behavior	BP
6	234	-0.502050339188	-	5.87e-01	GO:0007067	mitotic nuclear division	BP
1	39	-0.502050339188	-	1.00e+00	GO:0071377	cellular response to glucagon stimulus	BP
1	39	-0.502050339188	-	1.00e+00	GO:0007190	activation of adenylate cyclase activity	BP
2	78	-0.502050339188	-	1.00e+00	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	BP
1	39	-0.502050339188	-	1.00e+00	GO:0090002	establishment of protein localization to plasma membrane	BP
1	39	-0.502050339188	-	1.00e+00	GO:0007162	negative regulation of cell adhesion	BP
1	39	-0.502050339188	-	1.00e+00	GO:0009411	response to UV	BP
1	39	-0.502050339188	-	1.00e+00	GO:0000413	protein peptidyl-prolyl isomerization	BP
1	39	-0.502050339188	-	1.00e+00	GO:0006695	cholesterol biosynthetic process	BP
1	39	-0.502050339188	-	1.00e+00	GO:0003755	peptidyl-prolyl cis-trans isomerase activity	MF
1	39	-0.502050339188	-	1.00e+00	GO:0015459	potassium channel regulator activity	MF
6	235	-0.50820256617	-	1.00e+00	GO:0007166	cell surface receptor signaling pathway	BP
5	198	-0.524076645518	-	6.89e-01	GO:0006281	DNA repair	BP
3	119	-0.526503382913	-	1.00e+00	GO:0006935	chemotaxis	BP
3	120	-0.538576215213	-	1.00e+00	GO:0044267	cellular protein metabolic process	BP
1	40	-0.538576215213	-	1.00e+00	GO:0045668	negative regulation of osteoblast differentiation	BP
2	80	-0.538576215213	-	1.00e+00	GO:0030307	positive regulation of cell growth	BP
1	40	-0.538576215213	-	1.00e+00	GO:0060291	long-term synaptic potentiation	BP
1	40	-0.538576215213	-	1.00e+00	GO:0051539	4 iron, 4 sulfur cluster binding	MF
2	81	-0.556498123211	-	6.79e-01	GO:0035725	sodium ion transmembrane transport	BP
2	81	-0.556498123211	-	1.00e+00	GO:0031145	anaphase-promoting complex-dependent catabolic process	BP
2	81	-0.556498123211	-	1.00e+00	GO:0007626	locomotory behavior	BP
2	81	-0.556498123211	-	1.00e+00	GO:0006890	retrograde vesicle-mediated transport, Golgi to ER	BP
5	204	-0.56714536741	-	6.29e-01	GO:0006898	receptor-mediated endocytosis	BP
1	41	-0.574200124944	-	5.89e-01	GO:0006024	glycosaminoglycan biosynthetic process	BP
4	164	-0.574200124944	-	8.21e-01	GO:0060271	cilium assembly	BP
7	287	-0.574200124944	-	1.00e+00	GO:0006810	transport	BP
2	83	-0.591687551673	-	1.00e+00	GO:0006928	movement of cell or subcellular component	BP
3	126	-0.608965543105	-	8.01e-01	GO:0002576	platelet degranulation	BP
1	42	-0.608965543105	-	1.00e+00	GO:0034080	CENP-A containing nucleosome assembly	BP
1	42	-0.608965543105	-	1.00e+00	GO:0046426	negative regulation of JAK-STAT cascade	BP
7	295	-0.613864342518	-	1.00e+00	GO:0007267	cell-cell signaling	BP
3	127	-0.620370306377	-	1.00e+00	GO:0019221	cytokine-mediated signaling pathway	BP
9	382	-0.624151946919	-	4.57e-01	GO:0035556	intracellular signal transduction	BP
32	1364	-0.63027604935	-	2.26e-02	GO:0003723	RNA binding	MF
1	43	-0.642912875028	-	1.00e+00	GO:0032880	regulation of protein localization	BP
1	43	-0.642912875028	-	1.00e+00	GO:0034260	negative regulation of GTPase activity	BP
1	43	-0.642912875028	-	1.00e+00	GO:0006635	fatty acid beta-oxidation	BP
1	43	-0.642912875028	-	1.00e+00	GO:0051496	positive regulation of stress fiber assembly	BP
1	43	-0.642912875028	-	1.00e+00	GO:0032755	positive regulation of interleukin-6 production	BP
4	174	-0.659591616175	-	8.23e-01	GO:0051260	protein homooligomerization	BP
1	44	-0.676079738963	-	1.00e+00	GO:0007193	adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway	BP
1	44	-0.676079738963	-	1.00e+00	GO:0035338	long-chain fatty-acyl-CoA biosynthetic process	BP
1	44	-0.676079738963	-	1.00e+00	GO:0002224	toll-like receptor signaling pathway	BP
1	44	-0.676079738963	-	1.00e+00	GO:0007077	mitotic nuclear envelope disassembly	BP
1	44	-0.676079738963	-	1.00e+00	GO:0042552	myelination	BP
1	44	-0.676079738963	-	1.00e+00	GO:0032729	positive regulation of interferon-gamma production	BP
1	44	-0.676079738963	-	1.00e+00	GO:0032147	activation of protein kinase activity	BP
1	44	-0.676079738963	-	1.00e+00	GO:0030276	clathrin binding	MF
1	44	-0.676079738963	-	1.00e+00	GO:0000149	SNARE binding	MF
2	89	-0.692381551292	-	2.70e-01	GO:0006956	complement activation	BP
9	402	-0.697774810063	-	1.00e+00	GO:0006955	immune response	BP
4	180	-0.708501216656	-	5.74e-01	GO:0050776	regulation of immune response	BP
1	45	-0.708501216656	-	1.00e+00	GO:0007157	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	BP
1	45	-0.708501216656	-	1.00e+00	GO:0006909	phagocytosis	BP
3	135	-0.708501216656	-	1.00e+00	GO:0005975	carbohydrate metabolic process	BP
1	45	-0.708501216656	-	1.00e+00	GO:0000186	activation of MAPKK activity	BP
1	45	-0.708501216656	-	1.00e+00	GO:0007187	G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	BP
1	45	-0.708501216656	-	2.83e-01	GO:0034987	immunoglobulin receptor binding	MF
1	45	-0.708501216656	-	1.00e+00	GO:0019902	phosphatase binding	MF
1	45	-0.708501216656	-	1.00e+00	GO:0008047	enzyme activator activity	MF
13	587	-0.713425095295	-	6.89e-01	GO:0055114	oxidation-reduction process	BP
3	136	-0.719148460855	-	6.32e-01	GO:0008360	regulation of cell shape	BP
3	137	-0.729717702565	-	1.00e+00	GO:0005506	iron ion binding	MF
2	92	-0.740210076383	-	7.72e-01	GO:0019886	antigen processing and presentation of exogenous peptide antigen via MHC class II	BP
1	46	-0.740210076383	-	1.00e+00	GO:0032956	regulation of actin cytoskeleton organization	BP
1	46	-0.740210076383	-	1.00e+00	GO:0008307	structural constituent of muscle	MF
4	187	-0.763542580214	-	5.31e-01	GO:0000287	magnesium ion binding	MF
1	47	-0.771236972004	-	1.00e+00	GO:0061077	chaperone-mediated protein folding	BP
1	47	-0.771236972004	-	1.00e+00	GO:0051781	positive regulation of cell division	BP
3	141	-0.771236972004	-	1.00e+00	GO:0005215	transporter activity	MF
2	95	-0.786503728657	-	1.00e+00	GO:0004867	serine-type endopeptidase inhibitor activity	MF
7	333	-0.78867156534	-	2.21e-01	GO:0051301	cell division	BP
2	96	-0.801610621047	-	7.71e-01	GO:0006936	muscle contraction	BP
1	48	-0.801610621047	-	1.00e+00	GO:0006687	glycosphingolipid metabolic process	BP
1	48	-0.801610621047	-	1.00e+00	GO:0010977	negative regulation of neuron projection development	BP
3	146	-0.821510178485	-	6.32e-01	GO:0016887	ATPase activity	MF
1	49	-0.831357964441	-	1.00e+00	GO:0065009	regulation of molecular function	BP
1	49	-0.831357964441	-	1.00e+00	GO:0007266	Rho protein signal transduction	BP
1	49	-0.831357964441	-	1.00e+00	GO:0010212	response to ionizing radiation	BP
1	49	-0.831357964441	-	1.00e+00	GO:0006606	protein import into nucleus	BP
5	247	-0.843087257023	-	1.00e+00	GO:0055085	transmembrane transport	BP
4	199	-0.85327274087	-	4.23e-01	GO:0007049	cell cycle	BP
1	50	-0.860504310101	-	1.00e+00	GO:0007269	neurotransmitter secretion	BP
1	50	-0.860504310101	-	1.00e+00	GO:0006644	phospholipid metabolic process	BP
1	50	-0.860504310101	-	1.00e+00	GO:0008092	cytoskeletal protein binding	MF
3	151	-0.87009035893	-	8.01e-01	GO:0008201	heparin binding	MF
1	51	-0.889073462297	-	1.00e+00	GO:0060326	cell chemotaxis	BP
1	51	-0.889073462297	-	1.00e+00	GO:0075733	intracellular transport of virus	BP
6	310	-0.907810024879	-	2.51e-01	GO:0000166	nucleotide binding	MF
1	52	-0.917087838467	-	1.00e+00	GO:0006521	regulation of cellular amino acid metabolic process	BP
1	52	-0.917087838467	-	1.00e+00	GO:0030170	pyridoxal phosphate binding	MF
3	157	-0.926306368496	-	6.33e-01	GO:0006511	ubiquitin-dependent protein catabolic process	BP
1	53	-0.944568574889	-	1.00e+00	GO:0019233	sensory perception of pain	BP
2	107	-0.958115106727	-	5.91e-01	GO:0000187	activation of MAPK activity	BP
1	54	-0.971535622489	-	1.00e+00	GO:0016049	cell growth	BP
3	162	-0.971535622489	-	6.32e-01	GO:0008083	growth factor activity	MF
1	54	-0.971535622489	-	1.00e+00	GO:0004860	protein kinase inhibitor activity	MF
1	54	-0.971535622489	-	1.00e+00	GO:0008168	methyltransferase activity	MF
5	273	-0.987477166358	-	2.92e-01	GO:0003779	actin binding	MF
1	55	-0.998007833851	-	1.00e+00	GO:0045727	positive regulation of translation	BP
2	111	-1.01106398668	-	5.89e-01	GO:0048015	phosphatidylinositol-mediated signaling	BP
1	56	-1.02400304238	-	1.00e+00	GO:0051259	protein oligomerization	BP
1	56	-1.02400304238	-	1.00e+00	GO:0032981	mitochondrial respiratory chain complex I assembly	BP
1	56	-1.02400304238	-	1.00e+00	GO:0006950	response to stress	BP
1	56	-1.02400304238	-	1.00e+00	GO:0003725	double-stranded RNA binding	MF
1	56	-1.02400304238	-	1.00e+00	GO:0042277	peptide binding	MF
1	57	-1.04953813449	-	7.24e-01	GO:0005070	SH3/SH2 adaptor activity	MF
1	57	-1.04953813449	-	1.00e+00	GO:0001664	G-protein coupled receptor binding	MF
2	115	-1.06213817127	-	4.47e-01	GO:0000184	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	BP
1	58	-1.07462911545	-	1.00e+00	GO:0005546	phosphatidylinositol-4,5-bisphosphate binding	MF
1	58	-1.07462911545	-	1.00e+00	GO:0050839	cell adhesion molecule binding	MF
2	118	-1.09929116969	-	5.96e-01	GO:0005088	Ras guanyl-nucleotide exchange factor activity	MF
1	59	-1.09929116969	-	7.24e-01	GO:0001948	glycoprotein binding	MF
2	120	-1.12353871593	-	3.38e-01	GO:0006958	complement activation, classical pathway	BP
2	120	-1.12353871593	-	5.96e-01	GO:0030036	actin cytoskeleton organization	BP
1	60	-1.12353871593	-	7.24e-01	GO:0009967	positive regulation of signal transduction	BP
1	61	-1.14738545789	-	7.24e-01	GO:0006006	glucose metabolic process	BP
1	61	-1.14738545789	-	1.00e+00	GO:0007613	memory	BP
1	61	-1.14738545789	-	1.00e+00	GO:0050896	response to stimulus	BP
2	123	-1.15916262567	-	7.71e-01	GO:0070588	calcium ion transmembrane transport	BP
4	247	-1.16501535191	-	1.00e+00	GO:0004252	serine-type endopeptidase activity	MF
1	62	-1.17084443071	-	7.25e-01	GO:0030433	ubiquitin-dependent ERAD pathway	BP
1	62	-1.17084443071	-	1.00e+00	GO:0030593	neutrophil chemotaxis	BP
1	63	-1.19392804383	-	7.27e-01	GO:0016197	endosomal transport	BP
1	63	-1.19392804383	-	1.00e+00	GO:0016740	transferase activity	MF
1	64	-1.21664812033	-	7.28e-01	GO:0000226	microtubule cytoskeleton organization	BP
1	64	-1.21664812033	-	1.00e+00	GO:0008236	serine-type peptidase activity	MF
1	65	-1.23901593335	-	7.25e-01	GO:0007015	actin filament organization	BP
1	65	-1.23901593335	-	7.25e-01	GO:0050790	regulation of catalytic activity	BP
2	130	-1.23901593335	-	1.00e+00	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	BP
1	65	-1.23901593335	-	1.00e+00	GO:0050830	defense response to Gram-positive bacterium	BP
2	131	-1.25007112186	-	3.38e-01	GO:0000086	G2/M transition of mitotic cell cycle	BP
2	132	-1.26104223968	-	2.45e-01	GO:0006413	translational initiation	BP
1	66	-1.26104223968	-	7.27e-01	GO:0006396	RNA processing	BP
1	66	-1.26104223968	-	7.25e-01	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	MF
2	134	-1.28273731078	-	7.75e-01	GO:0010951	negative regulation of endopeptidase activity	BP
1	67	-1.28273731078	-	7.26e-01	GO:0001618	virus receptor activity	MF
5	337	-1.29132480662	-	8.14e-02	GO:0004842	ubiquitin-protein transferase activity	MF
3	203	-1.29702153679	-	4.99e-01	GO:0034220	ion transmembrane transport	BP
1	68	-1.30411096158	-	7.31e-01	GO:0008565	protein transporter activity	MF
1	69	-1.3251725771	-	5.21e-01	GO:0007265	Ras protein signal transduction	BP
3	207	-1.3251725771	-	2.23e-01	GO:0008017	microtubule binding	MF
1	69	-1.3251725771	-	5.21e-01	GO:0043130	ubiquitin binding	MF
4	286	-1.3765194571	-	5.08e-02	GO:0045296	cadherin binding	MF
1	72	-1.38657312177	-	7.28e-01	GO:0006661	phosphatidylinositol biosynthetic process	BP
1	72	-1.38657312177	-	1.00e+00	GO:0050853	B cell receptor signaling pathway	BP
3	217	-1.39323685205	-	1.27e-01	GO:0000209	protein polyubiquitination	BP
1	74	-1.42610148595	-	7.26e-01	GO:0022617	extracellular matrix disassembly	BP
1	74	-1.42610148595	-	7.24e-01	GO:0005089	Rho guanyl-nucleotide exchange factor activity	MF
1	74	-1.42610148595	-	7.33e-01	GO:0035091	phosphatidylinositol binding	MF
1	75	-1.44546681082	-	7.28e-01	GO:0043086	negative regulation of catalytic activity	BP
6	456	-1.46457563377	-	9.58e-02	GO:0007155	cell adhesion	BP
1	76	-1.46457563377	-	5.22e-01	GO:0007030	Golgi organization	BP
1	76	-1.46457563377	-	7.30e-01	GO:0007018	microtubule-based movement	BP
3	230	-1.47717567055	-	9.41e-02	GO:0061024	membrane organization	BP
1	77	-1.48343466102	-	7.24e-01	GO:0007286	spermatid development	BP
9	694	-1.48551497146	-	5.52e-02	GO:0005509	calcium ion binding	MF
2	156	-1.50205033919	-	1.50e-01	GO:0007608	sensory perception of smell	BP
2	156	-1.50205033919	-	2.47e-01	GO:0007010	cytoskeleton organization	BP
1	78	-1.50205033919	-	5.22e-01	GO:0000724	double-strand break repair via homologous recombination	BP
1	78	-1.50205033919	-	5.22e-01	GO:0046718	viral entry into host cell	BP
1	78	-1.50205033919	-	7.25e-01	GO:0035023	regulation of Rho protein signal transduction	BP
6	481	-1.54157870337	-	1.48e-02	GO:0043312	neutrophil degranulation	BP
7	571	-1.56664013363	-	4.49e-03	GO:0043547	positive regulation of GTPase activity	BP
1	82	-1.57420012494	-	5.26e-01	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	BP
1	82	-1.57420012494	-	5.31e-01	GO:0008543	fibroblast growth factor receptor signaling pathway	BP
2	165	-1.58297033457	-	1.81e-01	GO:0006457	protein folding	BP
2	165	-1.58297033457	-	1.86e-01	GO:0008380	RNA splicing	BP
6	497	-1.58878766117	-	1.99e-01	GO:0006508	proteolysis	BP
1	85	-1.62603905646	-	3.73e-01	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	BP
1	85	-1.62603905646	-	7.30e-01	GO:1903955	positive regulation of protein targeting to mitochondrion	BP
1	85	-1.62603905646	-	1.00e+00	GO:0006486	protein glycosylation	BP
1	86	-1.64291287503	-	3.74e-01	GO:0048013	ephrin receptor signaling pathway	BP
1	86	-1.64291287503	-	1.00e+00	GO:0016787	hydrolase activity	MF
2	173	-1.65127634796	-	4.51e-01	GO:0005125	cytokine activity	MF
2	174	-1.65959161617	-	1.32e-01	GO:0006412	translation	BP
1	87	-1.65959161617	-	3.73e-01	GO:0070126	mitochondrial translational termination	BP
1	88	-1.67607973896	-	5.21e-01	GO:0016311	dephosphorylation	BP
1	89	-1.69238155129	-	3.75e-01	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	BP
1	89	-1.69238155129	-	3.73e-01	GO:0004725	protein tyrosine phosphatase activity	MF
2	178	-1.69238155129	-	4.45e-01	GO:0030246	carbohydrate binding	MF
1	90	-1.70850121666	-	3.72e-01	GO:0010976	positive regulation of neuron projection development	BP
1	93	-1.75580693143	-	5.34e-01	GO:0006464	cellular protein modification process	BP
1	94	-1.771236972	-	2.65e-01	GO:0006368	transcription elongation from RNA polymerase II promoter	BP
1	94	-1.771236972	-	7.24e-01	GO:0005179	hormone activity	MF
1	96	-1.80161062105	-	5.21e-01	GO:0016491	oxidoreductase activity	MF
1	99	-1.84600474041	-	2.69e-01	GO:0016236	macroautophagy	BP
1	99	-1.84600474041	-	3.73e-01	GO:0006469	negative regulation of protein kinase activity	BP
1	99	-1.84600474041	-	3.76e-01	GO:0046854	phosphatidylinositol phosphorylation	BP
1	99	-1.84600474041	-	3.83e-01	GO:0035335	peptidyl-tyrosine dephosphorylation	BP
2	201	-1.8676998115	-	7.72e-01	GO:0004888	transmembrane signaling receptor activity	MF
1	101	-1.87485960308	-	2.70e-01	GO:0007062	sister chromatid cohesion	BP
2	212	-1.94456857489	-	5.04e-02	GO:0006886	intracellular protein transport	BP
2	212	-1.94456857489	-	1.86e-01	GO:0005198	structural molecule activity	MF
2	224	-2.02400304238	-	3.64e-02	GO:0003924	GTPase activity	MF
1	113	-2.03682708274	-	2.73e-01	GO:0051082	unfolded protein binding	MF
1	115	-2.06213817127	-	5.26e-01	GO:0004222	metalloendopeptidase activity	MF
1	116	-2.07462911545	-	5.31e-01	GO:0034765	regulation of ion transmembrane transport	BP
1	120	-2.12353871593	-	1.97e-01	GO:0017124	SH3 domain binding	MF
3	370	-2.16306708012	-	5.53e-03	GO:0005525	GTP binding	MF
1	124	-2.17084443071	-	1.37e-01	GO:0042393	histone binding	MF
1	125	-2.18243240499	-	1.97e-01	GO:0006470	protein dephosphorylation	BP
1	128	-2.21664812033	-	5.31e-01	GO:0071805	potassium ion transmembrane transport	BP
2	281	-2.35107444055	-	1.87e-02	GO:0005096	GTPase activator activity	MF
1	141	-2.35619947272	-	1.34e-01	GO:0051056	regulation of small GTPase mediated signal transduction	BP
1	156	-2.50205033919	-	3.72e-01	GO:0007156	homophilic cell adhesion via plasma membrane adhesion molecules	BP
4	655	-2.57199921675	-	7.93e-01	GO:0004930	G-protein coupled receptor activity	MF
2	350	-2.66785923216	-	1.68e-03	GO:0015031	protein transport	BP
1	201	-2.8676998115	-	1.09e-02	GO:0006364	rRNA processing	BP
1	215	-2.96484096992	-	1.58e-02	GO:0007264	small GTPase mediated signal transduction	BP
4	861	-2.96651754772	-	4.95e-02	GO:0007186	G-protein coupled receptor signaling pathway	BP
1	237	-3.10539136922	-	3.70e-03	GO:0000398	mRNA splicing, via spliceosome	BP
